Processing 00000000.tx.1: Primitive erythropoiesis in the Xenopus embryo: the synergistic role of LMO-2, SCL and GATA-binding proteins

Phrase: "Primitive erythropoiesis in the Xenopus embryo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2610445:primitive erythropoiesis [Cell Function]
   753   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]

Phrase: ":"

Phrase: "the synergistic role of LMO-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-binding proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C1333662:Gata-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.1: Paul E. 

Phrase: "Paul E."
Processing 00000000.tx.2: Mead1,*,  Anne E. 

Phrase: "Mead1,"

Phrase: "*,"

Phrase: "Anne E."
Processing 00000000.tx.3: Deconinck1,2,  Tara L. 

Phrase: "Deconinck1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "Tara L."
Processing 00000000.tx.4: Huber1,  Stuart H. 

Phrase: "Huber1,"

Phrase: "Stuart H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.5: Orkin1,2 and  Leonard I. 

Phrase: "Orkin1,"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "Leonard I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.6: Zon1,2,

Phrase: "Zon1,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.1: 1 Division of Hematology/Oncology, Department of Pediatrics, Harvard Medical School,

Phrase: "1 Division of Hematology/Oncology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1293097:Division [Therapeutic or Preventive Procedure]
   760   C2919030:Division [Organization]
   760   C2919031:Division [Activity]

Phrase: "Department of Pediatrics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587482:department pediatrics [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Harvard Medical School,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0036378:School, Medical [Health Care Related Organization,Manufactured Object]
   827   C0036375:School [Manufactured Object,Organization]
Processing 00000000.tx.1: 2 Howard Hughes Medical Institute, Childrens Hospital, 300 Longwood Ave, Boston, MA 02115, USA

Phrase: "2 Howard Hughes Medical Institute,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0021622:institute [Organization]
   804   C0205476:Medical [Functional Concept]
   804   C1272753:Institute [Idea or Concept]
   804   C1551730:Hughes [Population Group]

Phrase: "Childrens Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "300 Longwood Ave,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02115,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.1: * Present address: Department of Pathology, D4047C, St. 

Phrase: "* Present address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0376649:Address [Intellectual Product]
   861   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Department of Pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587487:Pathology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "D4047C,"

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.2: Jude Childrens Research Hospital, Memphis, TN 38103, USA

Phrase: "Jude Childrens"

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
  1000   C1510665:Hospital [Qualitative Concept]
   916 E C1609061:Hospitals [Intellectual Product]

Phrase: "Memphis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1061320:Memphis [Eukaryote]

Phrase: "TN 38103,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]
Processing 00000000.tx.1: Author for correspondence (e-mail: zon{at}rascal.med.harvard.edu)

Phrase: "Author for correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0221193:Author [Professional or Occupational Group]

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "zon{at}rascal.med.harvard.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: ")"
Processing 00000000.tx.1: Accepted March 26, 2001

Phrase: "Accepted March 26,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2001"
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Hematopoietic stem cells are derived from ventral mesoderm during vertebrate development. 

Phrase: "Hematopoietic stem cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0018956:Hematopoietic stem cells [Cell]
   901   C0038250:Stem cells [Cell]
   896   C2323499:Hematopoietic cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0018957:Haematopoietic [Body System]
   827   C0229601:Hematopoietic [Functional Concept]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: "are"

Phrase: "derived from ventral mesoderm"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025485:Mesoderm [Embryonic Structure]
   770   C1441547:Derived [Qualitative Concept]
   770   C1704448:Ventral [Spatial Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "during vertebrate development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.2: Gene targeting experiments in the mouse have demonstrated key roles for the basic helix-loop-helix transcription factor SCL and the GATA-binding protein GATA-1 in hematopoiesis. 

Phrase: "Gene targeting experiments in the mouse"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "have"

Phrase: "demonstrated key roles for the basic helix-loop-helix transcription factor SCL"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   736   C0035820:Roles [Social Behavior]
   703 E C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "the GATA-binding protein GATA-1 in hematopoiesis."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   822   C1333663:GATA-BINDING PROTEIN 1 [Gene or Genome]
           GATA-1
   822   C1530719:GATA Binding Protein 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           GATA-1
   800   C1333662:Gata-Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767 E C0033618:Protein Binding [Molecular Function]
   744   C0018951:Haematopoiesis [Organ or Tissue Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1427248:GatA [Gene or Genome]
Processing 00000000.tx.3: When overexpressed in Xenopus animal cap explants, SCL and GATA-1 are each capable of specifying mesoderm to become blood. 

Phrase: "When"

Phrase: "overexpressed in Xenopus animal cap explants,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1510894:Animal Cap [Embryonic Structure]
   753   C0003062:Animal [Animal]
   753   C0043342:Xenopus [Amphibian]
   753   C0043343:Xenopus [Amphibian]
   753   C0179586:Cap [Manufactured Object]
   753   C1504663:Xenopus [Amphibian]
   753   C1657858:CAP [Medical Device]
   753   C1706092:Cap [Medical Device]
   719   C1514559:overexpress [Genetic Function]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "are"

Phrase: "each capable of specifying mesoderm to"

Phrase: "become"

Phrase: "blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.4: Forced expression of either factor in whole embryos, however, does not lead to ectopic blood formation. 

Phrase: "Forced expression of either factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in whole embryos,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013935:Embryos [Embryonic Structure]
   827 E C1305370:Embryo [Embryonic Structure]

Phrase: "however,"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "lead to ectopic blood formation."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   797   C0853362:blood lead [Laboratory Procedure]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0220781:formation [Biologic Function]
   760   C0229664:Blood [Body Substance]
   760   C0439634:formation [Spatial Concept]
   760   C0574895:Ectopic [Spatial Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522492:Formation [Functional Concept]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.5: This apparent paradox between animal cap assays and whole embryo phenotype has led to the hypothesis that additional factors are involved in specifying hematopoietic mesoderm. 

Phrase: "This apparent paradox between animal cap assays"

Phrase: "and"

Phrase: "whole embryo phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031437:Phenotype [Organism Attribute]
   827   C1285572:Phenotype [Laboratory Procedure]

Phrase: "has"

Phrase: "led to the hypothesis"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C1512571:Hypothesis [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that additional factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "involved in specifying hematopoietic mesoderm."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0018957:Haematopoietic [Body System]
   760   C0025485:Mesoderm [Embryonic Structure]
   760   C0229601:Hematopoietic [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   726   C1521902:Specify [Qualitative Concept]
Processing 00000000.tx.6: SCL and GATA-1 interact in a transcriptional complex with the LIM domain protein LMO-2. 

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "interact in a transcriptional complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040649:Transcriptional [Genetic Function]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with the LIM domain protein LMO-2."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C1334343:LIM Domain Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1517692:LIM Domain [Amino Acid Sequence]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0449205:LIM [Body Location or Region]
   804   C1538613:LIM [Gene or Genome]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.7: We have cloned the Xenopus homolog of LMO-2 and show that it is expressed in a similar pattern to SCL during development. 

Phrase: "We"

Phrase: "have"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "the Xenopus homolog of LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homolog [Gene or Genome]

Phrase: "and"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "expressed in a similar pattern"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449774:Pattern [Spatial Concept]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "to SCL"

Phrase: "during development."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.8: LMO-2 can specify hematopoietic mesoderm in animal cap assays. 

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "specify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521902:Specify [Qualitative Concept]

Phrase: "hematopoietic mesoderm in animal cap assays."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0025485:Mesoderm [Embryonic Structure]
Processing 00000000.tx.9: SCL and LMO-2 act synergistically to expand the blood island when overexpressed in whole embryos. 

Phrase: "SCL"

Phrase: "and"

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "synergistically to"

Phrase: "expand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expand [Spatial Concept]

Phrase: "the blood island"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C1511224:Blood Island [Embryonic Structure]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0022130:Island [Geographic Area]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "when"

Phrase: "overexpressed in whole embryos."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0013935:Embryos [Embryonic Structure]
   770   C0444667:Whole [Quantitative Concept]
   737 E C1305370:Embryo [Embryonic Structure]
   737   C1514559:overexpress [Genetic Function]
Processing 00000000.tx.10: Furthermore, co-expression of GATA-1 with SCL and LMO-2 leads to embryos that are ventralized and have blood throughout the dorsal-ventral axis. 

Phrase: "Furthermore,"

Phrase: "co-expression of GATA-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "with SCL"

Phrase: "and"

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "leads to embryos"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0013935:Embryos [Embryonic Structure]
   790   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   790   C0181586:leads [Medical Device]
   790   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   790   C1522538:Lead [Functional Concept]
   790   C2348269:Lead [Element, Ion, or Isotope]
   790   C3275067:LEAD [Therapeutic or Preventive Procedure]
   756 E C1305370:Embryo [Embryonic Structure]

Phrase: "that"

Phrase: "are"

Phrase: "ventralized"

Phrase: "and"

Phrase: "have"

Phrase: "blood throughout the dorsal-ventral axis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0229664:Blood [Body Substance]
Processing 00000000.tx.11: The synergistic effect of SCL, LMO-2 and GATA-1, taken together with the findings that these factors can form a complex in vitro, suggests that this complex specifies mesoderm to become blood during embryogenesis.

Phrase: "The synergistic effect of SCL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
   760   C2986495:Synergistic [Qualitative Concept]

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GATA-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "taken together with the findings"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C1883357:Together [Qualitative Concept]
   760   C1883727:Taken [Conceptual Entity]
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C1515187:Take [Health Care Activity]
   726 E C2825141:Finding [Finding]

Phrase: "that"

Phrase: "these factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "can"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a complex in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "specifies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521902:Specify [Qualitative Concept]

Phrase: "mesoderm to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025485:Mesoderm [Embryonic Structure]
   789 E C0521459:Mesodermal [Body Location or Region]

Phrase: "become"

Phrase: "blood during embryogenesis."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0005767:Blood [Tissue]
   790   C0005768:blood [Body Substance]
   790   C0229664:Blood [Body Substance]
   718 E C0333275:Bloody [Qualitative Concept]
   706 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   706 E C0392895:Bloods [Population Group]
   706 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   706 E C1511228:VESSEL, BLOOD [Tissue]
Processing 00000000.tx.1: Key words: Xenopus, LMO-2, SCL, GATA-binding factors, Hematopoiesis

Phrase: "Key words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "Xenopus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043342:Xenopus [Amphibian]
  1000   C0043343:Xenopus [Amphibian]
  1000   C1504663:Xenopus [Amphibian]

Phrase: "LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SCL,"

Phrase: "GATA-binding factors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1564871:GATA Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "Hematopoiesis"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0018951:Haematopoiesis [Organ or Tissue Function]
   928 E C0018957:Haematopoietic [Body System]
   928 E C0229601:Hematopoietic [Functional Concept]
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Blood cells are derived from ventral mesoderm early in embryonic development (Zon, 1995). 

Phrase: "Blood cells"
Meta Candidates (Total=17; Excluded=11; Pruned=0; Remaining=6)
  1000   C0005773:Blood Cells [Cell]
   955 E C2328697:Hemal cell [Cell]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0007634:Cells [Cell]
   861   C0229664:Blood [Body Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "are"

Phrase: "derived from ventral mesoderm early"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0025485:Mesoderm [Embryonic Structure]
   760   C1279919:Early [Temporal Concept]
   760   C1441547:Derived [Qualitative Concept]
   760   C1704448:Ventral [Spatial Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "in embryonic development"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0013936:Embryonic Development [Organ or Tissue Function]
  1000   C0243100:embryonic development [Functional Concept]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "(Zon,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.2: Like other mesoderm derivatives, the formation of blood cells can be traced back to early cleavage stages where inductive interactions give rise to the mesodermal germ layer. 

Phrase: "Like other mesoderm derivatives,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0243072:derivatives [Chemical Viewed Structurally]
   827 E C1527240:Derivative [Functional Concept]

Phrase: "the formation of blood cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0018951:blood cell formation [Organ or Tissue Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "traced"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "back to early cleavage stages where inductive interactions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004600:Back [Body Location or Region]
   744   C0205095:Back [Spatial Concept]
   744   C0460009:Back [Body Location or Region]
   744   C1995000:Back [Body Location or Region]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to the mesodermal germ layer."
Processing 00000000.tx.3: Patterning and specification events occur that limit the potential of the nascent mesoderm. 

Phrase: "Patterning"

Phrase: "and"

Phrase: "specification events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "that"

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "the potential of the nascent mesoderm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.4: These temporal and spatial signals direct the formation of hematopoietic stem cells (HSCs) that give rise, through proliferation and differentiation, to all of the blood cells in the body. 

Phrase: "These temporal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442043:Temporal [Spatial Concept]
  1000   C2362314:Temporal [Temporal Concept]

Phrase: "and"

Phrase: "spatial signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "the formation of hematopoietic stem cells (HSCs)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "that"

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise,"

Phrase: "through proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "to all"

Phrase: "of the blood cells"
Meta Candidates (Total=17; Excluded=11; Pruned=0; Remaining=6)
  1000   C0005773:Blood Cells [Cell]
   955 E C2328697:Hemal cell [Cell]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0007634:Cells [Cell]
   861   C0229664:Blood [Body Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "in the body."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242821:body [Human]
  1000   C0460148:Body [Anatomical Structure]
  1000   C1268086:Body [Anatomical Structure]
   916 E C1995017:Bodies [Cell Component]
Processing 00000000.tx.5: Vertebrate blood cell formation occurs in two successive waves, termed primitive and definitive hematopoiesis. 

Phrase: "Vertebrate blood cell formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0018951:blood cell formation [Organ or Tissue Function]
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "occurs in two successive waves,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0205448:Two [Quantitative Concept]
   760   C0678544:waves [Natural Phenomenon or Process]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726 E C1421479:WAVE [Gene or Genome]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "primitive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3645627:Primitive [Intellectual Product]

Phrase: "and"

Phrase: "definitive hematopoiesis."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C2262993:definitive haematopoiesis [Cell Function]
   861   C0018951:Haematopoiesis [Organ or Tissue Function]
   789 E C0018957:Haematopoietic [Body System]
   789 E C0229601:Hematopoietic [Functional Concept]
Processing 00000000.tx.6: The first, primitive hematopoiesis, gives rise to predominantly erythrocytes (primitive red blood cells) that are biochemically and morphologically distinct from definitive red blood cells. 

Phrase: "The first,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "primitive hematopoiesis,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C2262992:primitive haematopoiesis [Organ or Tissue Function]
   861   C0018951:Haematopoiesis [Organ or Tissue Function]
   789 E C0018957:Haematopoietic [Body System]
   789 E C0229601:Hematopoietic [Functional Concept]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise"

Phrase: "to predominantly erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014772:Erythrocytes [Laboratory Procedure]
   827   C0014792:Erythrocytes [Cell]

Phrase: "(primitive red blood cells"
Meta Candidates (Total=25; Excluded=11; Pruned=0; Remaining=14)
   923   C0014772:Red Blood Cells [Laboratory Procedure]
   923   C0014792:Red Blood Cells [Cell]
           Red cells
   923   C0439179:% red blood cells [Quantitative Concept]
   923   C1277078:Red blood cells [Pharmacologic Substance]
   886   C0872362:primitive cell [Cell]
   861   C0005773:Blood Cells [Cell]
   816 E C2328697:Hemal cell [Cell]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0007634:Cells [Cell]
   812   C0229664:Blood [Body Substance]
   812   C0332575:Red [Finding]
   812   C1260956:Red [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: ")"

Phrase: "that"

Phrase: "are"

Phrase: "biochemically"

Phrase: "and"

Phrase: "morphologically distinct from definitive red blood cells."
Processing 00000000.tx.7: All primitive erythrocytes are nucleated and express embryonic globin chains, while definitive erythrocytes from higher vertebrates are enucleated and express adult globin chains. 

Phrase: "All primitive erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014772:Erythrocytes [Laboratory Procedure]
   861   C0014792:Erythrocytes [Cell]

Phrase: "are"

Phrase: "nucleated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979936:Nucleated [Qualitative Concept]

Phrase: "and"

Phrase: "express"

Phrase: "embryonic globin chains,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   867   C0443781:Globin chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0337112:chains [Manufactured Object]
   827   C1149093:globin [Molecular Function]
   827   C1524075:Chains [Idea or Concept]

Phrase: "while"

Phrase: "definitive erythrocytes from higher vertebrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014772:Erythrocytes [Laboratory Procedure]
   760   C0014792:Erythrocytes [Cell]

Phrase: "are"

Phrase: "enucleated"

Phrase: "and"

Phrase: "express"

Phrase: "adult globin chains."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   867   C0443781:Globin chain [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0337112:chains [Manufactured Object]
   827   C1149093:globin [Molecular Function]
   827   C1524075:Chains [Idea or Concept]
Processing 00000000.tx.8: Primitive hematopoiesis takes place in the blood islands of vertebrates. 

Phrase: "Primitive hematopoiesis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C2262992:primitive haematopoiesis [Organ or Tissue Function]
   861   C0018951:Haematopoiesis [Organ or Tissue Function]
   789 E C0018957:Haematopoietic [Body System]
   789 E C0229601:Hematopoietic [Functional Concept]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place in the blood islands of vertebrates."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0442504:Place [Spatial Concept]
   748   C1704765:Place [Functional Concept]
   748   C1882509:Place [Activity]
   748   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.9: In amphibians, the blood islands are located along the ventral side of the embryo; 

Phrase: "In amphibians,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002668:Amphibians [Amphibian]

Phrase: "the blood islands"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   966   C1511224:Blood Island [Embryonic Structure]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0022130:Islands [Geographic Area]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "are"

Phrase: "located along the ventral side of the embryo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0013935:Embryo [Embryonic Structure]
   744   C0441987:Side [Spatial Concept]
   744   C1305370:Embryo [Embryonic Structure]
   744   C1704448:Ventral [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.10: the analogous structures in higher vertebrates are the extra-embryonic blood islands on the yolk sac. 

Phrase: "the analogous structures in higher vertebrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "the extra-embryonic blood islands on the yolk sac."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0005767:Blood [Tissue]
   742   C0005768:blood [Body Substance]
   742   C0022130:Islands [Geographic Area]
   742   C0229664:Blood [Body Substance]
   731   C1511224:Blood Island [Embryonic Structure]
   723   C0586331:Embryonic blood vessel [Embryonic Structure]
   723   C1283867:Embryonic blood vessel [Embryonic Structure]
Processing 00000000.tx.11: Definitive hematopoiesis occurs in the AGM (aorta-gonads-mesonephros) region of vertebrates and gives rise to all blood cell types that are required during the life span of the animal (Kau and Turpen, 1983; Cumano et al., 1996; Medvinsky and Dzierzak, 1996).

Phrase: "Definitive hematopoiesis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C2262993:definitive haematopoiesis [Cell Function]
   861   C0018951:Haematopoiesis [Organ or Tissue Function]
   789 E C0018957:Haematopoietic [Body System]
   789 E C0229601:Hematopoietic [Functional Concept]

Phrase: "occurs in the AGM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1415932:AGM [Gene or Genome]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "(aorta-gonads-mesonephros"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025492:Mesonephros [Embryonic Structure]
   827   C1281768:Mesonephros [Embryonic Structure]

Phrase: ")"

Phrase: "region of vertebrates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0017446:Region [Geographic Area]
   790   C0205147:Region [Spatial Concept]
   718 E C0205276:Regional [Spatial Concept]
   718 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to all blood cell types"

Phrase: "that"

Phrase: "are"

Phrase: "required during the life span of the animal"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0870809:life span [Group Attribute]
   744   C0003062:Animal [Animal]
   744   C0376558:Life [Idea or Concept]
   744   C1514873:Required [Functional Concept]
   744   C1711300:Span [Conceptual Entity]
   744   C2700613:Span [Quantitative Concept]

Phrase: "(Kau"

Phrase: "and"

Phrase: "Turpen,"

Phrase: "1983"

Phrase: "; Cumano et al.,"

Phrase: "1996"

Phrase: "; Medvinsky"

Phrase: "and"

Phrase: "Dzierzak,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.1: The formation of ventral mesoderm requires the activity of soluble growth factors such as bone morphogenetic proteins (BMPs). 

Phrase: "The formation of ventral mesoderm"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1160070:mesoderm formation [Organ or Tissue Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "requires"

Phrase: "the activity of soluble growth factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1149472:growth factor activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "such as bone morphogenetic proteins (BMPs)."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]
Processing 00000000.tx.2: Ectopic expression of BMP-4 in the developing Xenopus embryo leads to ventralization that is characterized by lack of notochord, decreased muscle formation and increased blood formation. 

Phrase: "Ectopic expression of BMP-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1512167:Ectopic Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the developing Xenopus embryo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013935:Embryo [Embryonic Structure]
   827   C1305370:Embryo [Embryonic Structure]

Phrase: "leads"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C0181586:leads [Medical Device]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to ventralization"

Phrase: "that"

Phrase: "is"

Phrase: "characterized by lack of notochord,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0028439:Notochord [Embryonic Structure]
   760   C0332268:lack [Qualitative Concept]
   760   C1281776:Notochord [Embryonic Structure]
   760   C1880022:Characterized [Activity]

Phrase: "decreased muscle formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "increased blood formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.3: Animal pole ectoderm explants from BMP-4-injected embryos express globin mRNA, suggesting that BMP-4 can directly induce erythroid differentiation (Dale et al., 1992; Jones et al., 1992). 

Phrase: "Animal pole ectoderm explants from BMP-4-injected embryos"

Phrase: "express"

Phrase: "globin mRNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that BMP-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0530979:BMP-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0279266:BMP [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "erythroid differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(Dale et al.,"

Phrase: "1992"

Phrase: "; Jones et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.4: Interference with normal BMP-4 signaling by ectopic expression of a truncated BMP-receptor results in dorsalized embryos with decreased blood formation (Graff et al., 1994; Maeno et al., 1994a; Suzuki et al., 1994). 

Phrase: "Interference with normal BMP-4 signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0521102:Interference [Qualitative Concept]

Phrase: "by ectopic expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1512167:Ectopic Expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of a truncated BMP-receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0289417:Receptor, BMP [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "results in dorsalized embryos"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0013935:Embryos [Embryonic Structure]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   737 E C1305370:Embryo [Embryonic Structure]

Phrase: "with decreased blood formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "(Graff et al.,"

Phrase: "1994"

Phrase: "; Maeno et al.,"

Phrase: "1994a"

Phrase: "; Suzuki et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.5: BMP-4 signaling results in expression of a variety of downstream targets including GATA-1, GATA-2 and SCL (Maeno et al., 1996; Zhang and Evans, 1996; Mead et al., 1998).

Phrase: "BMP-4 signaling results in expression of a variety of downstream targets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   703   C1274040:Result [Functional Concept]
   703   C1546471:Result [Idea or Concept]
   703   C2825142:Result [Finding]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "GATA-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "GATA-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427248:GatA [Gene or Genome]

Phrase: "and"

Phrase: "SCL (Maeno et al.,"

Phrase: "1996"

Phrase: "; Zhang"

Phrase: "and"

Phrase: "Evans,"

Phrase: "1996"

Phrase: "; Mead et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.1: GATA-1 and GATA-2 are zinc-finger DNA-binding proteins required for normal blood cell development. 

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "and"

Phrase: "GATA-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427248:GatA [Gene or Genome]

Phrase: "are"

Phrase: "zinc-finger DNA-binding proteins"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   988   C1418875:zinc-finger DNA-binding protein [Gene or Genome]
   894   C0078803:zinc-binding protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C0012940:DNA-Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867 E C0812382:DNA-binding protein [Gene or Genome]
   853   C0058610:dna proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   708   C1148621:zinc binding [Molecular Function]

Phrase: "required for normal blood cell development."
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   790   C0005773:Blood cell [Cell]
   790   C0815089:cell development [Cell Function]
   783   C0007634:Normal cell [Cell]
           Cell
   783   C1268443:Normal cell [Cell]
   783   C1821244:Normal development [Finding]
   762 E C2328697:Hemal cell [Cell]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0205307:Normal [Qualitative Concept]
   753   C0229664:Blood [Body Substance]
   753   C0243107:development [Physiologic Function]
   753   C0439166:% normal [Quantitative Concept]
   753   C0678723:Development [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1514873:Required [Functional Concept]
   753   C1527148:Development [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2347086:% Normal [Quantitative Concept]
   742   C1160250:blood vessel development [Organ or Tissue Function]
Processing 00000000.tx.2: Targeted disruption of each of these genes in mice results in a failure of hematopoiesis and death due to anemia (Pevny et al., 1991; Tsai et al., 1994). 

Phrase: "Targeted disruption of each of these genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332453:Disruption [Functional Concept]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "results in a failure of hematopoiesis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0018951:Haematopoiesis [Organ or Tissue Function]
   753   C0231174:Failure [Functional Concept]
   753   C0680095:failure [Individual Behavior]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "and"

Phrase: "death due to anemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011065:Death [Organism Function]
   770   C1306577:Death, NOS [Finding]

Phrase: "(Pevny et al.,"

Phrase: "1991"

Phrase: "; Tsai et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.3: In Xenopus, GATA-1 and GATA-2 are early markers of hematopoietic mesoderm (Kelley et al., 1994). 

Phrase: "In Xenopus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043342:Xenopus [Amphibian]
  1000   C0043343:Xenopus [Amphibian]
  1000   C1504663:Xenopus [Amphibian]

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "and"

Phrase: "GATA-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427248:GatA [Gene or Genome]

Phrase: "are"

Phrase: "early markers of hematopoietic mesoderm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0005516:Marker [Clinical Attribute]

Phrase: "(Kelley et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.4: GATA-1 expression is restricted to hematopoietic cells during embryogenesis whereas GATA-2 is more widely expressed (Kelley et al., 1994; Walmsley et al., 1994). 

Phrase: "GATA-1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1333663:GATA-1 [Gene or Genome]
   734   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "restricted to hematopoietic cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   816   C2323499:Hematopoietic cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0018957:Haematopoietic [Body System]
   770   C0229601:Hematopoietic [Functional Concept]
   770   C0443288:Restricted [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "during embryogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013936:Embryogenesis [Organ or Tissue Function]

Phrase: "whereas"

Phrase: "GATA-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427248:GatA [Gene or Genome]

Phrase: "is"

Phrase: "more widely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "expressed"

Phrase: "(Kelley et al.,"

Phrase: "1994"

Phrase: "; Walmsley et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.5: GATA-2 is present at a very low level as a maternal RNA and zygotic expression begins during gastrulation (Zon et al., 1991; Kelley et al., 1994). 

Phrase: "GATA-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427248:GatA [Gene or Genome]

Phrase: "is"

Phrase: "present at a very low level"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "as a maternal RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "zygotic expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "begins during gastrulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0259902:Gastrulation [Organism Function]
   790   C0439659:Begin [Temporal Concept]

Phrase: "(Zon et al.,"

Phrase: "1991"

Phrase: "; Kelley et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.6: GATA-1 is undetectable by in situ hybridization until late neurula stages when it becomes expressed in the ventral blood island (Kelley et al., 1994).

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "is"

Phrase: "undetectable by in situ hybridization"

Phrase: "until late neurula stages"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1279941:late stages [Temporal Concept]
   827   C1306673:Stages [Qualitative Concept]
   793 E C0205390:Stage [Temporal Concept]
   793 E C1300072:Stage [Clinical Attribute]

Phrase: "when"

Phrase: "it"

Phrase: "becomes"

Phrase: "expressed in the ventral blood island"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1511224:Blood Island [Embryonic Structure]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0022130:Island [Geographic Area]
   753   C0229664:Blood [Body Substance]
   753   C1704448:Ventral [Spatial Concept]

Phrase: "(Kelley et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.1: Stem cell leukemia (SCL) is a basic helix-loop-helix (bHLH) transcription factor and is an early marker of hematopoietic cells in the vertebrate embryo. 

Phrase: "Stem cell leukemia (SCL)"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0280141:Stem Cell Leukemia [Neoplastic Process]
  1000   C1378511:Stem cell leukaemia [Neoplastic Process]
   901   C0038250:Stem cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "a basic helix-loop-helix (bHLH) transcription factor"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   861   C0282642:helix loop helix [Spatial Concept]
   827   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018882:Helix [Eukaryote]
   799   C0040649:Transcription [Genetic Function]
   799   C0229304:Helix [Body Part, Organ, or Organ Component]
   799   C0419518:Loop [Medical Device]
   799   C0445022:Loop [Spatial Concept]
   799   C1521761:Factor [Functional Concept]
   799   C1527178:Basic [Functional Concept]
   799   C1704821:Helix [Spatial Concept]
   799   C1705682:Helix [Anatomical Structure]
   799   C2827422:Factor [Conceptual Entity]
   727 E C0920750:basicity [Quantitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "an early marker of hematopoietic cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0005516:Marker [Clinical Attribute]

Phrase: "in the vertebrate embryo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013935:Embryo [Embryonic Structure]
   861   C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.2: SCL was originally identified in a chromosomal translocation in T-cell acute lymphoblastic leukemia (Begley et al., 1989; Aplan et al., 1990; Bernard et al., 1990; Begley et al., 1991; Chen et al., 1990a; Chen et al., 1990b; Visvader et al., 1991). 

Phrase: "SCL"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0280141:Stem Cell Leukemia [Neoplastic Process]
  1000   C1378511:Stem cell leukaemia [Neoplastic Process]
   901   C0038250:Stem cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "originally"

Phrase: "identified in a chromosomal translocation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0040715:Chromosomal translocation [Cell or Molecular Dysfunction]
           Translocation
   760   C0008633:Chromosomal [Cell Component]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C2987521:Translocation [Activity]

Phrase: "in T-cell acute lymphoblastic leukemia"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
  1000   C1961099:Lymphoblastic Leukemia, Acute, T-Cell [Neoplastic Process]
   933   C0023493:t cell acute leukemia [Neoplastic Process]
   911   C0023492:Leukemia, T-Cell [Neoplastic Process]
   884   C0023449:Acute lymphoblastic leukaemia [Neoplastic Process]
           Lymphoblastic leukaemia
   884   C1961102:Lymphoblastic Leukemia, Acute [Neoplastic Process]
           Lymphoblastic Leukemia
   884   C3542401:Acute Lymphoblastic Leukemia [Intellectual Product]
   853   C0085669:Acute leukaemia [Neoplastic Process]
   853   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   840   C0023448:Lymphoblastic leukemia [Neoplastic Process]
   840   C0039194:T-cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0023418:Leukaemia [Neoplastic Process]
   804   C0205178:acute [Temporal Concept]
   804   C0229613:lymphoblastic [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   733 E C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "(Begley et al.,"

Phrase: "1989"

Phrase: "; Aplan et al.,"

Phrase: "1990"

Phrase: "; Bernard et al.,"

Phrase: "1990"

Phrase: "; Begley et al.,"

Phrase: "1991"

Phrase: "; Chen et al.,"

Phrase: "1990a"

Phrase: "; Chen et al.,"

Phrase: "1990b"

Phrase: "; Visvader et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.3: Gene targeting experiments have indicated an essential role for SCL in hematopoiesis and vasculogenesis (Shivdasani et al., 1995; Robb et al., 1995; Porcher et al., 1996; Visvader et al., 1998). 

Phrase: "Gene targeting experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0242613:Gene Targeting [Molecular Biology Research Technique]

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "an essential role for SCL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in hematopoiesis"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0018951:Haematopoiesis [Organ or Tissue Function]
   928 E C0018957:Haematopoietic [Body System]
   928 E C0229601:Hematopoietic [Functional Concept]

Phrase: "and"

Phrase: "vasculogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1123009:vasculogenesis [Organ or Tissue Function]

Phrase: "(Shivdasani et al.,"

Phrase: "1995"

Phrase: "; Robb et al.,"

Phrase: "1995"

Phrase: "; Porcher et al.,"

Phrase: "1996"

Phrase: "; Visvader et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.4: We have recently reported the cloning and characterization of Xenopus SCL and showed that ectopic expression of SCL was sufficient to direct primitive mesoderm to a hematopoietic fate. 

Phrase: "We"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "the cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "characterization of Xenopus SCL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ectopic expression of SCL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1512167:Ectopic Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "primitive mesoderm to a hematopoietic fate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0025485:Mesoderm [Embryonic Structure]
Processing 00000000.tx.5: SCL expression is induced by BMP-4 and we proposed that SCL lay downstream of BMP in a ventral signaling cascade to specify HSCs from undifferentiated mesoderm (Mead et al., 1998). 

Phrase: "SCL expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   756   C0280141:Stem Cell Leukemia [Neoplastic Process]
   756   C1378511:Stem cell leukaemia [Neoplastic Process]

Phrase: "is"

Phrase: "induced by BMP-4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0530979:BMP-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205263:Induced [Functional Concept]
   770   C0279266:BMP [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "we"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that SCL"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0280141:Stem Cell Leukemia [Neoplastic Process]
  1000   C1378511:Stem cell leukaemia [Neoplastic Process]
   901   C0038250:Stem cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "lay downstream of BMP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0279266:BMP [Therapeutic or Preventive Procedure]
   770   C0522506:Downstream [Spatial Concept]

Phrase: "in a ventral signaling cascade to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2611812:signaling cascade [Cell Function]
   812   C1707310:Cascade [Manufactured Object]

Phrase: "specify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521902:Specify [Qualitative Concept]

Phrase: "HSCs from undifferentiated mesoderm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1523748:HSC [Cell Component]
   737   C1705576:HSC [Therapeutic or Preventive Procedure]

Phrase: "(Mead et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.6: SCL binds DNA as a heterodimer in complex with the bHLH proteins E12/E47. 

Phrase: "SCL"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0280141:Stem Cell Leukemia [Neoplastic Process]
  1000   C1378511:Stem cell leukaemia [Neoplastic Process]
   901   C0038250:Stem cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA as a heterodimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "in complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with the bHLH proteins E12/E47."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1336596:E47 [Gene or Genome]
   740   C0288972:Basic Helix-Loop-Helix Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.7: Gel mobility shift studies have shown that SCL can associate in a high order complex on DNA that includes SCL, E12/E47, GATA-1, Ldb-1 and LMO-2 (Wadman et al., 1997).

Phrase: "Gel mobility shift studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that SCL"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0280141:Stem Cell Leukemia [Neoplastic Process]
  1000   C1378511:Stem cell leukaemia [Neoplastic Process]
   901   C0038250:Stem cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "associate in a high order complex"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   753   C0205250:High [Qualitative Concept]
   753   C0439855:Complex [Qualitative Concept]
   753   C0750490:Associate [Idea or Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   753   C1705175:Order [Intellectual Product]
   753   C1705176:Order [Qualitative Concept]
   753   C1705177:Order [Classification]
   753   C1705178:Order [Activity]
   753   C1706221:Associate [Professional or Occupational Group]
   753   C1882348:Order [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "on DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "SCL,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0280141:Stem Cell Leukemia [Neoplastic Process]
  1000   C1378511:Stem cell leukaemia [Neoplastic Process]
   901   C0038250:Stem cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0242767:Stem [Plant]
   827   C1186763:Stem [Body Part, Organ, or Organ Component]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "E12/E47,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1336596:E47 [Gene or Genome]

Phrase: "GATA-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "Ldb-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3640998:LDB-1 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Wadman et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.1: Like SCL, LMO-2 (LIM-only protein 2; also known as TTG-2 and Rbtn-2) was first identified as a chromosomal translocation associated with T-cell acute lymphoblastic leukemia (Royer-Pokora et al., 1991). 

Phrase: "Like SCL,"

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(LIM-only protein 2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0250437:LIM-Only Protein 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0205171:Only [Quantitative Concept]
   812   C0449205:LIM [Body Location or Region]
   812   C1538613:LIM [Gene or Genome]
   812   C1720467:Only [Intellectual Product]

Phrase: "; also"

Phrase: "known as TTG-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205309:Known [Qualitative Concept]

Phrase: "and"

Phrase: "Rbtn-2"

Phrase: ")"

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "identified as a chromosomal translocation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0040715:Chromosomal translocation [Cell or Molecular Dysfunction]
           Translocation
   760   C0008633:Chromosomal [Cell Component]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C2987521:Translocation [Activity]

Phrase: "associated with T-cell acute lymphoblastic leukemia"
Meta Candidates (Total=26; Excluded=3; Pruned=0; Remaining=23)
   897   C1961099:Lymphoblastic Leukemia, Acute, T-Cell [Neoplastic Process]
       E   T-Cell Leukemia, Acute
   840   C0023493:t cell acute leukemia [Neoplastic Process]
   814   C0023449:Acute lymphoblastic leukaemia [Neoplastic Process]
           Lymphoblastic leukaemia
   814   C1961102:Lymphoblastic Leukemia, Acute [Neoplastic Process]
           Lymphoblastic Leukemia
   814   C3542401:Acute Lymphoblastic Leukemia [Intellectual Product]
   804   C0023492:Leukemia, T-Cell [Neoplastic Process]
   778   C0023448:Lymphoblastic leukemia [Neoplastic Process]
   778   C0039194:T-cell [Cell]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   774   C0085669:Acute leukaemia [Neoplastic Process]
   774   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   774   C0699040:cell associated [Cell Component]
   748   C0007634:Cell [Cell]
   748   C0023418:Leukaemia [Neoplastic Process]
   748   C0205178:acute [Temporal Concept]
   748   C0229613:lymphoblastic [Cell]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   738   C1517806:Leukemic Cell [Cell]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(Royer-Pokora et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.2: LMO-2 is more broadly expressed than SCL, although high levels of LMO-2 expression are found in the sites of hematopoiesis (Foroni et al., 1992). 

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "more broadly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "expressed than SCL,"

Phrase: "although"

Phrase: "high levels of LMO-2 expression"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0456948:Level 2 [Intellectual Product]
   767   C3244092:expression level [Idea or Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "found in the sites of hematopoiesis"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   773   C2945843:Site of [Qualitative Concept]
   753   C0018951:Haematopoiesis [Organ or Tissue Function]
   753   C0150312:Found [Quantitative Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C0243095:Find [Finding]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "(Foroni et al.,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.3: Targeted gene disruption experiments in mice have shown an essential role for LMO-2 in hematopoiesis (Yamada et al., 1998). 

Phrase: "Targeted gene disruption experiments in mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "an essential role for LMO-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in hematopoiesis"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0018951:Haematopoiesis [Organ or Tissue Function]
   928 E C0018957:Haematopoietic [Body System]
   928 E C0229601:Hematopoietic [Functional Concept]

Phrase: "(Yamada et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.4: Homozygous mice null for LMO-2 die at day 9-10 of severe anemia and LMO-2-negative stem cells fail to contribute to the hematopoietic cells of adult chimeric mice. 

Phrase: "Homozygous mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "null for LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456148:Null [Quantitative Concept]

Phrase: "die at day 9-10 of severe anemia"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0238644:ANEMIA, SEVERE [Disease or Syndrome]
   744   C0002871:Anaemia [Disease or Syndrome]
   744   C0205082:Severe [Qualitative Concept]
   744   C0332173:/day [Temporal Concept]
   744   C0439228:day [Temporal Concept]
   744   C0439505:/day [Temporal Concept]
   744   C1000483:Anemia [Plant]

Phrase: "and"

Phrase: "LMO-2-negative stem cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C0038250:Stem cells [Cell]
   804   C0007634:Cells [Cell]
   804   C0242767:Stem [Plant]
   804   C1186763:Stem [Body Part, Organ, or Organ Component]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contribute to the hematopoietic cells of adult chimeric mice."
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   748   C2323499:Hematopoietic cell [Cell]
   742   C0001675:Adult [Age Group]
   742   C0007634:Cells [Cell]
   742   C0008109:chimeric [Organism]
   742   C0018957:Haematopoietic [Body System]
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0229601:Hematopoietic [Functional Concept]
   742   C1706450:Adult [Human]
   742   C1880177:Contribute [Activity]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.5: LMO-2 does not bind DNA, but instead acts as a bridging molecule between DNA-binding molecules such as SCL and GATA-1. 

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "but"

Phrase: "instead"

Phrase: "acts as a bridging molecule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0567416:Molecule [Substance]
   726   C0456378:Bridge [Medical Device]

Phrase: "between DNA-binding molecules"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   913   C0012854:dna molecules [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
           DNA
   901   C1148673:DNA Binding [Genetic Function]
   827   C0243122:binding [Functional Concept]
   827   C0567416:molecules [Substance]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "such as SCL"

Phrase: "and"

Phrase: "GATA-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]
Processing 00000000.tx.6: Wadman and colleagues have demonstrated that LMO-2 is an integral part of a five-member erythroid transcription-activating complex, which includes SCL, E2A, GATA-1, Ldb1/NL1 and LMO-2 (Wadman et al., 1997). 

Phrase: "Wadman"

Phrase: "and"

Phrase: "colleagues"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "an integral part of a five-member erythroid transcription-activating complex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1292711:Part of [Spatial Concept]
   738   C0449719:Part [Spatial Concept]
   738   C1709471:Part [Quantitative Concept]

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "SCL,"

Phrase: "E2A,"

Phrase: "GATA-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "Ldb1/NL1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1422548:NL1 [Gene or Genome]
   861   C1826261:NL1 [Gene or Genome]

Phrase: "and"

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Wadman et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.7: This erythroid complex recognizes a bipartite DNA motif of an E-box (CAGGTG) approximately nine base pairs upstream of a GATA site. 

Phrase: "This erythroid complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "recognizes"

Phrase: "a bipartite DNA motif of an E-box"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C3178798:DNA Motif [Nucleotide Sequence]
   744   C1514562:Motif [Amino Acid Sequence]

Phrase: "(CAGGTG"

Phrase: ")"

Phrase: "approximately nine base pairs upstream of a GATA site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0600436:Base Pairs [Molecular Function]
   742   C0002055:base [Inorganic Chemical]
   742   C0178499:Base [Chemical Viewed Functionally]
   742   C1709450:Pair [Qualitative Concept]
   742   C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.8: DNA-site CASTing experiments in T cells isolated from LMO-2 transgenic mice identified a novel LMO-2-containing complex that forms on two E-box sites separated by approximately ten base pairs (Grutz et al., 1998). 

Phrase: "DNA-site CASTing experiments in T cells"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "isolated from LMO-2 transgenic mice"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0025936:Mice, Transgenic [Mammal]
   790   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0003069:Transgenic [Animal]
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0205409:Isolated [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a novel LMO-2-containing complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that forms on two E-box sites"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "separated by approximately ten base pairs"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0600436:Base Pairs [Molecular Function]
   753   C0002055:base [Inorganic Chemical]
   753   C0014518:TEN [Disease or Syndrome]
   753   C0086972:Separated [Finding]
   753   C0178499:Base [Chemical Viewed Functionally]
   753   C0205456:Ten [Quantitative Concept]
   753   C0332232:Approximately [Qualitative Concept]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1709450:Pair [Qualitative Concept]
   753   C1880279:Base [Biomedical or Dental Material]

Phrase: "(Grutz et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.9: This complex is restricted to immature (CD8-/CD4-) T-cells and may indicate a role for this LMO-2-containing complex in the block in differentiation of pre-cancerous thymocytes. 

Phrase: "This complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "restricted to immature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205252:Immature [Temporal Concept]
   790   C0443288:Restricted [Functional Concept]

Phrase: "(CD8-/CD4-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0483191:cd8 cd4 [Laboratory or Test Result]
   861   C3541261:CD4 [Laboratory Procedure]

Phrase: ")"

Phrase: "T-cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "may"

Phrase: "indicate"

Phrase: "a role for this LMO-2-containing complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in the block"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]
   928 E C2983591:BLOCKED [Research Activity]

Phrase: "in differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "of pre-cancerous thymocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C1514295:Pre-Thymocyte [Cell]
   827   C0814999:Thymocytes [Cell]
Processing 00000000.tx.10: The 5' regulatory regions of the gene for GATA-1 contain sites that promote the formation of a multimeric erythroid complex suggesting that GATA-1 itself may be a transcriptional target of the complex (Vyas et al., 1999). 

Phrase: "The 5' regulatory regions of the gene"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0034987:Regulatory Regions [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   774   C0017362:Regulatory Gene [Gene or Genome]
   748   C0220905:regulatory [Regulation or Law]
   748   C1704735:Regulatory [Conceptual Entity]
   714   C0017446:Region [Geographic Area]
   714   C0205147:Region [Spatial Concept]

Phrase: "for GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the formation of a multimeric erythroid complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "itself"

Phrase: "may"

Phrase: "be"

Phrase: "a transcriptional target of the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "(Vyas et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.11: Recently, a pentameric protein complex (LMO-2, SCL, E2A, Ldb-1 and pRb), that assembles on a consensus SCL site, has been shown to downregulate the expression of c-kit in maturing erythroblasts (Vitelli et al., 2000). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "a pentameric protein complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1523872:protein complex [Cell Component]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SCL,"

Phrase: "E2A,"

Phrase: "Ldb-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3640998:LDB-1 [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "pRb"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080113:pRb [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "that"

Phrase: "assembles on a consensus SCL site,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205145:Site [Spatial Concept]
   753   C0376298:Consensus [Social Behavior]
   753   C1515974:Site [Body Location or Region]
   753   C1706853:Assemble [Activity]
   753   C2825164:Site [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "downregulate"

Phrase: "the expression of c-kit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in maturing erythroblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014762:Erythroblasts [Cell]

Phrase: "(Vitelli et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.12: Thus, LMO-2 plays a pivotal role in hematopoiesis by bridging multi-protein DNA-binding complexes to regulate transcription of downstream targets during blood cell formation.

Phrase: "Thus,"

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a pivotal role in hematopoiesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "by bridging multi-protein DNA-binding complexes to"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   863   C1323326:protein binding, bridging [Molecular Function]
   861   C2262832:binding, bridging [Molecular Function]
   841   C2246376:protein-DNA complex [Cell Component]
   829   C0033618:Protein Binding [Molecular Function]
   829   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   829   C1523872:protein complex [Cell Component]
   818   C0058610:protein dna [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1148673:DNA Binding [Genetic Function]
   795   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0243122:binding [Functional Concept]
   795   C1145667:Binding [Activity]
   795   C1167622:Binding [Molecular Function]
   795   C1704241:Complexes [Chemical Viewed Structurally]
   762 E C0439855:Complex [Qualitative Concept]

Phrase: "regulate"

Phrase: "transcription of downstream targets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040649:Transcription [Genetic Function]

Phrase: "during blood cell formation."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0018951:blood cell formation [Organ or Tissue Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
   734   C0005773:Blood cell [Cell]
   706 E C2328697:Hemal cell [Cell]
Processing 00000000.tx.1: We now report the cloning and functional characterization of Xenopus LMO-2. 

Phrase: "We now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "the cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "functional characterization of Xenopus LMO-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]
Processing 00000000.tx.2: In situ hybridization studies show that LMO-2 is highly expressed in the ventral region of the early neurula, and as development proceeds, becomes localized to the ventral blood island (VBI). 

Phrase: "In situ hybridization studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]
   756   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "expressed in the ventral region of the early neurula,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
   742   C1279919:Early [Temporal Concept]
   742   C1518306:Neurula [Embryonic Structure]
   742   C1704448:Ventral [Spatial Concept]

Phrase: "and as development proceeds,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1515981:And [Idea or Concept]
   770   C1527148:Development [Functional Concept]

Phrase: "becomes"

Phrase: "localized to the ventral blood island (VBI)."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1511224:Blood Island [Embryonic Structure]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0022130:Island [Geographic Area]
   753   C0229664:Blood [Body Substance]
   753   C0392752:Localized [Spatial Concept]
   753   C1704448:Ventral [Spatial Concept]
Processing 00000000.tx.3: LMO-2 is also highly expressed outside the hematopoietic system with abundant expression in the nascent tailbud region and in the brain. 

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "also highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205250:Highly [Qualitative Concept]

Phrase: "expressed"

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the hematopoietic system with abundant expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0018957:Haematopoietic system [Body System]
           Haematopoietic
   790   C1292123:HEMATOPOIETIC SYSTEM [Finding]
   753   C0229601:Hematopoietic [Functional Concept]
   753   C0449913:System [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "in the nascent tailbud region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and in the brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.4: Ectopic expression of LMO-2 in animal pole explants treated with basic fibroblast growth factor (bFGF) results in erythroid differentiation. 

Phrase: "Ectopic expression of LMO-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1512167:Ectopic Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in animal pole explants"

Phrase: "treated with basic fibroblast growth factor (bFGF)"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   882   C0380603:Fibroblast Growth Factor, Basic [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C0919506:FIBROBLAST GROWTH FACTOR, BASIC [Gene or Genome]
   882   C1522505:Basic Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   833   C0016026:Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0016030:Fibroblast [Cell]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1522326:Treated [Functional Concept]
   753   C1527178:Basic [Functional Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "results in erythroid differentiation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0007589:Differentiation [Cell Function]
   770   C1274040:Result [Functional Concept]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C1516960:Erythroid [Qualitative Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   770   C2945687:Differentiation [Functional Concept]
Processing 00000000.tx.5: Like SCL and GATA-1, ectopic expression of LMO-2 on its own has little effect on developing embryos; 

Phrase: "Like SCL"

Phrase: "and"

Phrase: "GATA-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "ectopic expression of LMO-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1512167:Ectopic Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "on its own"

Phrase: "has"

Phrase: "little effect on developing embryos"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.6: the embryos develop normally with normal blood island formation. 

Phrase: "the embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013935:Embryos [Embryonic Structure]
   966 E C1305370:Embryo [Embryonic Structure]

Phrase: "develop"

Phrase: "normally with normal blood island formation."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1511224:Blood Island [Embryonic Structure]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0022130:Island [Geographic Area]
   753   C0205307:Normal [Qualitative Concept]
   753   C0220781:formation [Biologic Function]
   753   C0229664:Blood [Body Substance]
   753   C0439166:% normal [Quantitative Concept]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
   753   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.7: Ectopic expression of both SCL and LMO-2, however, results in embryos developing with a truncated body and an enlarged ventral blood island. 

Phrase: "Ectopic expression of both SCL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1512167:Ectopic Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "however,"

Phrase: "results in embryos"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0013935:Embryos [Embryonic Structure]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   756 E C1305370:Embryo [Embryonic Structure]

Phrase: "developing with a truncated body"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "an enlarged ventral blood island."
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   861   C1511224:Blood Island [Embryonic Structure]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0022130:Island [Geographic Area]
   812   C0229664:Blood [Body Substance]
   812   C1704448:Ventral [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.8: This ventral phenotype is exaggerated by ectopic expression of GATA-1 together with SCL and LMO-2. 

Phrase: "This ventral phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "exaggerated by ectopic expression of GATA-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1333663:GATA-1 [Gene or Genome]
   778   C1512167:Ectopic Expression [Genetic Function]
   778   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0442801:Exaggerated [Qualitative Concept]
   748   C0574895:Ectopic [Spatial Concept]
   748   C1427248:GatA [Gene or Genome]

Phrase: "together with SCL"

Phrase: "and"

Phrase: "LMO-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.9: Embryos injected with LMO-2, SCL and GATA-1 mRNAs develop with virtually no dorsal-anterior structures and express globin throughout the body axis. 

Phrase: "Embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013935:Embryos [Embryonic Structure]
   966 E C1305370:Embryo [Embryonic Structure]

Phrase: "injected with LMO-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C1720154:Inject [Functional Concept]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1 mRNAs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1333663:GATA-1 [Gene or Genome]
   734   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "develop with virtually"

Phrase: "no dorsal-anterior structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "express"

Phrase: "globin throughout the body axis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1149093:globin [Molecular Function]
Processing 00000000.tx.10: These transcription factors also work synergistically in animal pole explant assays to induce the development of erythroid cells. 

Phrase: "These transcription factors also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "synergistically in animal pole explant assays to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0003062:Animal [Animal]
   748   C0935623:Pole [Body Location or Region]
   748   C1418729:POLE [Gene or Genome]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the development of erythroid cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0815089:cells development [Cell Function]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.11: Our studies strongly suggest that the formation of the LMO-2/SCL/GATA-1 complex in vivo specifies ventral mesoderm to become blood.

Phrase: "Our studies strongly"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of the LMO-2/SCL/GATA-1 complex in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "specifies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521902:Specify [Qualitative Concept]

Phrase: "ventral mesoderm to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0025485:Mesoderm [Embryonic Structure]
   755 E C0521459:Mesodermal [Body Location or Region]

Phrase: "become"

Phrase: "blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Cloning Xenopus LMO-2

Phrase: "Cloning Xenopus LMO-2"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0009015:Cloning [Research Activity]
   812   C0043342:Xenopus [Amphibian]
   812   C0043343:Xenopus [Amphibian]
   812   C1504663:Xenopus [Amphibian]
   779 E C0009013:Clone [Cell]
   779 E C1522642:Clone [Tissue]
Processing 00000000.tx.1: A fragment of the Xenopus LMO-2 cDNA was amplified using reverse transcriptase-polymerase chain reaction (RT-PCR) from total RNA isolated from Xenopus spleen. 

Phrase: "A fragment of the Xenopus LMO-2 cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "reverse transcriptase-polymerase chain reaction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0599161:Reverse Transcriptase Polymerase Chain Reaction [Molecular Biology Research Technique]
   884   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   840   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0337112:Chain [Manufactured Object]
   804   C0443286:Reaction [Functional Concept]
   804   C1114821:Reaction [Clinical Attribute]
   804   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1524075:Chain [Idea or Concept]
   804   C1555029:Reverse [Idea or Concept]
   804   C2257077:transcriptase [Genetic Function]

Phrase: "(RT-PCR) from total RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]

Phrase: "isolated from Xenopus spleen."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0037993:Spleen [Body Part, Organ, or Organ Component]
   770   C0043342:Xenopus [Amphibian]
   770   C0043343:Xenopus [Amphibian]
   770   C0205409:Isolated [Functional Concept]
   770   C0771377:SPLEEN [Tissue]
   770   C1278932:Spleen [Body Part, Organ, or Organ Component]
   770   C1504663:Xenopus [Amphibian]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.2: Primers used in the amplification process were designed to invariant regions in the murine, zebrafish and human LMO-2 protein sequences (5' oligonucleotide to human sequence EEPVDEV (amino acids 14 to 19) GA(AG) GA(AG) CCN GTN GA(TC) GA(AG) GT and 3' oligonucleotide to human sequence DIVCEQD (amino acids 141 to 147) TC(CT) TG(CT) TC(AG) CAN AC(TGA) AT(AG) TC). 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used in the amplification process"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C1184743:Process [Body Part, Organ, or Organ Component]
   760   C1273517:used [Finding]
   760   C1517480:Amplification [Molecular Biology Research Technique]
   760   C1521871:Amplification [Phenomenon or Process]
   760   C1522240:Process [Phenomenon or Process]
   760   C1705759:Amplification [Cell or Molecular Dysfunction]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "designed to invariant regions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]
   737   C1707689:Design [Activity]
   737   C2983265:DESIGN [Intellectual Product]

Phrase: "in the murine, zebrafish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043457:Zebra Fish [Fish]

Phrase: "and"

Phrase: "human LMO-2 protein sequences"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   875   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0002518:protein sequences [Amino Acid Sequence]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]

Phrase: "(5' oligonucleotide to human sequence EEPVDEV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(amino acids 14 to 19"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "GA(AG) GA(AG) CCN GTN GA(TC) GA(AG) GT"

Phrase: "and"

Phrase: "3' oligonucleotide to human sequence DIVCEQD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0028953:Oligonucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(amino acids 141 to 147"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "TC(CT) TG(CT) TC(AG)"

Phrase: "CAN"

Phrase: "AC(TGA) AT(AG) TC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0041405:TC [Geographic Area]
   804   C1824670:TC [Gene or Genome]
   804   C3272447:TC [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.3: The approximately 400 bp fragment was cloned into pGEM-T Easy (Promega, WI) and sequenced. 

Phrase: "The approximately 400 bp fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "cloned into pGEM-T"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0009013:cloned [Cell]
   770   C0049896:PGE-M [Eicosanoid]
   737 E C1522642:Clone [Tissue]

Phrase: "Easy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332219:Easy [Qualitative Concept]
   928 E C1331418:Ease [Mental Process]

Phrase: "(Promega,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072149:Promega [Lipid]

Phrase: "WI)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: "and"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.4: Clone L21 was identified as the Xenopus homolog of LMO-2 (sharing 96% amino acid identity with mouse LMO-2). 

Phrase: "Clone L21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419637:L21 [Gene or Genome]

Phrase: "was"

Phrase: "identified as the Xenopus homolog of LMO-2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0043342:Xenopus [Amphibian]
   744   C0043343:Xenopus [Amphibian]
   744   C0205396:Identified [Qualitative Concept]
   744   C1334043:Homolog [Gene or Genome]
   744   C1504663:Xenopus [Amphibian]
   744   C1550043:Identified [Finding]
   744   C1551388:Identified [Functional Concept]

Phrase: "("

Phrase: "sharing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Sharing [Social Behavior]

Phrase: "96% amino acid identity with mouse LMO-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0424215:Identity [Mental Process]
   744   C2003939:Identity [Finding]

Phrase: ")."
Processing 00000000.tx.5: A full length clone was isolated from a ZAP-Express Xenopus adult spleen cDNA library (Deconinck et al., 2000) by probing 8x105 plaques with radiolabeled L21. 

Phrase: "A full length clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0009013:Clone [Cell]
   827   C1522642:Clone [Tissue]
   755 E C1704387:Clonal [Qualitative Concept]
   727 E C0796368:clonality [Diagnostic Procedure]

Phrase: "was"

Phrase: "isolated from a ZAP-"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0205409:Isolated [Functional Concept]
   770   C1428222:ZAP [Gene or Genome]
   770   C1538127:ZAP [Gene or Genome]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "Express"

Phrase: "Xenopus adult spleen cDNA library"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   804   C0023621:Library [Manufactured Object,Organization]
   804   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Deconinck et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: "by probing 8x105 plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: "with radiolabeled L21."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419637:L21 [Gene or Genome]
Processing 00000000.tx.6: Multiple positives were identified and eight clones were purified by successive rounds of plaque hybridization. 

Phrase: "Multiple positives"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439178:% Positive [Quantitative Concept]
   827   C1446409:Positive [Qualitative Concept]
   827   C1514241:Positive [Finding]
   827   C2825490:Positive [Qualitative Concept]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "eight clones"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0009013:Clones [Cell]
   827 E C1522642:Clone [Tissue]
   777 E C1704387:Clonal [Qualitative Concept]
   755 E C0796368:clonality [Diagnostic Procedure]

Phrase: "were"

Phrase: "purified by successive rounds of plaque hybridization."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0011389:Plaque [Disease or Syndrome]
   748   C0020202:Hybridisation [Genetic Function]
   748   C0332461:Plaque [Finding]
   748   C0333463:plaque [Acquired Abnormality]
   748   C1300517:Hybridization [Laboratory Procedure]
   748   C1998793:Purified [Functional Concept]
   714   C0332490:Round [Spatial Concept]
Processing 00000000.tx.7: Plasmid sequences were rescued by in vivo excision and the resulting plasmids were sequenced. 

Phrase: "Plasmid sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "rescued by in vivo excision"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1515655:In Vivo [Spatial Concept]
           vivo
   760   C0015252:excision [Therapeutic or Preventive Procedure]
   760   C0728940:Excision [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the resulting plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "sequenced."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]
Processing 00000000.tx.8: All clones shared sequence identity with L21 and appeared to represent full-length Xenopus LMO-2 clones, hereafter referred to as XLMO-2. 

Phrase: "All"

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "shared sequence identity with L21"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0424215:Identity [Mental Process]
   760   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "full-length Xenopus LMO-2 clones,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   799   C0009013:Clones [Cell]
   766 E C1522642:Clone [Tissue]
   716 E C1704387:Clonal [Qualitative Concept]

Phrase: "hereafter"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "XLMO-2."
Processing 00000000.tx.9: Sequence analysis was performed using the DNASTAR molecular biology software package for Macintosh. 

Phrase: "Sequence analysis"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C0936012:Analysis [Research Activity]
   861   C1519249:Sequence [Functional Concept]
   861   C1524024:analysis [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the DNASTAR molecular biology software package for Macintosh."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0013194:Package [Medical Device]
   744   C2700580:Package [Manufactured Object]
Processing 00000000.tx.10: The GenBank Accession Number for Xenopus LMO-2 is AF374473.

Phrase: "The GenBank Accession Number for Xenopus LMO-2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1708200:GenBank_Accession_Number [Intellectual Product]
   770   C1510755:Accession Number [Intellectual Product]
           Accession
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1706078:Accession [Activity]

Phrase: "is"

Phrase: "AF374473."
Processing 00000000.tx.1: Whole embryo RNA in situ hybridization analysis and immunohistochemistry

Phrase: "Whole embryo RNA in situ hybridization analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   795   C0002778:Analysis [Laboratory Procedure]
   795   C0936012:Analysis [Research Activity]
   795   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]
Processing 00000000.tx.1: RNA in situ hybridization analysis using labeled probes was performed as described (Harland, 1991; Hemmati-Brivanlou et al., 1990a). 

Phrase: "RNA in situ hybridization analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "labeled probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "was"

Phrase: "performed as described"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Harland,"

Phrase: "1991"

Phrase: "; Hemmati-Brivanlou et al.,"

Phrase: "1990a"

Phrase: ")."
Processing 00000000.tx.2: Antisense XLMO-2 RNA probes were in vitro transcribed in the presence of digoxigenin-labeled rUTP (Boehringer Mannheim Biochemicals). 

Phrase: "Antisense XLMO-2 RNA probes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   897   C0078976:Anti-Sense Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   840   C0035683:RNA Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0182400:Probes [Medical Device]
   771 E C1704681:Probe [Gene or Genome]
   771 E C2347609:Probe [Chemical Viewed Functionally]
   771 E C3536729:Probe [Manufactured Object]
   708   C0080124:Anti-Sense RNA [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "in vitro transcribed in the presence of digoxigenin-labeled rUTP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021135:In Vitro [Intellectual Product]
   760   C1533691:in vitro [Qualitative Concept]
           vitro
   760   C2827718:In Vitro [Functional Concept]

Phrase: "(Boehringer Mannheim Biochemicals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205474:Biochemical [Functional Concept]

Phrase: ")."
Processing 00000000.tx.3: Whole embryo immunohistochemistry was performed, using a monoclonal antibody (L4-27) directed against tadpole -globin at 1/40 (v/v), as described (Hemmati-Brivanlou et al., 1990b). 

Phrase: "Whole embryo immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "(L4-27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419676:L4 [Gene or Genome]

Phrase: ")"

Phrase: "directed against tadpole -globin at 1/40"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0326967:Tadpole [Amphibian]
   748   C0439509:/40 [Temporal Concept]
   748   C1149093:globin [Molecular Function]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "(v/v),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560268:%V/V [Quantitative Concept]
  1000   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Hemmati-Brivanlou et al.,"

Phrase: "1990b"

Phrase: ")."
Processing 00000000.tx.4: Embryos were staged according to Nieuwkoops normal table of development (Nieuwkoop and Faber, 1967).

Phrase: "Embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013935:Embryos [Embryonic Structure]
   966 E C1305370:Embryo [Embryonic Structure]

Phrase: "were"

Phrase: "staged according to Nieuwkoops normal table of development"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   767   C1821244:Normal development [Finding]
   744   C0039224:Table [Manufactured Object]
   744   C0205307:Normal [Qualitative Concept]
   744   C0243107:development [Physiologic Function]
   744   C0439166:% normal [Quantitative Concept]
   744   C0678723:Development [Organism Function]
   744   C0680240:according [Social Behavior]
   744   C1527148:Development [Functional Concept]
   744   C1706073:Table [Medical Device]
   744   C1706074:Table [Intellectual Product]
   744   C2347086:% Normal [Quantitative Concept]
   714   C0870411:Developmental Stage [Temporal Concept]
   711   C0205390:Stage [Temporal Concept]
   711   C1300072:Stage [Clinical Attribute]
   711   C1306673:Stage [Qualitative Concept]

Phrase: "(Nieuwkoop"

Phrase: "and"

Phrase: "Faber,"

Phrase: "1967"

Phrase: ")."
Processing 00000000.tx.1: RT-PCR assay

Phrase: "RT-PCR assay"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0243073:assay [Qualitative Concept]
   827   C0677874:pCR [Finding]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.1: RNA extractions, first strand cDNA synthesis and PCR analysis were performed as previously described (Kelley et al., 1994). 

Phrase: "RNA extractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0185115:extractions [Therapeutic or Preventive Procedure]
   827 E C0684295:extraction [Laboratory Procedure]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "cDNA synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "and"

Phrase: "PCR analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0200931:PCR analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0677874:pCR [Finding]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Kelley et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.2: PCR primer sets and conditions for EF-1 and T3 globin were as described (Kelley et al., 1994). 

Phrase: "PCR primer sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "conditions for EF-1"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   833   C0059036:EF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0012634:condition [Disease or Syndrome]
   770   C0348080:Condition [Qualitative Concept]
   770   C1705253:Condition [Conceptual Entity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "and"

Phrase: "T3 globin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1149093:globin [Molecular Function]

Phrase: "were"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Kelley et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.3: PCR conditions were determined for each primer set to ensure that amplification was in the exponential range. 

Phrase: "PCR conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "determined for each primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was in the exponential range."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C1514721:Range [Quantitative Concept]
   760   C1552645:exponential [Qualitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]
Processing 00000000.tx.4: PCR primers for XLMO-2: forward 5'-GGG AAG TCG GAA GGA GAC-3'; 

Phrase: "PCR primers for XLMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ":"

Phrase: "forward"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439780:Forward [Spatial Concept]

Phrase: "5'-GGG AAG TCG GAA GGA GAC-3'"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0439084:>5 [Quantitative Concept]
   793   C0728893:+5 [Quantitative Concept]
   793   C0796552:AAG [Antibiotic,Organic Chemical]
   793   C1414899:GAA [Gene or Genome]
   793   C1417239:AAG [Gene or Genome]
   793   C2986643:AAG [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.5: and reverse, 5'-CGG TCA CCC ACG CAG AAG-3'. 

Phrase: "and"

Phrase: "reverse, 5'-CGG TCA CCC ACG CAG AAG-3'."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   791   C0041405:TCA [Geographic Area]
   791   C0050397:AcG [Amino Acid, Peptide, or Protein]
   791   C0085758:TCA [Congenital Abnormality]
   791   C0796552:AAG [Antibiotic,Organic Chemical]
   791   C1415587:TCA [Gene or Genome]
   791   C1417239:AAG [Gene or Genome]
   791   C1428097:ACG [Gene or Genome]
   791   C1555029:Reverse [Idea or Concept]
   791   C1864172:CGG [Disease or Syndrome]
   791   C2986643:AAG [Gene or Genome]
   791   C3536819:TCA [Pharmacologic Substance]
Processing 00000000.tx.6: These primers amplify a 208 bp fragment with an optimal annealing temperature of 55C.

Phrase: "These primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "amplify"

Phrase: "a 208 bp fragment with an optimal annealing temperature of 55C."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0332255:fragment [Functional Concept]
   738   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.1: In vitro transcription and micro-injection

Phrase: "In vitro transcription"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0040649:Transcription [Genetic Function]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "micro-injection"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0085672:MICRO [Laboratory Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1553035:Micro [Quantitative Concept]
   861   C1828121:Injection [Functional Concept]
Processing 00000000.tx.1: Synthetic mRNA was prepared from linearized plasmid DNA using mMessage mMachine in vitro transcription kits (Ambion, TX). 

Phrase: "Synthetic mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "prepared from linearized plasmid DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   726   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mMessage mMachine in vitro transcription kits"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   799   C1690540:Kits [Qualitative Concept]
   766 E C0812225:KIT [Medical Device]
   766 E C1150635:KIT [Molecular Function]
   766 E C1705212:Kit [Medical Device]
   766 E C1705213:KIT [Medical Device]
   766 E C3273202:Kit [Manufactured Object]

Phrase: "(Ambion,"

Phrase: "TX"

Phrase: ")."
Processing 00000000.tx.2: RNA yield was quantitated spectrophotometrically. 

Phrase: "RNA yield"

Phrase: "was"

Phrase: "quantitated"

Phrase: "spectrophotometrically."
Processing 00000000.tx.3: The integrity of the in vitro transcribed RNA was determined by agarose gel electrophoresis in the presence of formaldehyde. 

Phrase: "The integrity of the in vitro transcribed RNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205266:integrity [Qualitative Concept]
   744   C0872403:integrity [Individual Behavior]
   744   C1947912:Integrity [Qualitative Concept]

Phrase: "was"

Phrase: "determined by agarose gel electrophoresis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0013856:Electrophoresis, Agarose Gel [Laboratory Procedure]
   806   C0596607:Gel Electrophoresis [Laboratory Procedure]
   806   C1706746:Agarose Gel [Research Device]
   797 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   760   C0013855:Electrophoresis [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0036681:Agarose [Carbohydrate]
   760   C1382104:Gel [Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of formaldehyde."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016564:Formaldehyde [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.4: Injection of Xenopus embryos was as previously described (Smith and Harland, 1992). 

Phrase: "Injection of Xenopus embryos"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021485:injection [Therapeutic or Preventive Procedure]
   770   C1272883:Injection [Biomedical or Dental Material]
   770   C1533685:Injection [Therapeutic or Preventive Procedure]
   770   C1828121:Injection [Functional Concept]

Phrase: "was"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Smith"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "and"

Phrase: "Harland,"

Phrase: "1992"

Phrase: ")."
Processing 00000000.tx.5: o-dianisidine staining of isolated animal cap cells was as described (Huber et al., 1998). 

Phrase: "o-dianisidine staining of isolated animal cap cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Huber et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.6: Injection experiments were repeated at least three times with similar results.

Phrase: "Injection experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "repeated at least three times"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:times [Temporal Concept]
   760   C0205341:Repeated [Functional Concept]
   760   C0205449:Three [Quantitative Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C1547730:Repeat [Temporal Concept]
   726 E C1705914:Repeat [Conceptual Entity]
   726 E C3541383:Time [Temporal Concept]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Cloning and expression analysis of Xenopus LMO-2 (XLMO-2)

Phrase: "Cloning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "expression analysis of Xenopus LMO-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.1: A cDNA representing the full-length Xenopus LMO-2 mRNA was isolated from a Xenopus spleen cDNA library. 

Phrase: "A cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "the full-length Xenopus LMO-2 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated from a Xenopus spleen cDNA library."
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   778   C0751608:cDNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0023621:Library [Manufactured Object,Organization]
   748   C0037993:Spleen [Body Part, Organ, or Organ Component]
   748   C0043342:Xenopus [Amphibian]
   748   C0043343:Xenopus [Amphibian]
   748   C0205409:Isolated [Functional Concept]
   748   C0771377:SPLEEN [Tissue]
   748   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1278932:Spleen [Body Part, Organ, or Organ Component]
   748   C1504663:Xenopus [Amphibian]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.2: Sequence analysis of XLMO-2 predicted a 158 amino acid protein that shares greater than 90% sequence identity to the mouse (Boehm et al., 1991), human (Royer-Pokora et al., 1991) and zebrafish LMO-2 (Thompson et al., 1998) proteins (Fig. 1A). 

Phrase: "Sequence analysis of XLMO-2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0936012:Analysis [Research Activity]
   760   C1519249:Sequence [Functional Concept]
   760   C1524024:analysis [Functional Concept]

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "a 158 amino acid protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1874187:amino acid protein [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "shares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0237876:Share [Social Behavior]

Phrase: "greater than 90% sequence identity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0439093:Greater Than [Quantitative Concept]
   760   C0443228:greater [Quantitative Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]

Phrase: "to the mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "(Boehm et al.,"

Phrase: "1991"

Phrase: ")"

Phrase: ","

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "(Royer-Pokora et al.,"

Phrase: "1991"

Phrase: ")"

Phrase: "and"

Phrase: "zebrafish LMO-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0043457:Zebra Fish [Fish]

Phrase: "(Thompson et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.3: The phylogenetic tree also demonstrates close evolutionary conservation of the LMO-2 proteins from fish to humans (Fig. 1B). 

Phrase: "The phylogenetic tree also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0040811:Tree [Plant]
   827   C0699032:Tree [Functional Concept]
   827   C2362913:Tree [Spatial Concept]

Phrase: "demonstrates"

Phrase: "close evolutionary conservation of the LMO-2 proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2347858:Conservation [Qualitative Concept]

Phrase: "from fish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016163:Fish [Fish]
  1000   C2349190:Fish [Food]
  1000   C2700184:FISH [Qualitative Concept]

Phrase: "to humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.4: RT-PCR analysis for XLMO-2 transcripts on developmentally staged embryos (Nieuwkoop and Faber, 1967) revealed that XLMO-2 was not expressed as a maternal transcript and zygotic expression began after gastrulation at about stage 12.5 (Fig. 2; data not shown). 

Phrase: "RT-PCR analysis for XLMO-2 transcripts"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0200931:PCR analysis [Laboratory Procedure]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0677874:pCR [Finding]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "on developmentally staged embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013935:Embryos [Embryonic Structure]
   793 E C1305370:Embryo [Embryonic Structure]

Phrase: "(Nieuwkoop"

Phrase: "and"

Phrase: "Faber,"

Phrase: "1967"

Phrase: ")"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that XLMO-2"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "expressed as a maternal transcript"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1519595:Transcript [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C2347083:Maternal [Family Group]
   704 E C0026591:Mother [Family Group]

Phrase: "and"

Phrase: "zygotic expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "began after gastrulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0259902:Gastrulation [Organism Function]
   756   C0439659:Begin [Temporal Concept]

Phrase: "at about"

Phrase: "stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "12.5"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.5: For comparison, the expression profiles of XFOG and XGATA-2 are shown, both are present in the maternal RNA pool in the embryo (Kelley et al., 1994; Deconinck et al., 2000).

Phrase: "For comparison,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "the expression profiles of XFOG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "XGATA-2"

Phrase: "are"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "both"

Phrase: "are"

Phrase: "present in the maternal RNA pool"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "in the embryo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013935:Embryo [Embryonic Structure]
  1000   C1305370:Embryo [Embryonic Structure]

Phrase: "(Kelley et al.,"

Phrase: "1994"

Phrase: "; Deconinck et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.1: View larger version (60K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(60K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.3: Amino acid sequence homology between XLMO-2 and the mouse, human and zebrafish homologs. 

Phrase: "Amino acid sequence homology between XLMO-2"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   853   C0162777:Sequence Homology, Amino Acid [Quantitative Concept]
   803 E C0162776:Homologs, Amino Acid Sequence [Amino Acid Sequence]
   778   C0162775:Sequence Homology [Quantitative Concept]
   748   C1334043:Homology [Gene or Genome]
   748   C2697616:Homology [Qualitative Concept]
   728 E C0162774:Sequence Homolog [Molecular Sequence]

Phrase: "and"

Phrase: "the mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "and"

Phrase: "zebrafish homologs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1334043:Homolog [Gene or Genome]
   755 E C2697616:Homology [Qualitative Concept]
Processing 00000000.tx.4: (A) Pile-up analysis of the LMO-2 protein sequences reveals extensive sequence identity between vertebrate LMO-2 proteins. 

Phrase: "(A) Pile-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019112:pile [Acquired Abnormality]

Phrase: "up analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of the LMO-2 protein sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   861   C0002518:protein sequences [Amino Acid Sequence]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "extensive sequence identity between vertebrate LMO-2 proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0424215:Identity [Mental Process]
   744   C2003939:Identity [Finding]
Processing 00000000.tx.5: Accession Numbers for sequences used in this comparison: human (hLMO-2, NM_005574; Boehm et al., 1991), mouse (mLMO-2, NM_008505; Boehm et al., 1991) and zebrafish (zLMO-2, AF191560; Thompson et al., 1998). 

Phrase: "Accession Numbers for sequences"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C2348184:Sequence Number [Quantitative Concept]
   799   C1510755:Accession Number [Intellectual Product]
           Accession
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]
   770   C1706078:Accession [Activity]

Phrase: "used in this comparison"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1273517:used [Finding]
   770   C1707455:Comparison [Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: ":"

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "(hLMO-2,"

Phrase: "NM_005574"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "; Boehm et al.,"

Phrase: "1991"

Phrase: ")"

Phrase: ","

Phrase: "mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "(mLMO-2,"

Phrase: "NM_008505"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "; Boehm et al.,"

Phrase: "1991"

Phrase: ")"

Phrase: "and"

Phrase: "zebrafish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043457:Zebra Fish [Fish]

Phrase: "(zLMO-2,"

Phrase: "AF191560"

Phrase: "; Thompson et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.6: (B) A phylogenetic tree of the LIM-only proteins shows the close relationship of the vertebrate LMO-2 proteins.

Phrase: "(B) A phylogenetic tree of the LIM-only proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0040811:Tree [Plant]
   742   C0699032:Tree [Functional Concept]
   742   C2362913:Tree [Spatial Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the close relationship of the vertebrate LMO-2 proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C1821461:Close Relationship [Finding]
   742   C0439849:Relationship [Qualitative Concept]
   742   C1705630:Relationship [Idea or Concept]
   742   C1706279:Relationship [Idea or Concept]
   742   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: View larger version (90K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(90K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1334335:90K [Gene or Genome]
  1000   C1705384:90K [Gene or Genome]

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.3: Developmental expression of XLMO-2. 

Phrase: "Developmental expression of XLMO-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.4: RT-PCR analysis on developmentally staged embryos shows that XLMO-2 expression begins after gastrulation and is maintained during embryogenesis. 

Phrase: "RT-PCR analysis on developmentally staged embryos"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0200931:PCR analysis [Laboratory Procedure]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0677874:pCR [Finding]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that XLMO-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "begins after gastrulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0259902:Gastrulation [Organism Function]
   790   C0439659:Begin [Temporal Concept]

Phrase: "and"

Phrase: "is"

Phrase: "maintained during embryogenesis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0013936:Embryogenesis [Organ or Tissue Function]
   790   C1314677:Maintained [Functional Concept]
   756 E C0024501:Maintain [Activity]
Processing 00000000.tx.5: RT-PCR analysis of GATA-1, GATA-2 and XFOG transcripts are included for comparison. 

Phrase: "RT-PCR analysis of GATA-1,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0200931:PCR analysis [Laboratory Procedure]
   790   C0599161:RT-PCR [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0677874:pCR [Finding]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "GATA-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427248:GatA [Gene or Genome]

Phrase: "and"

Phrase: "XFOG transcripts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "are"

Phrase: "included for comparison."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0332257:included [Functional Concept]
   790   C1707455:Comparison [Activity]
   790   C3538986:INCLUDED [Gene or Genome]
   756 E C1552866:include [Idea or Concept]
   756 E C2700399:Include [Activity]
Processing 00000000.tx.6: Ornithine decarboxylase (ODC) is included as a control of RNA recovery. 

Phrase: "Ornithine decarboxylase (ODC)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029282:Ornithine Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0029277:Ornithine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "included as a control of RNA recovery."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   748   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0237820:Recovery [Activity]
   748   C0243148:control [Qualitative Concept]
   748   C0332257:included [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1555688:recovery [Idea or Concept]
   748   C1882979:Control [Conceptual Entity]
   748   C2004454:Recovery [Organism Function]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   748   C3538986:INCLUDED [Gene or Genome]
   714 E C1552866:include [Idea or Concept]
   714 E C2700399:Include [Activity]
Processing 00000000.tx.7: RT is a standard reaction that lacks reverse transcriptase and is included as a control for genomic DNA contamination.

Phrase: "RT"

Phrase: "is"

Phrase: "a standard reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "that"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1555029:Reverse [Idea or Concept]
   861   C2257077:transcriptase [Genetic Function]

Phrase: "and"

Phrase: "is"

Phrase: "included as a control"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C0332257:included [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "for genomic DNA contamination."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2936628:DNA Contamination [Human-caused Phenomenon or Process]
   827   C0259846:contamination [Human-caused Phenomenon or Process]
   827   C1881659:CONTAMINATION [Event]
   827   C2349974:Contamination [Idea or Concept]
   734   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Hematopoietic expression of XLMO-2

Phrase: "Hematopoietic expression of XLMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.1: In situ hybridization detects XLMO-2 expression by neurula stage 15, on the ventral side of the embryo (data not shown). 

Phrase: "In situ hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "XLMO-2 expression by neurula stage 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "on the ventral side"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441987:Side [Spatial Concept]

Phrase: "of the embryo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013935:Embryo [Embryonic Structure]
  1000   C1305370:Embryo [Embryonic Structure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.2: At this stage, the expression of XLMO-2 resembles that of GATA-2 (Kelley et al., 1994). 

Phrase: "At this stage,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "the expression of XLMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "resembles"

Phrase: "that of GATA-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1427248:GatA [Gene or Genome]

Phrase: "(Kelley et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.3: As the embryo develops, the ventral expression XLMO-2 becomes further restricted to the region of the developing ventral blood island (VBI). 

Phrase: "As the embryo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013935:Embryo [Embryonic Structure]
  1000   C1305370:Embryo [Embryonic Structure]

Phrase: "develops"

Phrase: ","

Phrase: "the ventral expression XLMO-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0185117:Expression [Therapeutic or Preventive Procedure]
   812   C1704448:Ventral [Spatial Concept]

Phrase: "becomes"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "restricted to the region of the developing ventral blood island (VBI)."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C1511224:Blood Island [Embryonic Structure]
   739   C0005767:Blood [Tissue]
   739   C0005768:blood [Body Substance]
   739   C0017446:Region [Geographic Area]
   739   C0022130:Island [Geographic Area]
   739   C0205147:Region [Spatial Concept]
   739   C0229664:Blood [Body Substance]
   739   C0443288:Restricted [Functional Concept]
   739   C1704448:Ventral [Spatial Concept]
Processing 00000000.tx.4: By stage 21, XLMO-2 staining in the ventral region is very similar to that of SCL and demarcates the nascent V-shaped VBI (Fig. 3A, lateral and ventral views; Mead et al., 1998). 

Phrase: "By stage 21,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "XLMO-2 staining in the ventral region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "very similar to that of SCL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "demarcates"

Phrase: "the nascent V-shaped VBI"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   827   C1511224:Blood Island [Embryonic Structure]
   799   C0005767:Blood [Tissue]
   799   C0005768:blood [Body Substance]
   799   C0022130:Island [Geographic Area]
   799   C0229664:Blood [Body Substance]
   799   C1704448:Ventral [Spatial Concept]
   727 E C0333275:Bloody [Qualitative Concept]
   716 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   716 E C0392895:Bloods [Population Group]
   716 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   716 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "(Fig. 3A,"

Phrase: "lateral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205093:Lateral [Spatial Concept]

Phrase: "and"

Phrase: "ventral views"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:Views [Spatial Concept]

Phrase: "; Mead et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.5: Transverse sections of a stage 26 embryo revealed that the XLMO-2 staining was present in the mesoderm layer beneath the ectoderm (Fig. 3E). 

Phrase: "Transverse sections of a stage 26 embryo"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0205106:Transverse [Spatial Concept]
   748   C0446380:Transverse [Spatial Concept]
           Transverse section
   714   C0205155:Section [Spatial Concept]
   714   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   714   C1522472:Section [Substance]
   714   C1552923:Section [Quantitative Concept]
   714   C1705191:Section [Physical Object]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the XLMO-2 staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "present in the mesoderm layer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "beneath the ectoderm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013574:Ectoderm [Embryonic Structure]
   928 E C0521458:Ectodermal [Body Location or Region]

Phrase: "(Fig. 3E"

Phrase: ")."
Processing 00000000.tx.6: XLMO-2 expression remains at a high level in developing blood cells in the VBI and expression can be detected in circulating blood cells of swimming tadpoles (Fig. 3C,D, asterisked arrowhead). 

Phrase: "XLMO-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "remains at a high level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299351:High [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700149:HIGH [Intellectual Product]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in developing blood cells"
Meta Candidates (Total=17; Excluded=11; Pruned=0; Remaining=6)
   901   C0005773:Blood Cells [Cell]
   856 E C2328697:Hemal cell [Cell]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0007634:Cells [Cell]
   827   C0229664:Blood [Body Substance]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "in the VBI"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   901   C1511224:Blood Island [Embryonic Structure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0022130:Island [Geographic Area]
   827   C0229664:Blood [Body Substance]
   827   C1704448:Ventral [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "be"

Phrase: "detected in circulating blood cells of swimming tadpoles"
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   770   C0005773:Blood Cells [Cell]
   770   C0440738:Circulating blood [Body Substance]
   750   C3156187:cell swimming [Cell Function]
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0007634:Cells [Cell]
   744   C0039003:Swimming [Daily or Recreational Activity]
   744   C0175630:Circulating [Functional Concept]
   744   C0229664:Blood [Body Substance]
   744   C0326967:Tadpoles [Amphibian]
   744   C0442726:Detected [Finding]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C3282337:Cells [Cell]
   734   C0333722:Tadpole cell [Cell]
   726 E C2328697:Hemal cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "asterisked arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0453107:Arrowhead [Food]
   861   C1080898:Arrowhead [Plant]

Phrase: ")."
Processing 00000000.tx.7: XLMO-2 staining is also evident in the dorsal lateral plate (DLP) of the late neurula and early tailbud embryos (Fig. 3A,B, black arrowheads). 

Phrase: "XLMO-2 staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "also evident in the dorsal lateral plate (DLP) of the late neurula"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0332120:Evidence of [Functional Concept]

Phrase: "and"

Phrase: "early tailbud embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013935:Embryos [Embryonic Structure]
   793 E C1305370:Embryo [Embryonic Structure]

Phrase: "(Fig. 3A,"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "black arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1080898:Arrowheads [Plant]
   827 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.8: The DLP, the anatomical equivalent of the mammalian aorta-gonad-mesonephros (AGM) region, is the site of definitive hematopoiesis in the tadpole (Kau and Turpen, 1983). 

Phrase: "The DLP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005971:Plate [Medical Device]
   827   C1139930:plate [Medical Device]
   827   C3537155:Plate [Manufactured Object]

Phrase: "the anatomical equivalent of the mammalian aorta-gonad-mesonephros (AGM) region,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205163:Equivalent [Qualitative Concept]
   739   C0439185:equivalent [Quantitative Concept]

Phrase: "is"

Phrase: "the site of definitive hematopoiesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "in the tadpole"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326967:Tadpole [Amphibian]

Phrase: "(Kau"

Phrase: "and"

Phrase: "Turpen,"

Phrase: "1983"

Phrase: ")."
Processing 00000000.tx.9: XLMO-2 expression in this region is very similar to that of SCL. 

Phrase: "XLMO-2 expression in this region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "very similar to that of SCL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.10: Like SCL, XLMO-2 expression in the DLP diminishes during tailbud stages (Mead et al., 1998). 

Phrase: "Like SCL,"

Phrase: "XLMO-2 expression in the DLP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "diminishes during tailbud stages"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205216:diminish [Quantitative Concept]
   770   C1306673:Stages [Qualitative Concept]
   737 E C0205390:Stage [Temporal Concept]
   737 E C1300072:Stage [Clinical Attribute]

Phrase: "(Mead et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.11: During early neurula stages, as staining becomes condensed within the developing VBI, XLMO-2 expression is also detected at high levels in the tailbud region (Fig. 3A-D). 

Phrase: "During early neurula stages,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   913   C2363430:early stages [Temporal Concept]
   896 E C1517886:Early Stage [Classification]
   827   C1306673:Stages [Qualitative Concept]
   793 E C0205390:Stage [Temporal Concept]
   793 E C1300072:Stage [Clinical Attribute]

Phrase: "as"

Phrase: "staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "becomes"

Phrase: "condensed within the developing VBI,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1511224:Blood Island [Embryonic Structure]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0022130:Island [Geographic Area]
   748   C0229664:Blood [Body Substance]
   748   C1155631:Condensed [Cell Function]
   748   C1704448:Ventral [Spatial Concept]

Phrase: "XLMO-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "also"

Phrase: "detected at high levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   770   C0205250:High [Qualitative Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1299351:High [Qualitative Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C2700149:HIGH [Intellectual Product]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the tailbud region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "(Fig. 3A-"

Phrase: "D)."
Processing 00000000.tx.12: Transverse sections of a neurula revealed that XLMO-2 is detected in the circumblastoporal collar in the nascent tailbud region (Fig. 3F). 

Phrase: "Transverse sections of a neurula"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   773   C0446380:Transverse section [Spatial Concept]
           Transverse
   760   C0205106:Transverse [Spatial Concept]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that XLMO-2"

Phrase: "is"

Phrase: "detected in the circumblastoporal collar"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0175751:Collar [Medical Device]
   760   C0180008:COLLAR [Medical Device]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "in the nascent tailbud region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "(Fig. 3F"

Phrase: ")."
Processing 00000000.tx.13: XLMO-2 expression is also detected in the central nervous system. 

Phrase: "XLMO-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "also"

Phrase: "detected in the central nervous system."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   833   C0927232:Central Nervous System [Body System]
   833   C1269563:Central nervous system [Body System]
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0205099:Central [Spatial Concept]
   753   C0442726:Detected [Finding]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1879652:Central - [Laboratory Procedure]
   734 E C0205494:Neurologic [Qualitative Concept]
Processing 00000000.tx.14: The hematopoietic expression pattern of XLMO-2 is very similar to that of SCL and GATA-1 at the swimming tadpole stage (Fig. 4). 

Phrase: "The hematopoietic expression pattern of XLMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Pattern [Spatial Concept]

Phrase: "is"

Phrase: "very similar to that of SCL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "GATA-1 at the swimming tadpole stage"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1333663:GATA-1 [Gene or Genome]
   778   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0441766:Stage 1 [Intellectual Product]
   748   C0039003:Swimming [Daily or Recreational Activity]
   748   C0205390:Stage [Temporal Concept]
   748   C0326967:Tadpole [Amphibian]
   748   C1300072:Stage [Clinical Attribute]
   748   C1306673:Stage [Qualitative Concept]
   748   C1427248:GatA [Gene or Genome]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.15: While all three are highly expressed in the VBI, LMO-2 and SCL are also present in other tissues such as the tailbud and brain. 

Phrase: "While"

Phrase: "all three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "expressed in the VBI,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1511224:Blood Island [Embryonic Structure]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0022130:Island [Geographic Area]
   753   C0229664:Blood [Body Substance]
   753   C1704448:Ventral [Spatial Concept]

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "SCL"

Phrase: "are"

Phrase: "also"

Phrase: "present in other tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0040300:Tissues [Tissue]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   737 E C1547928:Tissue [Intellectual Product]

Phrase: "such as the tailbud"

Phrase: "and"

Phrase: "brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.16: GATA-1 expression is restricted to the developing erythrocytes within the VBI.

Phrase: "GATA-1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1333663:GATA-1 [Gene or Genome]
   734   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "restricted to the developing erythrocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0014772:Erythrocytes [Laboratory Procedure]
   760   C0014792:Erythrocytes [Cell]
   760   C0443288:Restricted [Functional Concept]

Phrase: "within the VBI."
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   901   C1511224:Blood Island [Embryonic Structure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0022130:Island [Geographic Area]
   827   C0229664:Blood [Body Substance]
   827   C1704448:Ventral [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.1: View larger version (74K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(74K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.3: XLMO-2 expression pattern in embryos. 

Phrase: "XLMO-2 expression pattern in embryos."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]
Processing 00000000.tx.4: RNA in situ hybridization analysis was performed with full-length antisense digoxigenin-labeled probes on albino Xenopus laevis embryos. 

Phrase: "RNA in situ hybridization analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "performed with full-length antisense digoxigenin-labeled probes"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
   767   C0078976:Anti-Sense Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0012264:Digoxigenin [Biologically Active Substance,Pharmacologic Substance,Steroid]
   744   C0182400:Probes [Medical Device]
   744   C0443225:Full [Qualitative Concept]
   744   C0884358:Performed [Functional Concept]
   744   C1444754:Length [Quantitative Concept]
   744   C1706316:LENGTH [Research Activity]
   744   C1708632:Labeled [Qualitative Concept]
   711 E C0181496:Label [Manufactured Object]
   711 E C1704681:Probe [Gene or Genome]
   711 E C2347609:Probe [Chemical Viewed Functionally]
   711 E C2827499:Label [Governmental or Regulatory Activity]
   711 E C2947996:Perform [Pharmacologic Substance]
   711 E C3536729:Probe [Manufactured Object]

Phrase: "on albino Xenopus laevis embryos."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0013935:Embryos [Embryonic Structure]
   779 E C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.5: (A) Stage 21; 

Phrase: "(A) Stage 21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205390:Stage [Temporal Concept]
   827   C1300072:Stage [Clinical Attribute]
   827   C1306673:Stage [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.6: lateral, dorsal and ventral views of the same embryo showing extensive staining in the nascent ventral blood island (VBI), the tailbud region and the dorsal lateral plate (DLP) mesoderm (black arrowheads). 

Phrase: "lateral, dorsal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205095:Dorsal [Spatial Concept]

Phrase: "and"

Phrase: "ventral views of the same embryo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449911:Views [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "extensive staining in the nascent ventral blood island (VBI),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0005835:blood staining [Body Substance]
   744   C0487602:Staining [Laboratory Procedure]
   744   C1704680:Staining [Finding]

Phrase: "the tailbud region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the dorsal lateral plate (DLP) mesoderm"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C1284011:Lateral Plate Mesoderm [Embryonic Structure]
   902   C1284009:Dorsal Mesoderm [Embryonic Structure]
   875   C1517749:Lateral Mesoderm [Embryonic Structure]
   812   C0025485:Mesoderm [Embryonic Structure]
   741 E C0521459:Mesodermal [Body Location or Region]

Phrase: "(black arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1080898:Arrowheads [Plant]
   827 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.7: (B) Stage 26; 

Phrase: "(B) Stage 26"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205390:Stage [Temporal Concept]
   827   C1300072:Stage [Clinical Attribute]
   827   C1306673:Stage [Qualitative Concept]
   827   C2347469:/B [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.8: lateral view. 

Phrase: "lateral view."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]
Processing 00000000.tx.9: Staining is evident in the VBI, DLP (black arrowhead) and tailbud region. 

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "evident in the VBI,"

Phrase: "DLP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005971:Plate [Medical Device]
   827   C1139930:plate [Medical Device]
   827   C3537155:Plate [Manufactured Object]

Phrase: "(black arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0453107:Arrowhead [Food]
   861   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: "and"

Phrase: "tailbud region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.10: Staining is also seen in the brain and in the eye. 

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "also"

Phrase: "seen in the brain"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C0205397:Seen [Qualitative Concept]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "and in the eye."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0015392:Eye [Body Part, Organ, or Organ Component]
   770   C1280202:Eye [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
   715 E C0029144:optic [Occupation or Discipline]
   715 E C0042789:Ocular [Organism Function]
   715 E C1299003:Ocular [Spatial Concept]
Processing 00000000.tx.11: (C) Stage 33; 

Phrase: "(C) Stage 33"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0441785:c stage [Intellectual Product]
   827   C0205390:Stage [Temporal Concept]
   827   C1300072:Stage [Clinical Attribute]
   827   C1306673:Stage [Qualitative Concept]
   827   C1553033:[c] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.12: lateral view. 

Phrase: "lateral view."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]
Processing 00000000.tx.13: Expression of XLMO-2 is maintained at a high level in the VBI but has diminished in the DLP region (black arrowhead). 

Phrase: "Expression of XLMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "maintained at a high level"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299351:High [Qualitative Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700149:HIGH [Intellectual Product]
   760   C2946261:Level [Pharmacologic Substance]
   726 E C0024501:Maintain [Activity]

Phrase: "in the VBI"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   901   C1511224:Blood Island [Embryonic Structure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0022130:Island [Geographic Area]
   827   C0229664:Blood [Body Substance]
   827   C1704448:Ventral [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "but"

Phrase: "has"

Phrase: "diminished in the DLP region"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   774   C0230171:Lateral region [Body Location or Region]
   774   C1456859:Dorsal region [Body Location or Region]
   748   C0005971:Plate [Medical Device]
   748   C0017446:Region [Geographic Area]
   748   C0205093:Lateral [Spatial Concept]
   748   C0205095:Dorsal [Spatial Concept]
   748   C0205147:Region [Spatial Concept]
   748   C0205216:Diminished [Quantitative Concept]
   748   C1139930:plate [Medical Device]
   748   C3537155:Plate [Manufactured Object]

Phrase: "(black arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0453107:Arrowhead [Food]
   861   C1080898:Arrowhead [Plant]

Phrase: ")."
Processing 00000000.tx.14: Staining in the tailbud has condensed to a small region at the tip of the outgrowing tail. 

Phrase: "Staining in the tailbud"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]

Phrase: "has"

Phrase: "condensed to a small region"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0700321:Small [Quantitative Concept]
   760   C1155631:Condensed [Cell Function]

Phrase: "at the tip"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710425:Tip [Medical Device]
  1000   C3282898:Tip [Qualitative Concept]

Phrase: "of the outgrowing tail."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039259:Tail [Body Part, Organ, or Organ Component]
Processing 00000000.tx.15: (D) Stage 37; 

Phrase: "("

Phrase: "D)"

Phrase: "Stage 37"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.16: lateral view. 

Phrase: "lateral view."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449911:View [Spatial Concept]
Processing 00000000.tx.17: Staining is evident throughout the circulatory system as XLMO-2 expression is maintained in circulating primitive erythrocytes (asterisked arrowhead). 

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "evident throughout the circulatory system"

Phrase: "as XLMO-2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "maintained in circulating primitive erythrocytes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0014772:Erythrocytes [Laboratory Procedure]
   760   C0014792:Erythrocytes [Cell]
   760   C0175630:Circulating [Functional Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C3645627:Primitive [Intellectual Product]
   726 E C0024501:Maintain [Activity]

Phrase: "(asterisked arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0453107:Arrowhead [Food]
   861   C1080898:Arrowhead [Plant]

Phrase: ")."
Processing 00000000.tx.18: Expression in the tailbud region has condensed to the very tip of the tail. 

Phrase: "Expression in the tailbud region"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "condensed to the very"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442824:Very [Qualitative Concept]
   770   C1155631:Condensed [Cell Function]

Phrase: "tip of the tail."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1980004:tail tip [Cell Component]
   770   C0039259:Tail [Body Part, Organ, or Organ Component]
   770   C1710425:Tip [Medical Device]
   770   C3282898:Tip [Qualitative Concept]
Processing 00000000.tx.19: (E) Transverse section of a stage 26 embryo (ventral half only). 

Phrase: "(E) Transverse section of a stage 26 embryo"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0446380:Transverse section [Spatial Concept]
           Transverse
   744   C0205106:Transverse [Spatial Concept]
   744   C0205155:Section [Spatial Concept]
   744   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   744   C1522472:Section [Substance]
   744   C1552923:Section [Quantitative Concept]
   744   C1705191:Section [Physical Object]

Phrase: "(ventral half only"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825407:Half [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.20: XLMO-2 stains the ventral blood island (hematopoietic) mesoderm. 

Phrase: "XLMO-2"

Phrase: "stains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "the ventral blood island"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   901   C1511224:Blood Island [Embryonic Structure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0022130:Island [Geographic Area]
   827   C0229664:Blood [Body Substance]
   827   C1704448:Ventral [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "(hematopoietic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018957:Haematopoietic [Body System]
  1000   C0229601:Hematopoietic [Functional Concept]
   928 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: ")"

Phrase: "mesoderm."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0025485:Mesoderm [Embryonic Structure]
   928 E C0521459:Mesodermal [Body Location or Region]
Processing 00000000.tx.21: (F) Transverse section of a stage 21 embryo stained with XLMO-2. 

Phrase: "(F) Transverse section of a stage 21 embryo"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0446380:Transverse section [Spatial Concept]
           Transverse
   744   C0205106:Transverse [Spatial Concept]
   744   C0205155:Section [Spatial Concept]
   744   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   744   C1522472:Section [Substance]
   744   C1552923:Section [Quantitative Concept]
   744   C1705191:Section [Physical Object]

Phrase: "stained with XLMO-2."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.22: Staining is diffuse throughout the mesoderm of the nascent tail bud.

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "diffuse throughout the mesoderm of the nascent tail bud."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205219:Diffuse [Qualitative Concept]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: View larger version (134K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(134K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 4. 

Phrase: "4."
Processing 00000000.tx.3: Comparison of XLMO-2, GATA-1 and SCL expression patterns. 

Phrase: "Comparison of XLMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Comparison [Activity]

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "and"

Phrase: "SCL expression patterns."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]
Processing 00000000.tx.4: RNA in situ hybridization analysis reveals that these genes have very similar expression patterns. 

Phrase: "RNA in situ hybridization analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0872262:RNA Analysis [Laboratory Procedure,Research Activity]
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "that"

Phrase: "these genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "have"

Phrase: "very similar expression patterns."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449774:Patterns [Spatial Concept]
Processing 00000000.tx.5: Each gene is expressed at a high level in the VBI. 

Phrase: "Each gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "expressed at a high level"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299351:High [Qualitative Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700149:HIGH [Intellectual Product]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in the VBI."
Processing 00000000.tx.6: GATA-1 expression is restricted to erythrocytes whereas SCL and XLMO-2 are also expressed in other embryonic tissues such as the brain and tailbud.

Phrase: "GATA-1 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1333663:GATA-1 [Gene or Genome]
   734   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "restricted to erythrocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0014772:Erythrocytes [Laboratory Procedure]
   790   C0014792:Erythrocytes [Cell]
   790   C0443288:Restricted [Functional Concept]

Phrase: "whereas"

Phrase: "SCL"

Phrase: "and"

Phrase: "XLMO-2"

Phrase: "are"

Phrase: "also"

Phrase: "expressed in other embryonic tissues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0920502:Embryonic tissue [Embryonic Structure]
   760   C0013935:Embryonic [Embryonic Structure]
   760   C0040300:Tissues [Tissue]
   726 E C1547928:Tissue [Intellectual Product]

Phrase: "such as the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "tailbud."
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Growth factor induction of XLMO-2

Phrase: "Growth factor induction of XLMO-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induction [Functional Concept]
   753   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.1: To determine the growth factor sensitivity of XLMO-2 expression, we performed animal cap assays. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the growth factor sensitivity of XLMO-2 expression,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0036667:Sensitivity [Quantitative Concept]
   744   C0312418:Sensitivity [Mental Process]
   744   C0427965:Sensitivity [Finding]
   744   C1511883:Sensitivity [Quantitative Concept]
   744   C1522640:Sensitivity [Qualitative Concept]
   744   C2346484:SENSITIVITY [Phenomenon or Process]
   744   C2349185:Sensitivity [Qualitative Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "animal cap assays."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]
   734   C1510894:Animal Cap [Embryonic Structure]
Processing 00000000.tx.2: Animal pole explants loaded with a variety of growth factors were assayed for XLMO-2 expression by semi-quantitative RT-PCR (Fig. 5). 

Phrase: "Animal pole explants"

Phrase: "loaded with a variety of growth factors"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0960756:factor A [Organic Chemical]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C1708715:Loaded [Activity]
   748   C1883525:Variety [Conceptual Entity]
   748   C2346866:Variety [Conceptual Entity]
   748   C2911660:Growth [Activity]
   714   C1521761:Factor [Functional Concept]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "were"

Phrase: "assayed for XLMO-2 expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "by semi-quantitative RT-PCR (Fig. 5"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   827   C0522525:Semi-quantitative [Quantitative Concept]
   827   C0599161:RT-PCR [Molecular Biology Research Technique]
   799   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   799   C0349966:Fig [Food]
   799   C0392762:Quantitative [Quantitative Concept]
   799   C0677874:pCR [Finding]
   799   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.3: Ectopic expression of BMP-4 resulted in high levels of XLMO-2 in the primitive ectoderm explants. 

Phrase: "Ectopic expression of BMP-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1512167:Ectopic Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "resulted in high levels of XLMO-2"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   757   C0456948:Level 2 [Intellectual Product]
   748   C0205250:High [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1299351:High [Qualitative Concept]
   748   C2700149:HIGH [Intellectual Product]
   714 E C0456079:Level [Classification]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714 E C1547707:Level [Geographic Area]
   714   C2825142:Result [Finding]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the primitive ectoderm explants."
Processing 00000000.tx.4: As expected, ectopic expression of the BMP-4 responsive SMAD, XMAD1, also elicited high levels of XLMO-2 expression in the primitive ectoderm explants. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "ectopic expression of the BMP-4 responsive SMAD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1512167:Ectopic Expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "XMAD1,"

Phrase: "also"

Phrase: "elicited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicited [Qualitative Concept]

Phrase: "high levels of XLMO-2 expression"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0456948:Level 2 [Intellectual Product]
   767   C3244092:expression level [Idea or Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the primitive ectoderm explants."
Processing 00000000.tx.5: The sensitivity of XLMO-2 expression to BMP-4 signaling probably accounts for the high level of expression of this transcription factor in nascent hematopoietic mesoderm. 

Phrase: "The sensitivity of XLMO-2 expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to BMP-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0530979:BMP-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0279266:BMP [Therapeutic or Preventive Procedure]

Phrase: "signaling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037083:Signaling [Cell Function]
  1000   C3537152:signaling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "accounts for the high level of expression of this transcription factor"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   756   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C3244092:expression level [Idea or Concept]
   738   C0040649:Transcription [Genetic Function]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0205250:High [Qualitative Concept]
   738   C0441889:Level [Qualitative Concept]
   738   C0456079:Level [Classification]
   738   C1299351:High [Qualitative Concept]
   738   C1521761:Factor [Functional Concept]
   738   C1547707:Level [Geographic Area]
   738   C1551359:account [Idea or Concept]
   738   C2700149:HIGH [Intellectual Product]
   738   C2741673:Account # [Clinical Attribute]
   738   C2827422:Factor [Conceptual Entity]
   738   C2946261:Level [Pharmacologic Substance]
   738   C2981730:Account [Classification]

Phrase: "in nascent hematopoietic mesoderm."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0025485:Mesoderm [Embryonic Structure]
   755 E C0521459:Mesodermal [Body Location or Region]
Processing 00000000.tx.6: A low level of XLMO-2 expression was also seen with the other growth factors assayed (activin, AVg and FGF), and most likely reflects the expression of XLMO-2 outside the hematopoietic system (i.e. in the brain and the tailbud region). 

Phrase: "A low level of XLMO-2 expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0456948:Level 2 [Intellectual Product]
   774   C3244092:expression level [Idea or Concept]
   748   C0205251:low [Qualitative Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1299352:Low [Qualitative Concept]
   748   C1547707:Level [Geographic Area]
   748   C1550472:low [Idea or Concept]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "also"

Phrase: "seen with the"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "other growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "(activin,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0050668:Activin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1135154:ActiVin [Organic Chemical,Pharmacologic Substance]
  1000   C1149454:activin [Molecular Function]
  1000   C1522182:Activin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "AVg"

Phrase: "and"

Phrase: "FGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016026:FGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the expression of XLMO-2 outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the hematopoietic system"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0018957:Haematopoietic system [Body System]
           Haematopoietic
  1000   C1292123:HEMATOPOIETIC SYSTEM [Finding]
   861   C0229601:Hematopoietic [Functional Concept]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0018951:Haematopoiesis [Organ or Tissue Function]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the tailbud region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.7: Untreated animal pole explants do not express LMO-2.

Phrase: "Untreated animal pole explants"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "express"

Phrase: "LMO-2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.1: View larger version (61K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(61K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.3: Growth factor sensitivity of XLMO-2. 

Phrase: "Growth factor sensitivity of XLMO-2."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.4: Animal pole explants were dissected from embryos injected with various growth factors. 

Phrase: "Animal pole explants"

Phrase: "were"

Phrase: "dissected from embryos"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0013935:Embryos [Embryonic Structure]
   790   C0205239:dissected [Functional Concept]
   756 E C1305370:Embryo [Embryonic Structure]

Phrase: "injected with various growth factors."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2911660:Growth [Activity]
   726   C1521761:Factor [Functional Concept]
   726   C1720154:Inject [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.5: Injections were at the 1-cell stage and animal caps were harvested at stage 8. 

Phrase: "Injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "were at the 1-cell stage"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0441766:Stage 1 [Intellectual Product]
   753   C0007634:Cell [Cell]
   753   C0205390:Stage [Temporal Concept]
   753   C1269647:Cell [Cell]
   753   C1300072:Stage [Clinical Attribute]
   753   C1306673:Stage [Qualitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "animal caps"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1510894:Animal Cap [Embryonic Structure]
   861   C0179586:Cap [Manufactured Object]
   861   C1657858:CAP [Medical Device]
   861   C1706092:Cap [Medical Device]

Phrase: "were"

Phrase: "harvested at stage 8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]
   737   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.6: Basic human fibroblast growth factor (bFGF) (20 ng/ml) was applied to uninjected animal caps immediately after dissection. 

Phrase: "Basic human fibroblast growth factor (bFGF)"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   933   C0380603:Fibroblast Growth Factor, Basic [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   933   C0919506:FIBROBLAST GROWTH FACTOR, BASIC [Gene or Genome]
   933   C1522505:Basic Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   884   C0016026:Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0016030:Fibroblast [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: "(20 ng/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "applied to uninjected animal"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0003062:Animal [Animal]
   770   C0185125:Applied [Health Care Activity]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "caps"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0179586:Cap [Manufactured Object]
  1000   C1657858:CAP [Medical Device]
  1000   C1706092:Cap [Medical Device]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "dissection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012737:Dissection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.7: AVg is a chimeric molecule containing the prodomain of activin fused to the functional domain of Vg1. 

Phrase: "AVg"

Phrase: "is"

Phrase: "a chimeric molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the prodomain of activin"

Phrase: "fused to the functional domain of Vg1."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0205245:Functional [Functional Concept]
   748   C0542341:Functional [Functional Concept]
   748   C0699952:Fused [Functional Concept]
   748   C1880389:Domain [Functional Concept]
   748   C1883221:Domain [Conceptual Entity]
   748   C2700217:Functional [Conceptual Entity]
   748   C3541951:Domain [Intellectual Product]
   714 E C1414861:FUSE [Gene or Genome]
   714 E C1708111:Fuse [Manufactured Object]
Processing 00000000.tx.8: Explants and untreated control siblings were harvested at stage 33. 

Phrase: "Explants"

Phrase: "and"

Phrase: "untreated control siblings"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0037047:Siblings [Family Group]
   793 E C1611273:Sibling [Intellectual Product]

Phrase: "were"

Phrase: "harvested at stage 33."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]
   737   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.9: XLMO-2 and GATA-1 transcripts were assayed by semi-quantitative RT-PCR analysis. 

Phrase: "XLMO-2"

Phrase: "and"

Phrase: "GATA-1 transcripts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1519595:Transcripts [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1333663:GATA-1 [Gene or Genome]
   734   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "assayed by semi-quantitative RT-PCR analysis."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C1514628:Quantitative RTPCR [Molecular Biology Research Technique]
   804   C2733022:Quantitative PCR analysis [Laboratory Procedure]
   778   C0200931:PCR analysis [Laboratory Procedure]
   778   C0522525:Semi-quantitative [Quantitative Concept]
   778   C0599161:RT-PCR [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0677874:pCR [Finding]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.10: ODC is ornithine decarboxylase and is used a loading control; 

Phrase: "ODC"

Phrase: "is"

Phrase: "ornithine decarboxylase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029282:Ornithine Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0029277:Ornithine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a loading control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.11: RT is a standard reaction that lacks reverse transcriptase and is included as a control for genomic DNA contamination. 

Phrase: "RT"

Phrase: "is"

Phrase: "a standard reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "that"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1555029:Reverse [Idea or Concept]
   861   C2257077:transcriptase [Genetic Function]

Phrase: "and"

Phrase: "is"

Phrase: "included as a control"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C0332257:included [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "for genomic DNA contamination."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2936628:DNA Contamination [Human-caused Phenomenon or Process]
   827   C0259846:contamination [Human-caused Phenomenon or Process]
   827   C1881659:CONTAMINATION [Event]
   827   C2349974:Contamination [Idea or Concept]
   734   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.12: WE is a whole-embryo positive control.

Phrase: "WE"

Phrase: "is"

Phrase: "a whole-embryo positive control."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C1883676:Positive Control [Conceptual Entity]
   812   C0243148:control [Qualitative Concept]
   812   C0439178:% Positive [Quantitative Concept]
   812   C1446409:Positive [Qualitative Concept]
   812   C1514241:Positive [Finding]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C2825490:Positive [Qualitative Concept]
   812   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: XLMO-2 induces globin gene expression

Phrase: "XLMO-2"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "globin gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.1: To determine whether XLMO-2 can induce globin gene expression in nascent mesoderm we performed an animal pole explant assay. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "XLMO-2"

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "globin gene expression in nascent mesoderm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "an animal pole explant assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.2: Ectopic expression of XLMO-2 in FGF-treated animal pole explants results in extensive globin gene expression as determined by RT-PCR analysis (Fig. 6). 

Phrase: "Ectopic expression of XLMO-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1512167:Ectopic Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in FGF-treated animal pole explants"

Phrase: "results in extensive globin gene expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Gene [Gene or Genome]
   753   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0205231:Extensive [Qualitative Concept]
   753   C1149093:globin [Molecular Function]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "as"

Phrase: "determined by RT-PCR analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0200931:PCR analysis [Laboratory Procedure]
   806   C0599161:RT-PCR [Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0677874:pCR [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.3: Neither FGF treatment alone nor expression of XLMO-2 alone were sufficient to induce globin gene expression (Fig. 6; data not shown).

Phrase: "Neither FGF treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "nor"

Phrase: "expression of XLMO-2 alone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "globin gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.1: View larger version (52K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(52K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 6. 

Phrase: "6."
Processing 00000000.tx.3: Ectopic expression of XLMO-2 in FGF-treated animal caps induces globin gene expression. 

Phrase: "Ectopic expression of XLMO-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1512167:Ectopic Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in FGF-treated animal caps"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1510894:Animal Cap [Embryonic Structure]
   812   C0179586:Cap [Manufactured Object]
   812   C1657858:CAP [Medical Device]
   812   C1706092:Cap [Medical Device]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "globin gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.4: (Top) Animal pole explants were harvested from embryos injected with XLMO-2 mRNA, treated with 20 ng/ml bFGF and allowed to develop to stage 33. 

Phrase: "(Top) Animal pole explants"

Phrase: "were"

Phrase: "harvested from embryos"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0013935:Embryos [Embryonic Structure]
   756 E C1305370:Embryo [Embryonic Structure]
   756   C1512335:Harvest [Health Care Activity]

Phrase: "injected with XLMO-2 mRNA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   726   C1720154:Inject [Functional Concept]

Phrase: "treated with 20 ng/ml bFGF"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0439275:ng/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "33."
Processing 00000000.tx.5: (Bottom) RT-PCR analysis was performed for tadpole -globin and SCL. 

Phrase: "(Bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "RT-PCR analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0200931:PCR analysis [Laboratory Procedure]
   901   C0599161:RT-PCR [Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0677874:pCR [Finding]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed for tadpole -globin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0326967:Tadpole [Amphibian]
   770   C0884358:Performed [Functional Concept]
   770   C1149093:globin [Molecular Function]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "SCL."
Processing 00000000.tx.6: XLMO-2 expression in FGF-treated animal caps leads to expression of -globin and SCL. 

Phrase: "XLMO-2 expression in FGF-treated animal caps"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "leads to expression of -globin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1149093:globin [Molecular Function]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "SCL."
Processing 00000000.tx.7: EF-1 was included as a control for RNA recovery. 

Phrase: "EF-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0059036:EF-1 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "included as a control"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C0332257:included [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "for RNA recovery."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237820:Recovery [Activity]
   861   C1555688:recovery [Idea or Concept]
   861   C2004454:Recovery [Organism Function]
Processing 00000000.tx.8: Embryo lane is a whole sibling embryo used as a positive control for the RT-PCR procedure; 

Phrase: "Embryo lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "is"

Phrase: "a whole sibling embryo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013935:Embryo [Embryonic Structure]
   827   C1305370:Embryo [Embryonic Structure]

Phrase: "used as a positive control"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C1883676:Positive Control [Conceptual Entity]
   760   C0243148:control [Qualitative Concept]
   760   C0439178:% Positive [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C2825490:Positive [Qualitative Concept]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "for the RT-PCR procedure"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]
   734   C0599161:RT-PCR [Molecular Biology Research Technique]

Phrase: ";"
Processing 00000000.tx.9: RT is a standard reaction that lacks reverse transcriptase and is included as a control for genomic DNA contamination.

Phrase: "RT"

Phrase: "is"

Phrase: "a standard reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "that"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "reverse transcriptase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035379:Reverse Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040646:Transcriptase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1555029:Reverse [Idea or Concept]
   861   C2257077:transcriptase [Genetic Function]

Phrase: "and"

Phrase: "is"

Phrase: "included as a control"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C0332257:included [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "for genomic DNA contamination."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2936628:DNA Contamination [Human-caused Phenomenon or Process]
   827   C0259846:contamination [Human-caused Phenomenon or Process]
   827   C1881659:CONTAMINATION [Event]
   827   C2349974:Contamination [Idea or Concept]
   734   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Synergistic hematopoietic activity of LMO-2, SCL and GATA-1

Phrase: "Synergistic hematopoietic activity of LMO-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]
Processing 00000000.tx.1: The effect of ectopic expression of XLMO-2 was examined in whole embryos. 

Phrase: "The effect of ectopic expression of XLMO-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "examined in whole embryos."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0013935:Embryos [Embryonic Structure]
   770   C0332128:Examined [Finding]
   770   C0444667:Whole [Quantitative Concept]
   737 E C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.2: Micro-injection of mRNA encoding LMO-2, SCL or GATA-1 alone have no effect on development (Fig. 7; Mead et al., 1998). 

Phrase: "Micro-injection of mRNA encoding LMO-2,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0021485:injection [Therapeutic or Preventive Procedure]
   748   C0085672:MICRO [Laboratory Procedure]
   748   C1272883:Injection [Biomedical or Dental Material]
   748   C1533685:Injection [Therapeutic or Preventive Procedure]
   748   C1553035:Micro [Quantitative Concept]
   748   C1828121:Injection [Functional Concept]

Phrase: "SCL"

Phrase: "or"

Phrase: "GATA-1 alone"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205171:Alone [Quantitative Concept]
   827   C0439044:alone [Finding]
   827   C0679994:alone [Group Attribute]
   734   C1333663:GATA-1 [Gene or Genome]
   734   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "no effect on development"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "; Mead et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.3: Increasing doses of these transcription factors alone have no apparent effect on development until RNA toxicity problems are encountered at very high doses (data not shown). 

Phrase: "Increasing doses of these transcription factors"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0178602:Doses [Quantitative Concept]
   719 E C0869039:Dose [Quantitative Concept]
   719 E C1114758:Dose # [Clinical Attribute]
   719 E C1428722:DOS [Gene or Genome]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "have"

Phrase: "no apparent effect on development"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "until RNA toxicity problems"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1546466:Problems [Idea or Concept]
   793 E C0033213:Problem [Finding]

Phrase: "are"

Phrase: "encountered at very high doses"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C0442804:Very high [Finding]
   790   C0444956:High dose [Quantitative Concept]
   760   C0178602:Doses [Quantitative Concept]
   760   C0205250:High [Qualitative Concept]
   760   C0442824:Very [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C2700149:HIGH [Intellectual Product]
   726   C0545082:Encounter [Behavior]
   726 E C0869039:Dose [Quantitative Concept]
   726 E C1114758:Dose # [Clinical Attribute]
   726 E C1428722:DOS [Gene or Genome]
   726   C1512346:encounter [Health Care Activity]
   726   C1947978:Encounter [Behavior]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.4: We have previously shown that ectopic expression of SCL in developing Xenopus or zebrafish embryos does not alter normal embryonic development (Mead et al., 1998; Liao et al., 1998; Porcher et al., 1999). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that ectopic expression of SCL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1512167:Ectopic Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in developing Xenopus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0043342:Xenopus [Amphibian]
   861   C0043343:Xenopus [Amphibian]
   861   C1504663:Xenopus [Amphibian]

Phrase: "or"

Phrase: "zebrafish embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013935:Embryos [Embryonic Structure]
   827 E C1305370:Embryo [Embryonic Structure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "normal embryonic development"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C1821244:Normal development [Finding]
   901   C0013936:Embryonic Development [Organ or Tissue Function]
   901   C0243100:embryonic development [Functional Concept]
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]

Phrase: "(Mead et al.,"

Phrase: "1998"

Phrase: "; Liao et al.,"

Phrase: "1998"

Phrase: "; Porcher et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.5: At odds with these findings, Green and co-workers have reported that ectopic expression of SCL alone in the zebrafish is sufficient to perturb normal development, resulting in overproduction of hematopoietic and endothelial progenitors at the expense of pronephric duct and somite tissue (Gering et al., 1998). 

Phrase: "At odds with these findings,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "Green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that ectopic expression of SCL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1512167:Ectopic Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "alone in the zebrafish"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Alone [Quantitative Concept]
   770   C0439044:alone [Finding]
   770   C0679994:alone [Group Attribute]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "perturb"

Phrase: "normal development,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1821244:Normal development [Finding]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "resulting in overproduction of hematopoietic"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0332294:Resulting in [Functional Concept]
   760   C0018957:Haematopoietic [Body System]
   760   C0229601:Hematopoietic [Functional Concept]
   760   C0678226:resulting [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "endothelial progenitors at the expense of pronephric duct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0870134:Progenitor [Family Group]

Phrase: "and"

Phrase: "somite tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "(Gering et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.6: These differences may be due to the differing doses of SCL mRNA and the expression constructs used by the two groups.

Phrase: "These differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "may"

Phrase: "be due to the differing doses of SCL mRNA"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   764   C0678226:Due to [Functional Concept]
           due
   742   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0178602:Doses [Quantitative Concept]
   742   C2987476:Be [Conceptual Entity]
   742   C3146286:Due [Idea or Concept]
   708 E C0869039:Dose [Quantitative Concept]
   708 E C1114758:Dose # [Clinical Attribute]
   708 E C1428722:DOS [Gene or Genome]

Phrase: "and"

Phrase: "the expression constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "used by the two groups."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   806   C1273517:Used by [Finding]
           used
   760   C0205448:Two [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.1: View larger version (91K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(91K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 7. 

Phrase: "7."
Processing 00000000.tx.3: Synergistic activity of LMO-2, SCL and GATA-1 expression in whole embryos. 

Phrase: "Synergistic activity of LMO-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1 expression in whole embryos."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.4: (Top) Embryos were injected at the one cell stage with synthetic mRNAs encoding SCL and LMO-2 (1 ng). 

Phrase: "(Top) Embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013935:Embryos [Embryonic Structure]
   827 E C1305370:Embryo [Embryonic Structure]

Phrase: "were"

Phrase: "injected at the one cell stage"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0007634:Cell [Cell]
   753   C0205390:Stage [Temporal Concept]
   753   C0205447:One [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1300072:Stage [Clinical Attribute]
   753   C1306673:Stage [Qualitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C1720154:Inject [Functional Concept]

Phrase: "with synthetic mRNAs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "SCL"

Phrase: "and"

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1 ng"

Phrase: ")."
Processing 00000000.tx.5: Embryos were cultured to stage 33 and stained for tadpole -globin protein by immunohistochemistry. 

Phrase: "Embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013935:Embryos [Embryonic Structure]
   966 E C1305370:Embryo [Embryonic Structure]

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205390:Stage [Temporal Concept]
  1000   C1300072:Stage [Clinical Attribute]
  1000   C1306673:Stage [Qualitative Concept]

Phrase: "33"

Phrase: "and"

Phrase: "stained for tadpole -globin protein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0326967:Tadpole [Amphibian]
   760   C1149093:globin [Molecular Function]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "by immunohistochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]
Processing 00000000.tx.6: (Bottom) Tadpoles injected with SCL, LMO-2 or GATA-1 alone develop normally and globin expression is limited to the ventral blood island (VBI, black arrows). 

Phrase: "(Bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "Tadpoles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326967:Tadpoles [Amphibian]

Phrase: "injected with SCL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1720154:Inject [Functional Concept]

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "GATA-1 alone"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205171:Alone [Quantitative Concept]
   827   C0439044:alone [Finding]
   827   C0679994:alone [Group Attribute]
   734   C1333663:GATA-1 [Gene or Genome]
   734   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "develop"

Phrase: "normally"

Phrase: "and"

Phrase: "globin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "limited to the ventral blood island"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C1511224:Blood Island [Embryonic Structure]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0022130:Island [Geographic Area]
   753   C0229664:Blood [Body Substance]
   753   C0439801:Limited [Functional Concept]
   753   C1704448:Ventral [Spatial Concept]
   753   C3542948:Limited [Intellectual Product]
   719 E C1549649:Limit [Idea or Concept]
   719 E C2349209:Limit [Conceptual Entity]

Phrase: "(VBI,"

Phrase: "black arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.7: Combination of SCL and LMO-2 mRNA results in developmental abnormalities. 

Phrase: "Combination of SCL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "LMO-2 mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   734   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "results in developmental abnormalities."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   816   C0000768:Developmental abnormality [Congenital Abnormality]
           Abnormalities
   777   C0459424:Abnormal result [Finding]
   770   C0000769:abnormalities [Functional Concept]
   770   C0458003:Developmental [Qualitative Concept]
   770   C0678723:Developmental [Organism Function]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]
   737 E C1704258:Abnormality [Finding]
Processing 00000000.tx.8: Head structures are diminished or completely missing and globin expression extends laterally around the embryo, reaching at least half way up the body. 

Phrase: "Head structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0018670:Head structure [Body Location or Region]
   861   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "or"

Phrase: "completely missing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C1551393:Missing [Idea or Concept]
   861   C1705492:Missing [Qualitative Concept]
   861   C3272743:MISSING [Qualitative Concept]
   827 E C2349206:Miss [Conceptual Entity]

Phrase: "and"

Phrase: "globin expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "laterally around the embryo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0013935:Embryo [Embryonic Structure]
   770   C1305370:Embryo [Embryonic Structure]

Phrase: "reaching at least half way"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2584321:Reaching [Organism Function]
   760   C2825407:Half [Quantitative Concept]

Phrase: "up the body."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242821:body [Human]
  1000   C0460148:Body [Anatomical Structure]
  1000   C1268086:Body [Anatomical Structure]
   916 E C1995017:Bodies [Cell Component]
Processing 00000000.tx.9: Co-injection of LMO-2, SCL and GATA-1 results in severe developmental abnormalities: dorsal/anterior structures are absent and globin staining is evident throughout the body axis.

Phrase: "Co-injection of LMO-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1 results in severe developmental abnormalities"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   732   C0459424:abnormal results [Finding]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: ":"

Phrase: "dorsal/anterior structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "absent"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332197:Absent [Quantitative Concept]
  1000   C2699517:ABSENT [Finding]
   928 E C0424530:Absences [Finding]
   928 E C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "globin staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "is"

Phrase: "evident throughout the body axis."
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Based on the observation that LMO-2, SCL and GATA-1 exist in a transcriptional complex (Wadman et al., 1997), we tested the effect of overexpression of combinations of these transcription factors in whole embryos. 

Phrase: "Based on the observation"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   770   C1964257:Observation [Diagnostic Procedure]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "exist in a transcriptional complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0040649:Transcriptional [Genetic Function]
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]
   760   C2987476:Exist [Conceptual Entity]

Phrase: "(Wadman et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the effect of overexpression of combinations of these transcription factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "in whole embryos."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013935:Embryos [Embryonic Structure]
   827 E C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.2: Surprisingly, co-injection of SCL and LMO-2 (1 ng each) results in dramatic phenotypic changes: head structures are diminished and the length of the body is decreased. 

Phrase: "Surprisingly,"

Phrase: "co-injection of SCL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021485:injection [Therapeutic or Preventive Procedure]
   770   C1272883:Injection [Biomedical or Dental Material]
   770   C1533685:Injection [Therapeutic or Preventive Procedure]
   770   C1828121:Injection [Functional Concept]

Phrase: "and"

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(1 ng"

Phrase: "each"

Phrase: ")"

Phrase: "results in dramatic phenotypic changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   726 E C1705241:Change [Quantitative Concept]

Phrase: ":"

Phrase: "head structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0018670:Head structure [Body Location or Region]
   861   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "and"

Phrase: "the length of the body"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C0221097:Length of body [Organism Attribute]
           Body length
   797   C0005890:Body length, NOS [Organism Attribute]
   760   C1444754:Length [Quantitative Concept]
   760   C1706316:LENGTH [Research Activity]

Phrase: "is"

Phrase: "decreased."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.3: Globin expression, as determined by whole-mount immunohistochemistry, is no longer restricted to the ventral surface of the embryo and is extended laterally up the side of the embryo (Fig. 7). 

Phrase: "Globin expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "determined by whole-mount immunohistochemistry,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021044:Immunohistochemistry [Laboratory Procedure]
   760   C0181909:Mount [Medical Device]
   760   C0444667:Whole [Quantitative Concept]
   760   C0449878:mount [Finding]

Phrase: "is"

Phrase: "no longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205166:Long [Qualitative Concept]
   966   C1706317:Long [Qualitative Concept]

Phrase: "restricted to the ventral surface of the embryo"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0013935:Embryo [Embryonic Structure]
   744   C0205148:Surface [Spatial Concept]
   744   C0443288:Restricted [Functional Concept]
   744   C1305370:Embryo [Embryonic Structure]
   744   C1704448:Ventral [Spatial Concept]

Phrase: "and"

Phrase: "is"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "laterally up the side of the embryo"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0013935:Embryo [Embryonic Structure]
   748   C0441987:Side [Spatial Concept]
   748   C1305370:Embryo [Embryonic Structure]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.4: Qualitatively, there appear to be many more globin-positive cells in the LMO-2- and SCL-injected embryos than in the controls. 

Phrase: "Qualitatively,"

Phrase: "there"

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "many more globin-positive cells in the LMO-2-"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   764   C0439178:% positive cells [Quantitative Concept]
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "SCL-injected embryos than"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0013935:Embryos [Embryonic Structure]
   737 E C1305370:Embryo [Embryonic Structure]

Phrase: "in the controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.5: This mild ventralization is greatly enhanced by including GATA-1 mRNA in the injection cocktail. 

Phrase: "This mild ventralization"

Phrase: "is"

Phrase: "greatly"

Phrase: "enhanced by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2349975:Enhanced [Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "GATA-1 mRNA in the injection cocktail."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.6: Embryos injected with LMO-2, SCL and GATA-1 develop without normal dorsal/anterior structures and the body axis is severely truncated. 

Phrase: "Embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013935:Embryos [Embryonic Structure]
   966 E C1305370:Embryo [Embryonic Structure]

Phrase: "injected with LMO-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C1720154:Inject [Functional Concept]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "develop without normal dorsal/anterior structures"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0442001:Anterior dorsal [Spatial Concept]
   753   C0205094:Anterior [Spatial Concept]
   753   C0205095:Dorsal [Spatial Concept]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C0678594:structures [Spatial Concept]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "the body axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: "is"

Phrase: "severely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205082:Severely [Qualitative Concept]

Phrase: "truncated."
Processing 00000000.tx.7: Globin immunohistochemistry revealed that the triple-injected embryos contain large numbers of globin-expressing cells all over the body (Fig. 7).

Phrase: "Globin immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the triple-injected embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013935:Embryos [Embryonic Structure]
   793 E C1305370:Embryo [Embryonic Structure]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "large numbers of globin-expressing cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "all over the body"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242821:body [Human]
  1000   C0460148:Body [Anatomical Structure]
  1000   C1268086:Body [Anatomical Structure]
   916 E C1995017:Bodies [Cell Component]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.1: In an attempt to quantitate the synergy between these hematopoietic transcription factors, we used an animal pole explant assay. 

Phrase: "In an attempt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516084:Attempt [Event]

Phrase: "quantitate"

Phrase: "the synergy between these hematopoietic transcription factors,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an animal pole explant assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.2: Embryos were injected with CMV-driven plasmids encoding LMO-2, SCL and GATA-1, either alone, in pairs, or all three together. 

Phrase: "Embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013935:Embryos [Embryonic Structure]
   966 E C1305370:Embryo [Embryonic Structure]

Phrase: "were"

Phrase: "injected with CMV-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1720154:Inject [Functional Concept]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "either alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Alone [Quantitative Concept]
   861   C0439044:alone [Finding]
   861   C0679994:alone [Group Attribute]

Phrase: "in pairs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "or"

Phrase: "all three together."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205449:Three [Quantitative Concept]
   861   C1883357:Together [Qualitative Concept]
Processing 00000000.tx.3: Animal pole explants were dissected from the embryos at stage 8 and treated with activin (100 pM). 

Phrase: "Animal pole explants"

Phrase: "were"

Phrase: "dissected from the embryos"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0013935:Embryos [Embryonic Structure]
   770   C0205239:dissected [Functional Concept]
   737 E C1305370:Embryo [Embryonic Structure]

Phrase: "at stage 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "and"

Phrase: "treated with activin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0050668:Activin [Amino Acid, Peptide, or Protein,Hormone]
   790   C1135154:ActiVin [Organic Chemical,Pharmacologic Substance]
   790   C1149454:activin [Molecular Function]
   790   C1522182:Activin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(100 pM"

Phrase: ")."
Processing 00000000.tx.4: The explants were cultured to swimming tadpole stage (Stage 33) and then dissociated with collagenase. 

Phrase: "The explants"

Phrase: "were"

Phrase: "cultured to swimming tadpole stage"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0039003:Swimming [Daily or Recreational Activity]
   760   C0205390:Stage [Temporal Concept]
   760   C0326967:Tadpole [Amphibian]
   760   C1300072:Stage [Clinical Attribute]
   760   C1306673:Stage [Qualitative Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "(Stage 33"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "dissociated with collagenase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.5: Animal cap cell suspensions were stained with o-dianisidine to identify hemoglobin-containing erythrocytes. 

Phrase: "Animal cap cell suspensions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0038960:Suspensions [Biomedical or Dental Material]
   779 E C1382107:Suspension [Substance]
   779 E C1705537:Suspension [Functional Concept]

Phrase: "were"

Phrase: "stained with o-dianisidine to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0011969:Dianisidine [Hazardous or Poisonous Substance,Organic Chemical]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "identify"

Phrase: "hemoglobin-containing erythrocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0014772:Erythrocytes [Laboratory Procedure]
   827   C0014792:Erythrocytes [Cell]
Processing 00000000.tx.6: The cell suspensions were transferred to glass slides and the hemoglobin-positive cells counted under a microscope (Fig. 8). 

Phrase: "The cell suspensions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0038960:Suspensions [Biomedical or Dental Material]
   827 E C1382107:Suspension [Substance]
   827 E C1705537:Suspension [Functional Concept]

Phrase: "were"

Phrase: "transferred to glass slides"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0017596:Glass [Manufactured Object]
   770   C0348011:transferred [Functional Concept]
   770   C0444330:slides [Research Device]
   770   C1947936:Glass [Medical Device]
   737 E C0040671:Transfer [Mental Process]
   737 E C1705201:Slide [Manufactured Object]
   737 E C1705822:Transfer [Activity]

Phrase: "and"

Phrase: "the hemoglobin-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0439178:% positive cells [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "counted under a microscope"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0181839:Microscope [Medical Device]
   770   C1706379:Microscope [Medical Device]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.7: Activin treatment alone does not induce erythrocyte development: activin induces dorsal mesoderm such as muscle and notochord and not ventral mesoderm (blood). 

Phrase: "Activin treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "erythrocyte development"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1820246:erythrocyte development [Cell Function]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: ":"

Phrase: "activin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0050668:Activin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1135154:ActiVin [Organic Chemical,Pharmacologic Substance]
  1000   C1149454:activin [Molecular Function]
  1000   C1522182:Activin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "dorsal mesoderm such as muscle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1284009:Dorsal Mesoderm [Embryonic Structure]
   760   C0025485:Mesoderm [Embryonic Structure]

Phrase: "and"

Phrase: "notochord"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028439:Notochord [Embryonic Structure]
  1000   C1281776:Notochord [Embryonic Structure]

Phrase: "and"

Phrase: "not ventral mesoderm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0025485:Mesoderm [Embryonic Structure]
   755 E C0521459:Mesodermal [Body Location or Region]

Phrase: "(blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.8: Expression of LMO-2, SCL or GATA-1 alone results in the formation of a small number of red blood cells in the animal pole explants (100 hemoglobin-positive cells). 

Phrase: "Expression of LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "SCL"

Phrase: "or"

Phrase: "GATA-1 alone results in the formation of a small number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704   C2825142:Result [Finding]

Phrase: "of red blood cells"
Meta Candidates (Total=24; Excluded=11; Pruned=0; Remaining=13)
  1000   C0014772:Red Blood Cells [Laboratory Procedure]
  1000   C0014792:Red Blood Cells [Cell]
           Red cells
  1000   C0439179:% red blood cells [Quantitative Concept]
  1000   C1277078:Red blood cells [Pharmacologic Substance]
   901   C0005773:Blood Cells [Cell]
   856 E C2328697:Hemal cell [Cell]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0007634:Cells [Cell]
   827   C0229664:Blood [Body Substance]
   827   C0332575:Red [Finding]
   827   C1260956:Red [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "in the animal pole explants"

Phrase: "(100 hemoglobin-positive cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C1441340:100 cells [Cell]
   861   C0439178:% positive cells [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.9: Injection of the transcription factors in pairs results in a moderate increase in the number of red blood cells. 

Phrase: "Injection of the transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "in pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "results in a moderate increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205081:Moderate [Qualitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1881878:Moderate [Qualitative Concept]
   760   C2825142:Result [Finding]

Phrase: "in the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of red blood cells."
Meta Candidates (Total=24; Excluded=11; Pruned=0; Remaining=13)
  1000   C0014772:Red Blood Cells [Laboratory Procedure]
  1000   C0014792:Red Blood Cells [Cell]
           Red cells
  1000   C0439179:% red blood cells [Quantitative Concept]
  1000   C1277078:Red blood cells [Pharmacologic Substance]
   901   C0005773:Blood Cells [Cell]
   856 E C2328697:Hemal cell [Cell]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0007634:Cells [Cell]
   827   C0229664:Blood [Body Substance]
   827   C0332575:Red [Finding]
   827   C1260956:Red [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.10: Combination of LMO-2, SCL and GATA-1 in the injection cocktail results in a massive increase in the numbers of hemoglobinized cells in the animal pole explants. 

Phrase: "Combination of LMO-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1 in the injection cocktail"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C1333663:GATA-1 [Gene or Genome]
   790   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C0678420:Cocktail [Food]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1427248:GatA [Gene or Genome]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1828121:Injection [Functional Concept]

Phrase: "results in a massive increase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0442805:Increase [Functional Concept]
   760   C0522501:Massive [Qualitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "in the numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of hemoglobinized cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "in the animal pole explants."
Processing 00000000.tx.11: The number of erythrocytes produced by the combination of LMO-2, SCL and GATA-1 is higher than the additive value for each transcription factor alone, indicating that these transcription factors synergize in nascent mesoderm to promote primitive hematopoiesis. 

Phrase: "The number of erythrocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C0014772:Erythrocyte Number [Laboratory Procedure]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "produced by the combination of LMO-2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205195:Combination [Qualitative Concept]
   748   C1947911:Combination [Physical Object]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "is"

Phrase: "higher than the additive value"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]

Phrase: "for each transcription factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "indicating"

Phrase: "that"

Phrase: "these transcription factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040649:Transcription [Genetic Function]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "synergize in nascent mesoderm to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0025485:Mesoderm [Embryonic Structure]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "primitive hematopoiesis."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C2262992:primitive haematopoiesis [Organ or Tissue Function]
   861   C0018951:Haematopoiesis [Organ or Tissue Function]
   789 E C0018957:Haematopoietic [Body System]
   789 E C0229601:Hematopoietic [Functional Concept]
Processing 00000000.tx.12: The total number of red blood cells is approximately tenfold higher in the triple-injected embryos compared with the single transcription factors alone. 

Phrase: "The total number of red blood cells"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   788   C0005771:Blood Cell Number [Laboratory Procedure]
   774   C1441375:Cells.total [Cell]
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "is"

Phrase: "approximately tenfold higher in the triple-injected embryos"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0205250:High [Qualitative Concept]
   711   C1299351:High [Qualitative Concept]
   711   C2700149:HIGH [Intellectual Product]

Phrase: "compared with the single transcription factors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0037179:Single [Population Group]
   753   C0040649:Transcription [Genetic Function]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   753   C1707455:Compared [Activity]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.13: Similar results were obtained when basic FGF was used as the mesoderm-inducing agent on the dissected animal pole explants instead of activin (data not shown).

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "basic FGF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016026:FGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "used as the mesoderm-inducing agent"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   783   C0449881:Agent used [Functional Concept]
   753   C0025485:Mesoderm [Embryonic Structure]
   753   C0205263:Inducing [Functional Concept]
   753   C0450442:Agent [Chemical Viewed Functionally]
   753   C1254351:Agent [Pharmacologic Substance]
   753   C1273517:used [Finding]
   753   C1521826:Agent [Intellectual Product]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "on the dissected animal pole explants"

Phrase: "instead of activin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0050668:Activin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1135154:ActiVin [Organic Chemical,Pharmacologic Substance]
  1000   C1149454:activin [Molecular Function]
  1000   C1522182:Activin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.1: View larger version (40K):

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(40K"

Phrase: ")"

Phrase: ":"
Processing 00000000.tx.1: [in this window]

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"
Processing 00000000.tx.1: [in a new window] &nbsp;

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "] &nbsp"

Phrase: ";"
Processing 00000000.tx.1: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.2: 8 LMO-2, SCL and GATA-1 act synergistically in animal pole explants to stimulate red blood cell production. 

Phrase: "8 LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "synergistically in animal pole explants to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0003062:Animal [Animal]
   753   C0935623:Pole [Body Location or Region]
   753   C1418729:POLE [Gene or Genome]

Phrase: "stimulate"

Phrase: "red blood cell production."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0033268:production [Occupational Activity]
   756   C0014792:Red blood cell [Cell]
           Red Cell
Processing 00000000.tx.3: (Top) Embryos were injected at the one-cell stage with CMV-driven plasmids encoding LMO-2, SCL and GATA-1 alone or in combination (100 pg). 

Phrase: "(Top) Embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013935:Embryos [Embryonic Structure]
   827 E C1305370:Embryo [Embryonic Structure]

Phrase: "were"

Phrase: "injected at the one-cell stage"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0007634:Cell [Cell]
   753   C0205390:Stage [Temporal Concept]
   753   C0205447:One [Quantitative Concept]
   753   C1269647:Cell [Cell]
   753   C1300072:Stage [Clinical Attribute]
   753   C1306673:Stage [Qualitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C1720154:Inject [Functional Concept]

Phrase: "with CMV-"

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1 alone"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205171:Alone [Quantitative Concept]
   827   C0439044:alone [Finding]
   827   C0679994:alone [Group Attribute]
   734   C1333663:GATA-1 [Gene or Genome]
   734   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or in combination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205195:Combination [Qualitative Concept]
   790   C1947911:Combination [Physical Object]

Phrase: "(100 pg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.4: Animal caps were dissected at stage 8, treated with activin (100 pM) and collected for analysis at stage 33. 

Phrase: "Animal caps"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1510894:Animal Cap [Embryonic Structure]
   861   C0179586:Cap [Manufactured Object]
   861   C1657858:CAP [Medical Device]
   861   C1706092:Cap [Medical Device]

Phrase: "were"

Phrase: "dissected at stage 8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205239:dissected [Functional Concept]
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]

Phrase: "treated with activin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0050668:Activin [Amino Acid, Peptide, or Protein,Hormone]
   790   C1135154:ActiVin [Organic Chemical,Pharmacologic Substance]
   790   C1149454:activin [Molecular Function]
   790   C1522182:Activin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(100 pM)"

Phrase: "and"

Phrase: "collected for analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   790   C1524024:analysis [Functional Concept]

Phrase: "at stage 33."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]
Processing 00000000.tx.5: Animal cap cells were enzymatically dissociated, stained with o-dianisidine and collected on glass slides in a cytocentrifuge. 

Phrase: "Animal cap cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C1510894:Animal Cap [Embryonic Structure]

Phrase: "were"

Phrase: "enzymatically"

Phrase: "dissociated"

Phrase: ","

Phrase: "stained with o-dianisidine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0011969:Dianisidine [Hazardous or Poisonous Substance,Organic Chemical]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "collected on glass"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0017596:Glass [Manufactured Object]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   790   C1947936:Glass [Medical Device]
   718 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   718 E C0522500:Glassy [Qualitative Concept]

Phrase: "slides in a cytocentrifuge."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0179837:CYTOCENTRIFUGE [Medical Device]
   770   C0444330:Slide [Research Device]
   770   C1705201:Slide [Manufactured Object]
Processing 00000000.tx.6: Hemoglobinzed cells (erythrocytes), stained brown with the chromogenic reagent, were counted on a bright field microscope. 

Phrase: "Hemoglobinzed cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(erythrocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014772:Erythrocytes [Laboratory Procedure]
  1000   C0014792:Erythrocytes [Cell]

Phrase: ")"

Phrase: ","

Phrase: "stained brown with the chromogenic reagent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "counted on a bright field microscope."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0441073:Bright field [Laboratory Procedure]
   753   C0181839:Microscope [Medical Device]
   753   C0423899:Bright [Finding]
   753   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   753   C1521738:Field [Conceptual Entity]
   753   C1706379:Microscope [Medical Device]
   753   C2346620:Field [Conceptual Entity]
   753   C2349184:Field [Conceptual Entity]
   753   C3539073:FIELD [Spatial Concept]
   753   C3539536:BRIGHT [Gene or Genome]
   719   C0750480:Count [Activity]
   719   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.7: (Graph) Activin treatment of animal pole explants does not result in the formation of red blood cells (mock column, animal pole explants treated with activin from uninjected embryos). 

Phrase: "(Graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: ")"

Phrase: "Activin treatment of animal pole explants"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in the formation of red blood cells"
Meta Candidates (Total=24; Excluded=4; Pruned=0; Remaining=20)
   800   C0014772:Red Blood Cells [Laboratory Procedure]
   800   C0014792:Red Blood Cells [Cell]
           Red cells
   800   C0439179:% red blood cells [Quantitative Concept]
   800   C1277078:Red blood cells [Pharmacologic Substance]
   776   C0018951:blood cell formation [Organ or Tissue Function]
   770   C0005773:Blood Cells [Cell]
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0007634:Cells [Cell]
   744   C0220781:formation [Biologic Function]
   744   C0229664:Blood [Body Substance]
   744   C0332575:Red [Finding]
   744   C0439634:formation [Spatial Concept]
   744   C1260956:Red [Qualitative Concept]
   744   C1274040:Result [Functional Concept]
   744   C1522492:Formation [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]
   744   C3282337:Cells [Cell]
   726 E C2328697:Hemal cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "(mock column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: "animal pole explants"

Phrase: "treated with activin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0050668:Activin [Amino Acid, Peptide, or Protein,Hormone]
   790   C1135154:ActiVin [Organic Chemical,Pharmacologic Substance]
   790   C1149454:activin [Molecular Function]
   790   C1522182:Activin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "from uninjected embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013935:Embryos [Embryonic Structure]
   827 E C1305370:Embryo [Embryonic Structure]

Phrase: ")."
Processing 00000000.tx.8: Expression of LMO-2, GATA-1 and SCL alone, or in tandem, gives rise to a moderate number of erythroid cells. 

Phrase: "Expression of LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "and"

Phrase: "SCL"

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or"

Phrase: "in tandem,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0075804:TANDEM [Organic Chemical,Pharmacologic Substance]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "rise to a moderate number of erythroid cells."
Processing 00000000.tx.9: Co-injection of LMO-2/GATA-1/SCL results in large numbers of o-dianisidine-positive cells in the embryonic explants.

Phrase: "Co-injection of LMO-2/GATA-1/SCL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1828121:Injection [Functional Concept]

Phrase: "results in large numbers of o-dianisidine-positive cells"
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   764   C0439178:% positive cells [Quantitative Concept]
           % Positive
   745   C0007584:Cell Number [Laboratory Procedure]
   742   C0007634:Cells [Cell]
   742   C0011969:Dianisidine [Hazardous or Poisonous Substance,Organic Chemical]
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C0549177:Large [Quantitative Concept]
   742   C1274040:Result [Functional Concept]
   742   C1446409:Positive [Qualitative Concept]
   742   C1514241:Positive [Finding]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]
   742   C2825490:Positive [Qualitative Concept]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "in the embryonic explants."
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Xenopus LMO-2 is expressed in hematopoietic mesoderm and is responsive to BMP-4 signaling.

Phrase: "Xenopus LMO-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0043342:Xenopus [Amphibian]
   827   C0043343:Xenopus [Amphibian]
   827   C1504663:Xenopus [Amphibian]

Phrase: "is"

Phrase: "expressed in hematopoietic mesoderm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0018957:Haematopoietic [Body System]
   770   C0025485:Mesoderm [Embryonic Structure]
   770   C0229601:Hematopoietic [Functional Concept]

Phrase: "and"

Phrase: "is"

Phrase: "responsive to BMP-4 signaling."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205342:Responsive [Functional Concept]
Processing 00000000.tx.1: We have cloned the Xenopus homolog of LMO-2, a gene first identified in humans with T-cell acute lymphoblastic leukemia. 

Phrase: "We"

Phrase: "have"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "the Xenopus homolog of LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1334043:Homolog [Gene or Genome]

Phrase: "a gene first"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "identified in humans"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0086418:Humans [Human]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "with T-cell acute lymphoblastic leukemia."
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
  1000   C1961099:Lymphoblastic Leukemia, Acute, T-Cell [Neoplastic Process]
   933   C0023493:t cell acute leukemia [Neoplastic Process]
   911   C0023492:Leukemia, T-Cell [Neoplastic Process]
   884   C0023449:Acute lymphoblastic leukaemia [Neoplastic Process]
           Lymphoblastic leukaemia
   884   C1961102:Lymphoblastic Leukemia, Acute [Neoplastic Process]
           Lymphoblastic Leukemia
   884   C3542401:Acute Lymphoblastic Leukemia [Intellectual Product]
   853   C0085669:Acute leukaemia [Neoplastic Process]
   853   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   840   C0023448:Lymphoblastic leukemia [Neoplastic Process]
   840   C0039194:T-cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0023418:Leukaemia [Neoplastic Process]
   804   C0205178:acute [Temporal Concept]
   804   C0229613:lymphoblastic [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   733 E C1167770:Lymphoblasts [Laboratory Procedure]
Processing 00000000.tx.2: Analysis of the expression profile of this gene in Xenopus indicates that it is expressed in ventral mesoderm shortly after gastrulation. 

Phrase: "Analysis of the expression profile of this gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   789   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "in Xenopus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043342:Xenopus [Amphibian]
  1000   C0043343:Xenopus [Amphibian]
  1000   C1504663:Xenopus [Amphibian]

Phrase: "indicates"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "expressed in ventral mesoderm shortly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0025485:Mesoderm [Embryonic Structure]
   760   C1704448:Ventral [Spatial Concept]

Phrase: "after"

Phrase: "gastrulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0259902:Gastrulation [Organism Function]
Processing 00000000.tx.3: In the early neurula, LMO-2 is expressed in a broader domain than SCL and resembles the expression pattern of GATA-2 on the ventral surface of the embryo. 

Phrase: "In the early neurula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518306:Neurula [Embryonic Structure]

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "expressed in a broader domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]
   726   C0332464:Broad [Spatial Concept]

Phrase: "than SCL"

Phrase: "and"

Phrase: "resembles"

Phrase: "the expression pattern of GATA-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "on the ventral surface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205148:Surface [Spatial Concept]
   861   C1704448:Ventral [Spatial Concept]

Phrase: "of the embryo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013935:Embryo [Embryonic Structure]
  1000   C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.4: Like GATA-2, LMO-2 expression in ventral mesoderm becomes restricted to the nascent ventral blood island (VBI) as development proceeds (Kelley et al., 1994; Walmsley et al., 1994). 

Phrase: "Like GATA-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427248:GatA [Gene or Genome]

Phrase: "LMO-2 expression in ventral mesoderm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "becomes"

Phrase: "restricted to the nascent ventral blood island (VBI)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1511224:Blood Island [Embryonic Structure]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0022130:Island [Geographic Area]
   748   C0229664:Blood [Body Substance]
   748   C0443288:Restricted [Functional Concept]
   748   C1704448:Ventral [Spatial Concept]

Phrase: "as development proceeds"

Phrase: "(Kelley et al.,"

Phrase: "1994"

Phrase: "; Walmsley et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.5: LMO-2 expression is maintained at a high level in the VBI and can be detected in circulating blood cells at swimming tadpole stages. 

Phrase: "LMO-2 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "maintained at a high level"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0205250:High [Qualitative Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1299351:High [Qualitative Concept]
   760   C1314677:Maintained [Functional Concept]
   760   C1547707:Level [Geographic Area]
   760   C2700149:HIGH [Intellectual Product]
   760   C2946261:Level [Pharmacologic Substance]
   726 E C0024501:Maintain [Activity]

Phrase: "in the VBI"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   901   C1511224:Blood Island [Embryonic Structure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0022130:Island [Geographic Area]
   827   C0229664:Blood [Body Substance]
   827   C1704448:Ventral [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "detected in circulating blood cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   806   C0005773:Blood Cells [Cell]
   806   C0440738:Circulating blood [Body Substance]
   762 E C2328697:Hemal cell [Cell]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0007634:Cells [Cell]
   760   C0175630:Circulating [Functional Concept]
   760   C0229664:Blood [Body Substance]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "at swimming tadpole stages."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1306673:Stages [Qualitative Concept]
   793 E C0205390:Stage [Temporal Concept]
   793 E C1300072:Stage [Clinical Attribute]
Processing 00000000.tx.6: LMO-2, like SCL and GATA-3, is also expressed in the dorsal lateral plate mesoderm  the site of definitive hematopoiesis in Xenopus (C. M. Kelley, PhD Thesis. Harvard University, Boston, MA, 1995; Kau and Turpen, 1983; Mead et al., 1998). 

Phrase: "LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like SCL"

Phrase: "and"

Phrase: "GATA-3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2699987:GATA-3 [Amino Acid, Peptide, or Protein]
   861   C1427248:GatA [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "expressed in the dorsal lateral plate mesoderm"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C1284011:Lateral Plate Mesoderm [Embryonic Structure]
   774   C1284009:Dorsal Mesoderm [Embryonic Structure]
   774   C1517749:Lateral Mesoderm [Embryonic Structure]
   748   C0005971:Plate [Medical Device]
   748   C0025485:Mesoderm [Embryonic Structure]
   748   C0205093:Lateral [Spatial Concept]
   748   C0205095:Dorsal [Spatial Concept]
   748   C1139930:plate [Medical Device]
   748   C3537155:Plate [Manufactured Object]

Phrase: "the site of definitive hematopoiesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C2945843:Site of [Qualitative Concept]
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "in Xenopus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043342:Xenopus [Amphibian]
  1000   C0043343:Xenopus [Amphibian]
  1000   C1504663:Xenopus [Amphibian]

Phrase: "(C. M. Kelley,"

Phrase: "PhD Thesis. Harvard University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0041740:University [Manufactured Object,Organization]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA,"

Phrase: "1995"

Phrase: "; Kau"

Phrase: "and"

Phrase: "Turpen,"

Phrase: "1983"

Phrase: "; Mead et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.7: LMO-2 is also expressed outside the hematopoietic compartment, with high levels evident in the tailbud region and in the brain.

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "also"

Phrase: "expressed"

Phrase: "outside"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205101:Outside [Spatial Concept]

Phrase: "the hematopoietic compartment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "with high levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "evident in the tailbud region"

Phrase: "and in the brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.1: Using animal cap explant assays we have shown that LMO-2 expression is upregulated by BMP-4 activity. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "animal cap explant assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that LMO-2 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "upregulated by BMP-4 activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0530979:BMP-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0279266:BMP [Therapeutic or Preventive Procedure]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.2: This is consistent with a role for LMO-2 in the regulation of primitive hematopoiesis. 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with a role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "for LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of primitive hematopoiesis."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C2262992:primitive haematopoiesis [Organ or Tissue Function]
   861   C0018951:Haematopoiesis [Organ or Tissue Function]
   789 E C0018957:Haematopoietic [Body System]
   789 E C0229601:Hematopoietic [Functional Concept]
Processing 00000000.tx.3: XLMO-2, which does not bind DNA itself, can induce the expression of -globin in FGF-treated animal pole explants. 

Phrase: "XLMO-2,"

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "itself,"

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of -globin in FGF-treated animal pole explants."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0017645:Globin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C1149093:globin [Molecular Function]
Processing 00000000.tx.4: Treatment of animal caps with FGF, however, results in a low level of SCL expression (Fig. 6; Mead et al., 1998). 

Phrase: "Treatment of animal caps"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with FGF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016026:FGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "however,"

Phrase: "results in a low level of SCL expression"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C3244092:expression level [Idea or Concept]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0205251:low [Qualitative Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1274040:Result [Functional Concept]
   744   C1299352:Low [Qualitative Concept]
   744   C1546471:Result [Idea or Concept]
   744   C1547707:Level [Geographic Area]
   744   C1550472:low [Idea or Concept]
   744   C2825142:Result [Finding]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "; Mead et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.5: In the presence of a small amount of SCL, ectopic LMO-2 expression may result in the stabilization of an erythroid-promoting transcription complex and thus upregulate -globin expression. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of a small amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:Amount [Quantitative Concept]

Phrase: "of SCL,"

Phrase: "ectopic LMO-2 expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1512167:Ectopic Expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "result in the stabilization of an erythroid-promoting transcription complex"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   739   C0033414:Promoting [Activity]
   739   C0040649:Transcription [Genetic Function]
   739   C0439855:Complex [Qualitative Concept]
   739   C1274040:Result [Functional Concept]
   739   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
   739   C1516960:Erythroid [Qualitative Concept]
   739   C1546471:Result [Idea or Concept]
   739   C1704241:Complex [Chemical Viewed Structurally]
   739   C2825142:Result [Finding]

Phrase: "and"

Phrase: "thus"

Phrase: "upregulate -"

Phrase: "globin expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.6: The GATA-binding factors, GATA-1 and GATA-2, are normally present in animal pole ectoderm and are thus likely to be able to participate in the multimeric transcription complex (Kelley et al., 1994). 

Phrase: "The GATA-binding factors,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1564871:GATA Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "and"

Phrase: "GATA-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427248:GatA [Gene or Genome]

Phrase: "are"

Phrase: "normally"

Phrase: "present in animal pole ectoderm"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003062:Animal [Animal]
   760   C0013574:Ectoderm [Embryonic Structure]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0935623:Pole [Body Location or Region]
   760   C1418729:POLE [Gene or Genome]

Phrase: "and"

Phrase: "are"

Phrase: "thus likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "participate in the multimeric transcription complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040649:Transcription [Genetic Function]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Kelley et al.,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.7: In support of this hypothesis, SCL expression is also upregulated in the presence of XLMO-2, perhaps indicating a positive feedback mechanism promoting erythroid differentiation (Fig. 6).

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "SCL expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "also"

Phrase: "upregulated in the presence of XLMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "perhaps"

Phrase: "indicating"

Phrase: "a positive feedback mechanism promoting erythroid differentiation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0007589:Differentiation [Cell Function]
   799   C1511938:Differentiation [Clinical Attribute]
   799   C2945687:Differentiation [Functional Concept]
   727 E C0205615:Differentiated [Qualitative Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.1: LMO-2, SCL and GATA-1 act synergistically to promote red blood cell formation

Phrase: "LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "synergistically to"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "red blood cell formation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0018951:blood cell formation [Organ or Tissue Function]
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]
   756   C0014792:Red blood cell [Cell]
           Red Cell
Processing 00000000.tx.1: Overexpression of SCL, LMO-2 and GATA-1 in activin-treated animal pole explants leads to the production of a large numbers of hemoglobinized cells. 

Phrase: "Overexpression of SCL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GATA-1 in activin-treated animal pole explants"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   770   C1333663:GATA-1 [Gene or Genome]
   770   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0003062:Animal [Animal]
   744   C0050668:Activin [Amino Acid, Peptide, or Protein,Hormone]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C0935623:Pole [Body Location or Region]
   744   C1135154:ActiVin [Organic Chemical,Pharmacologic Substance]
   744   C1149454:activin [Molecular Function]
   744   C1418729:POLE [Gene or Genome]
   744   C1427248:GatA [Gene or Genome]
   744   C1522182:Activin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1522326:Treated [Functional Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "leads to the production of a large numbers of hemoglobinized cells."
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   738   C0007634:Cells [Cell]
   738   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   738   C0033268:production [Occupational Activity]
   738   C0181586:leads [Medical Device]
   738   C0237753:*Number [Quantitative Concept]
   738   C0449788:Number [Quantitative Concept]
   738   C0549177:Large [Quantitative Concept]
   738   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   738   C1522538:Lead [Functional Concept]
   738   C2348269:Lead [Element, Ion, or Isotope]
   738   C3275067:LEAD [Therapeutic or Preventive Procedure]
   738   C3282337:Cells [Cell]
   737   C0007584:Cell Number [Laboratory Procedure]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.2: Expression of these transcription factors alone, or in pairs, leads to a mild increase in erythrocyte production. 

Phrase: "Expression of these transcription factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or in pairs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709450:Pair [Qualitative Concept]

Phrase: "leads to a mild increase"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0181586:leads [Medical Device]
   760   C0442805:Increase [Functional Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C2945599:Mild [Qualitative Concept]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in erythrocyte production."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014819:Erythrocyte production [Cell Function,Organ or Tissue Function]
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.3: The synergy of these transcription factors was also noted in the phenotypes resulting from embryos injected with LMO-2, SCL and GATA-1. 

Phrase: "The synergy of these transcription factors"

Phrase: "was"

Phrase: "also"

Phrase: "noted in the phenotypes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0031437:Phenotypes [Organism Attribute]
   737 E C1285572:Phenotype [Laboratory Procedure]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "resulting from embryos"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0013935:Embryos [Embryonic Structure]
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1305370:Embryo [Embryonic Structure]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]

Phrase: "injected with LMO-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C1720154:Inject [Functional Concept]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]
Processing 00000000.tx.4: The phenotype of the "triple-injected" embryos is reminiscent of those injected with BMP-4, where ventralization results in expansion of ventral mesoderm derivatives (such as blood) at the expense of dorsal structures (such as muscle and notochord). 

Phrase: "The phenotype of the """
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031437:Phenotype [Organism Attribute]
   770   C1285572:Phenotype [Laboratory Procedure]

Phrase: "triple-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triple [Quantitative Concept]

Phrase: "injected"" embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013935:Embryos [Embryonic Structure]
   827 E C1305370:Embryo [Embryonic Structure]

Phrase: "is"

Phrase: "reminiscent of those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0871247:reminiscence [Mental Process]

Phrase: "injected with BMP-4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0530979:BMP-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0279266:BMP [Therapeutic or Preventive Procedure]
   737   C1720154:Inject [Functional Concept]

Phrase: "where ventralization"

Phrase: "results in expansion of ventral mesoderm derivatives"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0025485:Mesoderm [Embryonic Structure]
   748   C0243072:derivatives [Chemical Viewed Structurally]
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C1704448:Ventral [Spatial Concept]
   748   C2825142:Result [Finding]
   714 E C1527240:Derivative [Functional Concept]

Phrase: "("

Phrase: "such as blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: ")"

Phrase: "at the expense"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680864:expense [Quantitative Concept]

Phrase: "of dorsal structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "("

Phrase: "such as muscle"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]

Phrase: "and"

Phrase: "notochord"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028439:Notochord [Embryonic Structure]
  1000   C1281776:Notochord [Embryonic Structure]

Phrase: ")."
Processing 00000000.tx.5: These data, taken together with the overlapping expression patterns of these transcription factors and the fact that these proteins interact in vitro, strongly suggest that LMO-2, SCL and GATA-1 act synergistically in a multi-protein complex to promote red blood cell formation. 

Phrase: "These data,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "taken together with the overlapping expression patterns of these transcription factors"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   756   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0040649:Transcription [Genetic Function]
   738   C0185027:Overlapping [Therapeutic or Preventive Procedure]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
   738   C0449774:Patterns [Spatial Concept]
   738   C1883357:Together [Qualitative Concept]
   738   C1883727:Taken [Conceptual Entity]
   738   C1948020:Overlapping [Conceptual Entity]
   704 E C1515187:Take [Health Care Activity]
   704   C1521761:Factor [Functional Concept]
   704   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "the fact"

Phrase: "that"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "interact"

Phrase: "in vitro, strongly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0021135:In Vitro [Intellectual Product]
   901   C1533691:in vitro [Qualitative Concept]
           vitro
   901   C2827718:In Vitro [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "synergistically in a multi-protein complex to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1523872:protein complex [Cell Component]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439064:Multi [Quantitative Concept]
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "red blood cell formation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0018951:blood cell formation [Organ or Tissue Function]
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]
   756   C0014792:Red blood cell [Cell]
           Red Cell
Processing 00000000.tx.6: It is important to note, however, that the activity of this transcription complex in explanted embryonic tissue may not necessarily reflect the response seen in the context of the whole embryo.

Phrase: "It"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: ","

Phrase: "however,"

Phrase: "that"

Phrase: "the activity of this transcription complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "in explanted embryonic tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0920502:Embryonic tissue [Embryonic Structure]
   827   C0040300:Tissue [Tissue]
   827   C1547928:Tissue [Intellectual Product]

Phrase: "may"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "seen in the context of the whole embryo."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0013935:Embryo [Embryonic Structure]
   744   C0205397:Seen [Qualitative Concept]
   744   C0444667:Whole [Quantitative Concept]
   744   C0449255:Context [Finding]
   744   C0542559:Context [Functional Concept]
   744   C1305370:Embryo [Embryonic Structure]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]
Processing 00000000.tx.1: Two models, which do not preclude each other, can be proposed to explain the phenotypic effects of the injecting these erythroid transcription factors. 

Phrase: "Two models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "which"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "preclude"

Phrase: "each other,"

Phrase: "can"

Phrase: "be"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "explain"

Phrase: "the phenotypic effects of the injecting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "these erythroid transcription factors."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   983   C1530719:Erythroid Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   983   C2827370:Erythroid Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0040648:Transcription Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040649:Transcription [Genetic Function]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.2: The first model predicts the cell autonomous activation of the blood program by the formation of the hematopoietic complex containing SCL, LMO-2 and GATA-1. 

Phrase: "The first model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "predicts"

Phrase: "the cell autonomous activation of the blood program"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1326120:cell activation [Cell Function]
   744   C1879547:Activation [Activity]

Phrase: "by the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of the hematopoietic complex containing SCL,"

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GATA-1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]
Processing 00000000.tx.3: In this manner, the complex provides a molecular address for hematopoietic mesoderm formation within the embryo and overrides endogenous signals that specify other tissues. 

Phrase: "In this manner,"

Phrase: "the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "a molecular address for hematopoietic mesoderm formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0376649:Address [Intellectual Product]
   748   C1442065:Address [Spatial Concept]

Phrase: "within the embryo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013935:Embryo [Embryonic Structure]
  1000   C1305370:Embryo [Embryonic Structure]

Phrase: "and"

Phrase: "overrides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547671:Override [Activity]

Phrase: "endogenous signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "that"

Phrase: "specify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521902:Specify [Qualitative Concept]

Phrase: "other tissues."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040300:Tissues [Tissue]
   966 E C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.4: For instance, when overexpressed, the erythroid complex (SCL, LMO-2 and GATA-1) may compete with a myogenic complex that specifies muscle. 

Phrase: "For instance,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550608:Instance [Idea or Concept]

Phrase: "when"

Phrase: "overexpressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: ","

Phrase: "the erythroid complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(SCL,"

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: ")"

Phrase: "may"

Phrase: "compete with a myogenic complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "specifies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521902:Specify [Qualitative Concept]

Phrase: "muscle."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026845:Muscle [Tissue]
   928 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.5: The second model posits that the overexpression of SCL, LMO-2 and GATA-1 acts, in part, in a non-cell autonomous manner. 

Phrase: "The second model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "posits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0814253:POSIT [Intellectual Product]

Phrase: "that"

Phrase: "the overexpression of SCL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GATA-1 acts,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0079613:ACT [Therapeutic or Preventive Procedure]
   734   C1333663:GATA-1 [Gene or Genome]
   734   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "in a non-cell autonomous manner."
Processing 00000000.tx.6: Non-neuronal ectoderm has been shown to participate in hematopoiesis in a non-cell autonomous manner, in part, through the action of bone morphogenetic proteins (BMPs). 

Phrase: "Non-neuronal ectoderm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0013574:Ectoderm [Embryonic Structure]
   755 E C0521458:Ectodermal [Body Location or Region]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate in hematopoiesis"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0018951:Haematopoiesis [Organ or Tissue Function]
   718 E C0018957:Haematopoietic [Body System]
   718 E C0229601:Hematopoietic [Functional Concept]

Phrase: "in a non-cell autonomous manner,"

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "through the action"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441472:Action [Functional Concept]
  1000   C3266814:Action [Activity]

Phrase: "of bone morphogenetic proteins (BMPs)."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0053932:Bone Morphogenetic Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   865   C2610491:bone morphogenesis [Organism Function]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   755   C0026559:Morphogenesis [Organism Function]
   755 E C0443157:Bony [Functional Concept]
Processing 00000000.tx.7: When ectodermal cells, a source of BMP signaling, are co-cultured with ventral mesoderm, there is an enhancement of blood formation (Maeno et al., 1994b). 

Phrase: "When"

Phrase: "ectodermal cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1183495:Ectodermal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "a source of BMP signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449416:Source [Finding]
   760   C1705919:Source [Idea or Concept]

Phrase: "are"

Phrase: "co-cultured with ventral mesoderm,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0282547:Co-culture [Laboratory Procedure]
   760   C0025485:Mesoderm [Embryonic Structure]
   760   C1704448:Ventral [Spatial Concept]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "there"

Phrase: "is"

Phrase: "an enhancement of blood formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "(Maeno et al.,"

Phrase: "1994b"

Phrase: ")."
Processing 00000000.tx.8: In support of this model, we have demonstrated that a cocktail of SCL, LMO-2 and GATA-1 can activate a BMP promoter reporter construct in Xenopus embryos (data not shown). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "a cocktail of SCL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678420:Cocktail [Food]

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "a BMP promoter reporter construct in Xenopus embryos"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2827421:Construct [Classification]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.9: Indeed, the BMP-4 promoter region contains multiple GATA and E-box binding sites and may be directly induced by factors that bind these sites (Kim et al., 1998). 

Phrase: "Indeed,"

Phrase: "the BMP-4 promoter region"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0017446:Region [Geographic Area]
   812   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "multiple GATA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1427248:GatA [Gene or Genome]

Phrase: "and"

Phrase: "E-box binding sites"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   923   C0949655:E-Box Sites [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   923   C2753969:E-box binding [Genetic Function]
   861   C0005456:Binding Sites [Receptor]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Sites [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "induced by factors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205263:Induced [Functional Concept]
   756   C1521761:Factor [Functional Concept]
   756   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "these sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "(Kim et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.10: BMP-4, secreted from cells expressing the LMO-2/SCL/GATA-1 transcription complex, could influence neighboring cells to adopt a ventral (hematopoietic) fate. 

Phrase: "BMP-4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0530979:BMP-4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0279266:BMP [Therapeutic or Preventive Procedure]

Phrase: "secreted from cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1327616:Secreted [Cell Function]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "the LMO-2/SCL/GATA-1 transcription complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0439855:Complex [Qualitative Concept]
   795   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "could"

Phrase: "influence"

Phrase: "neighboring cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "adopt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopt [Finding]

Phrase: "a ventral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704448:Ventral [Spatial Concept]

Phrase: "(hematopoietic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018957:Haematopoietic [Body System]
  1000   C0229601:Hematopoietic [Functional Concept]
   928 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: ")"

Phrase: "fate."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1539479:FATE [Gene or Genome]
   928 E C1302234:Fatal [Qualitative Concept]
   928 E C1705232:Fatal [Finding]
Processing 00000000.tx.11: An auto-activation loop of BMP signaling may then enhance the initial BMP induction (Metz et al., 1998). 

Phrase: "An auto-activation loop of BMP signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0419518:Loop [Medical Device]
   748   C0445022:Loop [Spatial Concept]

Phrase: "may"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the initial BMP induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205263:Induction [Functional Concept]
   827   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "(Metz et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.12: Such sequential activation of BMP may normally occur during embryonic development. 

Phrase: "Such sequential activation of BMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "may"

Phrase: "normally"

Phrase: "occur during embryonic development."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0013936:Embryonic Development [Organ or Tissue Function]
   833   C0243100:embryonic development [Functional Concept]
   770   C0013935:Embryonic [Embryonic Structure]
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.13: Our data do not rule out either model, and it is likely that the observed effects are the result of both cell autonomous and cell non-autonomous effects.

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out either model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the observed effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "the result of both cell"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "autonomous"

Phrase: "and"

Phrase: "cell non-autonomous effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1280500:effects [Qualitative Concept]
   779 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.1: Control of hematopoietic transcription in the developing embryo

Phrase: "Control of hematopoietic transcription"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C1158770:Transcriptional Control [Genetic Function]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "in the developing embryo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013935:Embryo [Embryonic Structure]
   861   C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.1: Our data show that the co-expression of LMO-2, SCL and GATA-1 can drive ectopic erythropoiesis in the Xenopus embryo. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the co-expression of LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "can"

Phrase: "drive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "ectopic erythropoiesis in the Xenopus embryo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0014819:Erythropoiesis [Cell Function,Organ or Tissue Function]
Processing 00000000.tx.2: A model for primitive erthryopoiesis emerges in which the overlapping expression patterns of LMO-2, SCL and GATA-1 allow the formation of a transcription activating complex that drives the early blood program. 

Phrase: "A model for primitive erthryopoiesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "emerges in which"

Phrase: "the overlapping expression patterns of LMO-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449774:Patterns [Spatial Concept]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the formation of a transcription activating complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "that"

Phrase: "drives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013126:Drive [Mental Process]

Phrase: "the early blood program."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]
Processing 00000000.tx.3: The composition of these transcription complexes may differ in a cell type- and cis-element-specific context. 

Phrase: "The composition of these transcription complexes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0486616:Composition [Clinical Attribute]
   753   C1555710:composition [Idea or Concept]

Phrase: "may"

Phrase: "differ in a cell type-"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007634:Cell Type [Cell]
           Cell
   806   C0449475:cell type [Intellectual Product]
   760   C0332307:Type [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1547052:*Type [Quantitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "cis-element-specific context."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0449255:Context [Finding]
   812   C0542559:Context [Functional Concept]
Processing 00000000.tx.4: Furthermore, the composition of the complex formed on discrete DNA binding sites may lead to either induction or repression of target genes (Visvader et al., 1997; Anderson et al., 1998; Ono et al., 1998; Vyas et al., 1999; Vitelli et al., 2000; Anderson et al., 2000). 

Phrase: "Furthermore,"

Phrase: "the composition of the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0486616:Composition [Clinical Attribute]
   760   C1555710:composition [Idea or Concept]

Phrase: "formed on discrete DNA binding sites"
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
   790   C0005456:Binding Sites [Receptor]
   790   C1148673:DNA Binding [Genetic Function]
   756 E C0682969:Binding Site [Amino Acid Sequence]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205145:Sites [Spatial Concept]
   753   C0205431:Formed [Functional Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C2699782:Discrete [Qualitative Concept]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1515974:Site [Body Location or Region]
   719 E C1522492:Form [Functional Concept]
   719 E C2825164:Site [Spatial Concept]

Phrase: "may"

Phrase: "lead to either induction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "repression of target genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0920533:Gene Repression [Genetic Function]
   770   C0035143:Repression [Mental Process]

Phrase: "(Visvader et al.,"

Phrase: "1997"

Phrase: "; Anderson et al.,"

Phrase: "1998"

Phrase: "; Ono et al.,"

Phrase: "1998"

Phrase: "; Vyas et al.,"

Phrase: "1999"

Phrase: "; Vitelli et al.,"

Phrase: "2000"

Phrase: "; Anderson et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.5: The interaction of proteins in these multimeric complexes allows exquisite control of gene regulation at the transcriptional level. 

Phrase: "The interaction of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0872079:interaction protein [Molecular Function]
   770   C1704675:Interaction [Functional Concept]

Phrase: "in these multimeric complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "exquisite control of gene regulation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "at the transcriptional level."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.6: Our experiments have indicated an inductive role for the combination of LMO-2, SCL and GATA-1 in developing Xenopus embryos. 

Phrase: "Our experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "have"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "an inductive role for the combination of LMO-2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1 in developing Xenopus embryos."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1333663:GATA-1 [Gene or Genome]
   790   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0013935:Embryos [Embryonic Structure]
   753   C0043342:Xenopus [Amphibian]
   753   C0043343:Xenopus [Amphibian]
   753   C1427248:GatA [Gene or Genome]
   753   C1504663:Xenopus [Amphibian]
   719 E C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.7: It will be of interest to include other potential members of the transcription complex in this type of mRNA cocktail injection experiments. 

Phrase: "It"

Phrase: "will"

Phrase: "be of interest to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0543488:Interest [Mental Process]
   770   C2987476:Be [Conceptual Entity]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "other potential members of the transcription complex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "in this type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332307:Type [Qualitative Concept]
  1000   C1547052:*Type [Quantitative Concept]

Phrase: "of mRNA cocktail injection experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.8: For example, the LIM-binding protein Ldb1, and LMO-2 itself, have been shown to be negative regulators of the erythroid differentiation in a proerythroblast cell line (Visvader et al., 1997). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the LIM-binding protein Ldb1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1416809:LDB1 [Gene or Genome]
   812   C1416810:LDB1 [Gene or Genome]

Phrase: "and"

Phrase: "LMO-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250437:LMO-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "itself,"

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "negative regulators of the erythroid differentiation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0182953:regulators [Medical Device]
   753   C0205160:Negative [Qualitative Concept]
   753   C1513916:Negative [Finding]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   719 E C1704734:Regulator [Medical Device]
   719 E C1704735:Regulator [Conceptual Entity]

Phrase: "in a proerythroblast cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0007600:Cell Line [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:Line [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(Visvader et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.9: Inhibitory factors, such as Ldb1, FOG and pRb (Visvader et al., 1997; Deconinck et al., 2000; Vitelli et al., 2000), may counteract the blood inducing activity of LMO-2, SCL and GATA-1 and may serve to limit erythroid differentiation. 

Phrase: "Inhibitory factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "such as Ldb1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416809:LDB1 [Gene or Genome]
  1000   C1416810:LDB1 [Gene or Genome]

Phrase: "FOG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450030:Fog [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "pRb (Visvader et al.,"

Phrase: "1997"

Phrase: "; Deconinck et al.,"

Phrase: "2000"

Phrase: "; Vitelli et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "may"

Phrase: "counteract"

Phrase: "the blood inducing activity of LMO-2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "SCL"

Phrase: "and"

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "and"

Phrase: "may"

Phrase: "serve"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "limit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "erythroid differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.10: Future studies will help dissect how complex transcription factor interactions regulate the hematopoietic program in the developing vertebrate embryo.

Phrase: "Future studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "will"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "dissect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissect [Functional Concept]

Phrase: "how complex transcription factor interactions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C1704675:Interaction [Functional Concept]

Phrase: "regulate"

Phrase: "the hematopoietic program in the developing vertebrate embryo."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1709697:Program [Conceptual Entity]
   744   C2728259:Program [Pharmacologic Substance]
   744   C3484370:Program [Functional Concept]
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: ACKNOWLEDGMENTS

Phrase: "ACKNOWLEDGMENTS"
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: We thank the members of the Zon and Orkin laboratories at Childrens Hospital, Boston for insightful discussions and suggestions. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "the members of the Zon"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0680022:members [Population Group]
   726 E C2698041:Member [Professional or Occupational Group]

Phrase: "and"

Phrase: "Orkin laboratories at Childrens Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0022879:Laboratories, Hospital [Health Care Related Organization,Manufactured Object]
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]

Phrase: "Boston for insightful discussions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0006037:Boston [Geographic Area]

Phrase: "and"

Phrase: "suggestions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038659:Suggestions [Idea or Concept]
   966 E C1705535:suggestion [Idea or Concept]
Processing 00000000.tx.2: We thank Drs Clair Kelley, Eric Liao and Paul Ney for comments on the manuscript, Dr Kim for the gift of the Xenopus BMP-4 promoter reporter construct, and Dr Whitman for the AVg construct. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs Clair Kelley,"

Phrase: "Eric Liao"

Phrase: "and"

Phrase: "Paul Ney for comments"

Phrase: "on the manuscript,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "Dr Kim for the gift"

Phrase: "of the Xenopus BMP-4 promoter reporter construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "Dr Whitman for the AVg construct."
Processing 00000000.tx.3: A. 

Phrase: "A."
Processing 00000000.tx.4: E. 

Phrase: "E."
Processing 00000000.tx.5: D. was supported by a Fulbright fellowship. 

Phrase: "D."

Phrase: "was"

Phrase: "supported by a Fulbright fellowship."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0015770:Fellowship [Educational Activity]
   760   C1521721:Supported [Conceptual Entity]
   726 E C0183683:Support [Medical Device]
Processing 00000000.tx.6: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.7: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.8: O. and L. 

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.9: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.10: Z. are Investigators with the Howard Hughes Medical Institute.

Phrase: "Z."

Phrase: "are"

Phrase: "Investigators with the Howard Hughes Medical Institute."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0035173:Investigators [Professional or Occupational Group]
Processing 00000000.tx.1: &nbsp;&nbsp; 

Phrase: "&nbsp"

Phrase: ";&nbsp"

Phrase: ";"
Processing 00000000.tx.2: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: TOP

Phrase: "TOP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]
Processing 00000000.tx.1: SUMMARY

Phrase: "SUMMARY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]
Processing 00000000.tx.1: INTRODUCTION

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]
Processing 00000000.tx.1: MATERIALS AND METHODS

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.1: RESULTS

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]
Processing 00000000.tx.1: DISCUSSION

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.1: REFERENCES

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1514811:Reference [Idea or Concept]
   966   C1706462:Reference [Conceptual Entity]
Processing 00000000.tx.1: &nbsp;

Phrase: "&nbsp"

Phrase: ";"
Processing 00000000.tx.1: Anderson, K. 

Phrase: "Anderson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: P., Crable, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Crable,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: C. and Lingrel, J. 

Phrase: "C."

Phrase: "and"

Phrase: "Lingrel,"

Phrase: "J."
Processing 00000000.tx.4: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.5: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.6: Multiple proteins binding to a GATA-E box-GATA motif regulate the erythroid Kruppel-like factor (EKLF) gene. 

Phrase: "Multiple proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binding to a GATA-E box-GATA motif"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0179400:Box [Manufactured Object]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1427248:GatA [Gene or Genome]
   744   C1514562:Motif [Amino Acid Sequence]
   744   C1533124:Box [Medical Device]

Phrase: "regulate"

Phrase: "the erythroid Kruppel-like factor (EKLF) gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0017337:Gene [Gene or Genome]
   771   C0215398:erythroid Kruppel-like factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1416657:ERYTHROID KRUPPEL-LIKE FACTOR [Gene or Genome]
Processing 00000000.tx.7: J. 

Phrase: "J."
Processing 00000000.tx.8: Biol. 

Phrase: "Biol."
Processing 00000000.tx.9: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.10: 273, 14347-14354.[Abstract/Free Full&nbsp;Text]

Phrase: "273,"

Phrase: "14347-14354."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Anderson, K. 

Phrase: "Anderson,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: P., Crable, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Crable,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: C. and Lingrel, J. 

Phrase: "C."

Phrase: "and"

Phrase: "Lingrel,"

Phrase: "J."
Processing 00000000.tx.4: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.5: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.6: The GATA-E box-GATA motif in the EKLF promoter is required for in vivo expression. 

Phrase: "The GATA-E box-GATA motif in the EKLF promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1514562:Motif [Amino Acid Sequence]

Phrase: "is"

Phrase: "required for in vivo expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1515655:In Vivo [Spatial Concept]
           vivo
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1514873:Required [Functional Concept]
Processing 00000000.tx.7: Blood 95, 1652-1655.[Abstract/Free Full&nbsp;Text]

Phrase: "Blood 95,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "1652-1655."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Aplan, P. 

Phrase: "Aplan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.2: D., Begley, C. 

Phrase: "D."

Phrase: ","

Phrase: "Begley,"

Phrase: "C."
Processing 00000000.tx.3: G., Bertness, V., Nussmeier, M., Ezquerra, A., Coligan, J. and Kirsch, I. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bertness,"

Phrase: "V.,"

Phrase: "Nussmeier,"

Phrase: "M."

Phrase: ","

Phrase: "Ezquerra,"

Phrase: "A.,"

Phrase: "Coligan,"

Phrase: "J."

Phrase: "and"

Phrase: "Kirsch,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.4: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.5: (1990). 

Phrase: "(1990"

Phrase: ")."
Processing 00000000.tx.6: The SCL gene is formed from a transcriptionally complex locus. 

Phrase: "The SCL gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "formed from a transcriptionally complex locus."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0205431:Formed [Functional Concept]
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
   753   C1708726:Locus [Gene or Genome]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]
   719 E C1522492:Form [Functional Concept]
Processing 00000000.tx.7: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.8: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.9: Biol. 

Phrase: "Biol."
Processing 00000000.tx.10: 10, 6426-6435.[Medline]

Phrase: "10,"

Phrase: "6426-6435."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Begley, C. 

Phrase: "Begley,"

Phrase: "C."
Processing 00000000.tx.2: G., Aplan, P. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Aplan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.3: D., Denning, S. 

Phrase: "D."

Phrase: ","

Phrase: "Denning,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0178587:DEN [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: M., Haynes, B. 

Phrase: "M."

Phrase: ","

Phrase: "Haynes,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.5: F., Waldmann, T. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Waldmann,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.6: A. and Kirsch, I. 

Phrase: "A."

Phrase: "and"

Phrase: "Kirsch,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.7: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.8: (1989). 

Phrase: "(1989"

Phrase: ")."
Processing 00000000.tx.9: The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. 

Phrase: "The gene SCL"

Phrase: "is"

Phrase: "expressed during early hematopoiesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0018951:Haematopoiesis [Organ or Tissue Function]
   770   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a differentiation-related DNA-binding motif."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C1511662:DNA Binding Motif [Amino Acid Sequence]
   853   C3178798:DNA Motif [Nucleotide Sequence]
   840   C1148673:DNA Binding [Genetic Function]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1514562:Motif [Amino Acid Sequence]
Processing 00000000.tx.10: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.11: Natl. 

Phrase: "Natl."
Processing 00000000.tx.12: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.13: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.14: USA 86, 10128-10132.[Abstract]

Phrase: "USA 86,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "10128-10132."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Begley, C. 

Phrase: "Begley,"

Phrase: "C."
Processing 00000000.tx.2: G., Visvader, J., Green, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Visvader,"

Phrase: "J.,"

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "A."
Processing 00000000.tx.3: R., Aplan, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Aplan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.4: D., Metcalf, D., Kirsch, I. 

Phrase: "D."

Phrase: ","

Phrase: "Metcalf,"

Phrase: "D."

Phrase: ","

Phrase: "Kirsch,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.5: R. and Gough, N. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Gough,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.6: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.7: (1991). 

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.8: Molecular cloning and chromosomal localization of the murine homolog of the human helix-loop-helix gene SCL. 

Phrase: "Molecular cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009017:Cloning, Molecular [Laboratory Procedure,Molecular Biology Research Technique]
   861   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "chromosomal localization of the murine homolog"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   754   C1657114:chromosome localisation [Biologic Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "of the human helix-loop-helix gene SCL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   709   C0314604:Human gene [Gene or Genome]
Processing 00000000.tx.9: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.10: Natl. 

Phrase: "Natl."
Processing 00000000.tx.11: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.12: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.13: USA 88, 869-873.[Abstract]

Phrase: "USA 88,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "869-873."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Bernard, O., Guglielmi, P., Jonveaux, P., Cherif, D., Gisselbrecht, S., Mauchauffe, M., Berger, R., Larsen, C. 

Phrase: "Bernard,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Guglielmi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jonveaux,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cherif,"

Phrase: "D."

Phrase: ","

Phrase: "Gisselbrecht,"

Phrase: "S."

Phrase: ","

Phrase: "Mauchauffe,"

Phrase: "M."

Phrase: ","

Phrase: "Berger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Larsen,"

Phrase: "C."
Processing 00000000.tx.2: J. and Mathieu-Mahul, D. 

Phrase: "J."

Phrase: "and"

Phrase: "Mathieu-Mahul,"

Phrase: "D."
Processing 00000000.tx.3: (1990). 

Phrase: "(1990"

Phrase: ")."
Processing 00000000.tx.4: Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias. 

Phrase: "Two distinct mechanisms for the SCL gene activation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0441712:Mechanisms [Functional Concept]
   711 E C1706376:Mechanism [Manufactured Object]

Phrase: "in the t(1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";14"

Phrase: ")"

Phrase: "translocation of T-cell leukemias."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]
Processing 00000000.tx.5: Genes Chromosomes Cancer 1, 194-208.[Medline]

Phrase: "Genes Chromosomes Cancer 1,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0919437:genes cancer [Gene or Genome]
   858   C0008651:Chromosome 1 [Cell Component]
   812   C0006826:Cancer [Neoplastic Process]
   812   C0008633:Chromosomes [Cell Component]
   812   C0017337:Genes [Gene or Genome]
   812   C0998265:Cancer [Eukaryote]
   812   C1306459:Cancer [Finding]

Phrase: "194-208."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Boehm, T., Foroni, L., Kaneko, Y., Perutz, M. 

Phrase: "Boehm,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Foroni,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kaneko,"

Phrase: "Y.,"

Phrase: "Perutz,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: F. and Rabbitts, T. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Rabbitts,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.3: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: (1991). 

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.5: The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. 

Phrase: "The rhombotin family of cysteine-rich LIM-domain oncogenes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0015576:Family [Family Group]
   742   C1704727:Family [Conceptual Entity]

Phrase: ":"

Phrase: "distinct members"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680022:members [Population Group]
   827 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "involved in T-cell translocations"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0039194:T-cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0040715:Translocations [Cell or Molecular Dysfunction]
   760   C1269647:Cell [Cell]
   760   C1314939:Involved [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C2987521:Translocation [Activity]

Phrase: "to human chromosomes 11p15"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1520364:11p15 [Cell Component]
   734   C0008643:Chromosomes, Human [Cell Component]

Phrase: "and"

Phrase: "11p13."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520361:11p13 [Cell Component]
Processing 00000000.tx.6: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.7: Natl. 

Phrase: "Natl."
Processing 00000000.tx.8: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.9: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.10: USA 88, 4367-4371.[Abstract]

Phrase: "USA 88,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "4367-4371."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Chen, Q., Cheng, J. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Q.,"

Phrase: "Cheng,"

Phrase: "J."
Processing 00000000.tx.2: T., Tasi, L. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tasi,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.3: H., Schneider, N., Buchanan, G., Carroll, A., Crist, W., Ozanne, B., Siciliano, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schneider,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Buchanan,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Carroll,"

Phrase: "A.,"

Phrase: "Crist,"

Phrase: "W.,"

Phrase: "Ozanne,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Siciliano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: J. and Baer, R. 

Phrase: "J."

Phrase: "and"

Phrase: "Baer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079319:BAER [Organ or Tissue Function]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.5: (1990a). 

Phrase: "(1990a"

Phrase: ")."
Processing 00000000.tx.6: The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. 

Phrase: "The tal gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "undergoes"

Phrase: "chromosome translocation in T cell leukemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040715:Chromosome Translocation [Cell or Molecular Dysfunction]
           Translocation
   753   C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "potentially"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "a helix-loop-helix protein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0282642:helix loop helix [Spatial Concept]
Processing 00000000.tx.7: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.8: 9, 415-424.[Abstract]

Phrase: "9,"

Phrase: "415-424."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Chen, Q., Yang, C. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Q.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "C."
Processing 00000000.tx.2: Y., Tsan, J. 

Phrase: "Y.,"

Phrase: "Tsan,"

Phrase: "J."
Processing 00000000.tx.3: T., Xia, Y., Ragab, A. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Ragab,"

Phrase: "A."
Processing 00000000.tx.4: H., Peiper, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Peiper,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.5: C., Carroll, A. and Baer, R. 

Phrase: "C., Carroll,"

Phrase: "A."

Phrase: "and"

Phrase: "Baer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079319:BAER [Organ or Tissue Function]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.6: (1990b). 

Phrase: "(1990b"

Phrase: ")."
Processing 00000000.tx.7: Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia. 

Phrase: "Coding sequences of the tal-1 gene"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   748   C0009219:Coding [Occupational Activity]
   748   C0162326:Sequences [Nucleotide Sequence]
   745   C0079941:Coding Sequence [Gene or Genome]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C0805701:Code [Intellectual Product]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "are"

Phrase: "disrupted by chromosome translocation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0040715:Chromosome Translocation [Cell or Molecular Dysfunction]
           Translocation
   770   C0008633:Chromosome [Cell Component]
   770   C0332454:Disrupted [Qualitative Concept]
   770   C2987521:Translocation [Activity]

Phrase: "in human T cell leukemia."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0023493:human T cell leukemia [Neoplastic Process]
   923   C0023492:Leukemia, T-Cell [Neoplastic Process]
   875   C0427861:human cell [Laboratory or Test Result]
   861   C0039194:T-cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0023418:Leukaemia [Neoplastic Process]
   812   C0086418:Human [Human]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.8: J. 

Phrase: "J."
Processing 00000000.tx.9: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.10: Med. 

Phrase: "Med."
Processing 00000000.tx.11: 172, 1403-1408.[Abstract]

Phrase: "172,"

Phrase: "1403-1408."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Cumano, A., Dieterlen-Lievre, F. and Godin, I. 

Phrase: "Cumano,"

Phrase: "A.,"

Phrase: "Dieterlen-Lievre,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Godin,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.2: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.3: Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. 

Phrase: "Lymphoid potential,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]

Phrase: "probed before circulation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0005775:Circulation [Physiologic Function]
   790   C1516559:Circulation [Organism Function]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "in mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "is"

Phrase: "restricted to caudal intraembryonic splanchnopleura."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205097:Caudal [Body Location or Region]
   760   C0443288:Restricted [Functional Concept]
Processing 00000000.tx.4: Cell 86, 907-916.[Medline]

Phrase: "Cell 86,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "907-916."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Dale, L., Howes, G., Price, B. 

Phrase: "Dale,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Howes,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.2: M. and Smith, J. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.3: C. 

Phrase: "C."
Processing 00000000.tx.4: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.5: Bone morphogenetic protein 4: a ventralizing factor in early Xenopus development. 

Phrase: "Bone morphogenetic protein 4"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0530979:bone morphogenetic protein 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412805:BONE MORPHOGENETIC PROTEIN 4 [Gene or Genome]
   923   C0053932:Bone Morphogenetic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C2610491:bone morphogenesis [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   741   C0026559:Morphogenesis [Organism Function]
   741 E C0443157:Bony [Functional Concept]

Phrase: ":"

Phrase: "a ventralizing factor in early Xenopus development."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   774   C0960756:factor A [Organic Chemical]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.6: Development 115, 573-585.[Abstract]

Phrase: "Development 115,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "573-585."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Deconinck, A. 

Phrase: "Deconinck,"

Phrase: "A."
Processing 00000000.tx.2: E., Mead, P. 

Phrase: "E.,"

Phrase: "Mead,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678406:mead [Food]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.3: E., Tevosian, S. 

Phrase: "E.,"

Phrase: "Tevosian,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: G., Crispino, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crispino,"

Phrase: "J."
Processing 00000000.tx.5: D., Katz, S. 

Phrase: "D."

Phrase: ","

Phrase: "Katz,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.6: G., Zon, L. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Zon,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.7: I. and Orkin, S. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Orkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.8: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.9: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.10: FOG acts as a repressor of red blood cell development in Xenopus. 

Phrase: "FOG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450030:Fog [Natural Phenomenon or Process]

Phrase: "acts as a repressor of red blood cell development"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   818   C1820246:red blood cell development [Cell Function]
   790   C0014792:Red blood cell [Cell]
           Red Cell
   764   C0005773:Blood cell [Cell]
   764   C0815089:cell development [Cell Function]
   742   C0005767:Blood [Tissue]
   742   C0005768:blood [Body Substance]
   742   C0007634:Cell [Cell]
   742   C0079613:ACT [Therapeutic or Preventive Procedure]
   742   C0229664:Blood [Body Substance]
   742   C0243107:development [Physiologic Function]
   742   C0332575:Red [Finding]
   742   C0678723:Development [Organism Function]
   742   C1260956:Red [Qualitative Concept]
   742   C1269647:Cell [Cell]
   742   C1336789:Repressor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C1527148:Development [Functional Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   736 E C2328697:Hemal cell [Cell]
   720   C1160250:blood vessel development [Organ or Tissue Function]

Phrase: "in Xenopus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043342:Xenopus [Amphibian]
  1000   C0043343:Xenopus [Amphibian]
  1000   C1504663:Xenopus [Amphibian]
Processing 00000000.tx.11: Development 127, 2031-2040.[Abstract/Free Full&nbsp;Text]

Phrase: "Development 127,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "2031-2040."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Foroni, L., Boehm, T., White, L., Forster, A., Sherrington, P., Liao, X. 

Phrase: "Foroni,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Boehm,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Forster,"

Phrase: "A.,"

Phrase: "Sherrington,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Liao,"

Phrase: "X."
Processing 00000000.tx.2: B., Brannan, C. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Brannan,"

Phrase: "C."
Processing 00000000.tx.3: I., Jenkins, N. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.4: A., Copeland, N. 

Phrase: "A.,"

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.5: G. and Rabbitts, T. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Rabbitts,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.6: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.7: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.8: The rhombotin gene family encode related LIM-domain proteins whose differing expression suggests multiple roles in mouse development. 

Phrase: "The rhombotin gene family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1517488:Gene Family [Gene or Genome]
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "related LIM-domain proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1334343:LIM Domain Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "whose differing expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "multiple roles in mouse development."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.9: J. 

Phrase: "J."
Processing 00000000.tx.10: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.11: Biol. 

Phrase: "Biol."
Processing 00000000.tx.12: 226, 747-761.[Medline]

Phrase: "226,"

Phrase: "747-761."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Gering, M., Rodaway, A.R.F., Gottgens, B., Patient, R. 

Phrase: "Gering,"

Phrase: "M."

Phrase: ","

Phrase: "Rodaway,"

Phrase: "A.R.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Gottgens,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: K. and Green, A. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "A."
Processing 00000000.tx.3: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.4: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.5: The SCL gene specifies haemangioblast development from early mesoderm. 

Phrase: "The SCL gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "specifies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521902:Specify [Qualitative Concept]

Phrase: "haemangioblast development from early mesoderm."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1160281:development mesoderm [Organ or Tissue Function]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]
Processing 00000000.tx.6: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.7: 17, 4029-4045.[Abstract/Free Full&nbsp;Text]

Phrase: "17,"

Phrase: "4029-4045."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Graff, J. 

Phrase: "Graff,"

Phrase: "J."
Processing 00000000.tx.2: M., Thies, R. 

Phrase: "M."

Phrase: ","

Phrase: "Thies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1080058:thies [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: S., Song, J. 

Phrase: "S."

Phrase: ","

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.4: J., Celeste, A. 

Phrase: "J.,"

Phrase: "Celeste,"

Phrase: "A."
Processing 00000000.tx.5: J. and Melton, D. 

Phrase: "J."

Phrase: "and"

Phrase: "Melton,"

Phrase: "D."
Processing 00000000.tx.6: A. 

Phrase: "A."
Processing 00000000.tx.7: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.8: Studies with a Xenopus BMP receptor suggest that ventral mesoderm-inducing signals override dorsal signals in vivo. 

Phrase: "Studies with a Xenopus BMP receptor"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0947630:studies [Laboratory Procedure]
   719 E C0557651:Study [Manufactured Object]
   719 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ventral mesoderm-inducing signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1710082:Signal [Phenomenon or Process]

Phrase: "override"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547671:Over-ride [Activity]

Phrase: "dorsal signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.9: Cell 79, 169-179.[Medline]

Phrase: "Cell 79,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "169-179."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Grutz, G. 

Phrase: "Grutz,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.2: G., Bucher, K., Lavenir, I., Larson, T., Larson, R. and Rabbitts, T. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bucher,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lavenir,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Larson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Larson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Rabbitts,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.3: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.5: The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells. 

Phrase: "The oncogenic T cell LIM-protein Lmo2"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "part of a DNA-binding complex specifically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "in immature T cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   913   C2708700:Immature cells [Cell]
   913   C3272950:Immature Cells [Laboratory Procedure]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.6: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.7: 17, 4594-4605.[Abstract/Free Full&nbsp;Text]

Phrase: "17,"

Phrase: "4594-4605."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Harland, R. 

Phrase: "Harland,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: (1991). 

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.4: In situ hybridization: an improved whole-mount method for Xenopus embryos. 

Phrase: "In situ hybridization"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   901   C0444498:In situ [Spatial Concept]
   827   C0020202:Hybridisation [Genetic Function]
   827   C1300517:Hybridization [Laboratory Procedure]

Phrase: ":"

Phrase: "an improved whole-mount method for Xenopus embryos."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025663:Method [Intellectual Product]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.5: Methods Cell Biol. 

Phrase: "Methods Cell Biol."
Processing 00000000.tx.6: 36, 685-695.[Medline]

Phrase: "36,"

Phrase: "685-695."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Hemmati-Brivanlou, A., Frank, D., Bolce, M. 

Phrase: "Hemmati-Brivanlou,"

Phrase: "A.,"

Phrase: "Frank,"

Phrase: "D."

Phrase: ","

Phrase: "Bolce,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: E., Brown, B. 

Phrase: "E.,"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.3: D., Sive, H. 

Phrase: "D."

Phrase: ","

Phrase: "Sive,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: L. and Harland, R. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Harland,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.5: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.6: (1990a). 

Phrase: "(1990a"

Phrase: ")."
Processing 00000000.tx.7: Localization of specific mRNAs in Xenopus embryos by whole-mount in situ hybridization. 

Phrase: "Localization of specific mRNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0475264:Localisation [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "in Xenopus embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013935:Embryos [Embryonic Structure]
   827 E C1305370:Embryo [Embryonic Structure]

Phrase: "by whole-mount in situ hybridization."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   840   C0444498:In situ [Spatial Concept]
   804   C0020202:Hybridisation [Genetic Function]
   804   C1300517:Hybridization [Laboratory Procedure]
Processing 00000000.tx.8: Development 110, 325-330.[Abstract]

Phrase: "Development 110,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "325-330."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Hemmati-Brivanlou, A., Stewart, R. 

Phrase: "Hemmati-Brivanlou,"

Phrase: "A.,"

Phrase: "Stewart,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551641:Stewart [Population Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: M. and Harland, R. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Harland,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: (1990b). 

Phrase: "(1990b"

Phrase: ")."
Processing 00000000.tx.5: Region-specific neural induction of an engrailed protein by anterior notochord in Xenopus. 

Phrase: "Region-specific neural induction of an engrailed protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205263:Induction [Functional Concept]
   744   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by anterior notochord"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028439:Notochord [Embryonic Structure]
   861   C1281776:Notochord [Embryonic Structure]

Phrase: "in Xenopus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043342:Xenopus [Amphibian]
  1000   C0043343:Xenopus [Amphibian]
  1000   C1504663:Xenopus [Amphibian]
Processing 00000000.tx.6: Science 250, 800-802.[Medline]

Phrase: "Science 250,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "800-802."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Huber, T. 

Phrase: "Huber,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.2: L., Zhou, Y., Mead, P. 

Phrase: "L., Zhou,"

Phrase: "Y.,"

Phrase: "Mead,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678406:mead [Food]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.3: E. and Zon, L. 

Phrase: "E."

Phrase: "and"

Phrase: "Zon,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.4: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.5: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.6: Cooperative effects of growth factors involved in the induction of hematopoietic mesoderm. 

Phrase: "Cooperative effects of growth factors"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "involved in the induction of hematopoietic mesoderm."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0018957:Haematopoietic [Body System]
   748   C0025485:Mesoderm [Embryonic Structure]
   748   C0205263:Induction [Functional Concept]
   748   C0229601:Hematopoietic [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]
   748   C1314939:Involved [Functional Concept]
   738   C1512382:Hematopoiesis Induction [Cell Function]
Processing 00000000.tx.7: Blood 92, 4128-4137.[Abstract/Free Full&nbsp;Text]

Phrase: "Blood 92,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "4128-4137."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Jones, C. 

Phrase: "Jones,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443013:Jones [Intellectual Product]

Phrase: "C."
Processing 00000000.tx.2: M., Lyons, K. 

Phrase: "M."

Phrase: ","

Phrase: "Lyons,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.3: M., Lapan, P. 

Phrase: "M."

Phrase: ","

Phrase: "Lapan,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.4: M., Wright, C. 

Phrase: "M."

Phrase: ","

Phrase: "Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "C."
Processing 00000000.tx.5: V. and Hogan, B. 

Phrase: "V."

Phrase: "and"

Phrase: "Hogan,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.6: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.7: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.8: DVR-4 (bone morphogenetic protein-4) as a posterior-ventralizing factor in Xenopus mesoderm induction. 

Phrase: "DVR-4"

Phrase: "(bone morphogenetic protein-4"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0530979:bone morphogenetic protein 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1412805:BONE MORPHOGENETIC PROTEIN 4 [Gene or Genome]
   923   C0053932:Bone Morphogenetic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   825   C2610491:bone morphogenesis [Organism Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   741   C0026559:Morphogenesis [Organism Function]
   741 E C0443157:Bony [Functional Concept]

Phrase: ")"

Phrase: "as a posterior-ventralizing factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "in Xenopus mesoderm induction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205263:Induction [Functional Concept]
   827   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.9: Development 115, 639-647.[Abstract/Free Full&nbsp;Text]

Phrase: "Development 115,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "639-647."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Kau, C. 

Phrase: "Kau,"

Phrase: "C."
Processing 00000000.tx.2: L. and Turpen, J. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Turpen,"

Phrase: "J."
Processing 00000000.tx.3: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.4: (1983). 

Phrase: "(1983"

Phrase: ")."
Processing 00000000.tx.5: Dual contribution of embryonic ventral blood island and dorsal lateral plate mesoderm during ontogeny of hemopoietic cells in Xenopus laevis. 

Phrase: "Dual contribution of embryonic ventral blood island"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "dorsal lateral plate mesoderm during ontogeny of hemopoietic cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1284011:Lateral Plate Mesoderm [Embryonic Structure]
   762   C1284009:Dorsal Mesoderm [Embryonic Structure]
   762   C1517749:Lateral Mesoderm [Embryonic Structure]
   745   C1183499:Mesoderm Cell [Cell]
   742   C0025485:Mesoderm [Embryonic Structure]

Phrase: "in Xenopus laevis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0043343:Xenopus laevis [Amphibian]
           Xenopus
   861   C0043342:Xenopus [Amphibian]
   861   C1504663:Xenopus [Amphibian]
Processing 00000000.tx.6: J. 

Phrase: "J."
Processing 00000000.tx.7: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.8: 131, 2262-2266.[Abstract/Free Full&nbsp;Text]

Phrase: "131,"

Phrase: "2262-2266."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Kelley, C., Yee, K., Harland, R. and Zon, L. 

Phrase: "Kelley,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yee,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Harland,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Zon,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.2: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.3: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.4: Ventral expression of GATA-1 and GATA-2 in the Xenopus embryo defines induction of hematopoietic mesoderm. 

Phrase: "Ventral expression of GATA-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "GATA-2 in the Xenopus embryo"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0013935:Embryo [Embryonic Structure]
   753   C0043342:Xenopus [Amphibian]
   753   C0043343:Xenopus [Amphibian]
   753   C1305370:Embryo [Embryonic Structure]
   753   C1427248:GatA [Gene or Genome]
   753   C1504663:Xenopus [Amphibian]

Phrase: "defines"

Phrase: "induction of hematopoietic mesoderm."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1512382:Hematopoiesis Induction [Cell Function]
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.5: Dev. 

Phrase: "Dev."
Processing 00000000.tx.6: Biol. 

Phrase: "Biol."
Processing 00000000.tx.7: 165, 193-205.[Medline]

Phrase: "165,"

Phrase: "193-205."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Kim, J., Ault, K. 

Phrase: "Kim,"

Phrase: "J.,"

Phrase: "Ault,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: T., Chen, H. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.3: D., Xu, R. 

Phrase: "D."

Phrase: ","

Phrase: "Xu,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.4: H., Roh, D. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Roh,"

Phrase: "D."
Processing 00000000.tx.5: H., Lin, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.6: C., Park, M. 

Phrase: "C., Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0562547:Park [Manufactured Object]
   861   C3160718:PARK [Disease or Syndrome]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.7: J. and Kung, H. 

Phrase: "J."

Phrase: "and"

Phrase: "Kung,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.8: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.9: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.10: Transcriptional regulation of BMP-4 in the Xenopus embryo: analysis of genomic BMP-4 and its promoter. 

Phrase: "Transcriptional regulation of BMP-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1158770:Transcriptional Regulation [Genetic Function]
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in the Xenopus embryo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013935:Embryo [Embryonic Structure]
   861   C1305370:Embryo [Embryonic Structure]

Phrase: ":"

Phrase: "analysis of genomic BMP-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "its promoter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.11: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.12: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.13: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.14: Commun. 

Phrase: "Commun."
Processing 00000000.tx.15: 250, 516-530.[Medline]

Phrase: "250,"

Phrase: "516-530."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Liao, E. 

Phrase: "Liao,"

Phrase: "E."
Processing 00000000.tx.2: C., Paw, B. 

Phrase: "C., Paw,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0687080:Paw [Body Part, Organ, or Organ Component]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.3: H., Oates, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Oates,"

Phrase: "A."
Processing 00000000.tx.4: C., Pratt, S. 

Phrase: "C., Pratt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.5: J., Postlethwait, J. 

Phrase: "J.,"

Phrase: "Postlethwait,"

Phrase: "J."
Processing 00000000.tx.6: H. and Zon, L. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Zon,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.7: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.8: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.9: SCL/Tal-1 transcription factor acts downstream of cloche to specify hematopoietic and vascular progenitors in zebrafish. 

Phrase: "SCL/Tal-1 transcription factor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   911   C0378781:SCL Transcription Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0040649:Transcription [Genetic Function]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "acts downstream of cloche to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0522506:Downstream [Spatial Concept]

Phrase: "specify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521902:Specify [Qualitative Concept]

Phrase: "hematopoietic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018957:Haematopoietic [Body System]
  1000   C0229601:Hematopoietic [Functional Concept]
   928 E C0018951:Haematopoiesis [Organ or Tissue Function]

Phrase: "and"

Phrase: "vascular progenitors in zebrafish."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0870134:Progenitor [Family Group]
Processing 00000000.tx.10: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.11: 12, 621-626.[Abstract/Free Full&nbsp;Text]

Phrase: "12,"

Phrase: "621-626."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Maeno, M., Ong, R. 

Phrase: "Maeno,"

Phrase: "M."

Phrase: ","

Phrase: "Ong,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: C., Suzuki, A., Ueno, N. and Kung, H. 

Phrase: "C., Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0998924:suzuki [Fish]

Phrase: "A.,"

Phrase: "Ueno,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Kung,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.3: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.4: (1994a). 

Phrase: "(1994a"

Phrase: ")."
Processing 00000000.tx.5: A truncated bone morphogenetic protein 4 receptor alters the fate of ventral mesoderm to dorsal mesoderm: roles of animal pole tissue in the development of ventral mesoderm. 

Phrase: "A truncated bone morphogenetic protein 4 receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   839   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   734   C0530979:bone morphogenetic protein 4 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1412805:BONE MORPHOGENETIC PROTEIN 4 [Gene or Genome]

Phrase: "alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the fate of ventral mesoderm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1539479:FATE [Gene or Genome]

Phrase: "to dorsal mesoderm"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1284009:Dorsal Mesoderm [Embryonic Structure]
   861   C0025485:Mesoderm [Embryonic Structure]
   789 E C0521459:Mesodermal [Body Location or Region]

Phrase: ":"

Phrase: "roles of animal pole tissue"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0035820:Roles [Social Behavior]
   726 E C1705810:Role [Conceptual Entity]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of ventral mesoderm."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025485:Mesoderm [Embryonic Structure]
   789 E C0521459:Mesodermal [Body Location or Region]
Processing 00000000.tx.6: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.7: Natl. 

Phrase: "Natl."
Processing 00000000.tx.8: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.9: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.10: USA 91, 10260-10264.[Abstract/Free Full&nbsp;Text]

Phrase: "USA 91,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "10260-10264."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Maeno, M., Ong, R. 

Phrase: "Maeno,"

Phrase: "M."

Phrase: ","

Phrase: "Ong,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: C., Xue, Y., Nishimatsu, S., Ueno, N. and Kung, H. 

Phrase: "C., Xue,"

Phrase: "Y.,"

Phrase: "Nishimatsu,"

Phrase: "S."

Phrase: ","

Phrase: "Ueno,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Kung,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.3: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.4: (1994b). 

Phrase: "(1994b"

Phrase: ")."
Processing 00000000.tx.5: Regulation of primary erythropoiesis in the ventral mesoderm of Xenopus gastrula embryo: evidence for the expression of a stimulatory factor(s) in animal pole tissue. 

Phrase: "Regulation of primary erythropoiesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "in the ventral mesoderm"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025485:Mesoderm [Embryonic Structure]
   789 E C0521459:Mesodermal [Body Location or Region]

Phrase: "of Xenopus gastrula embryo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013935:Embryo [Embryonic Structure]
   827   C1305370:Embryo [Embryonic Structure]

Phrase: ":"

Phrase: "evidence for the expression of a stimulatory factor(s"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: ")"

Phrase: "in animal pole tissue."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0229982:Animal tissue [Tissue]
   827   C0040300:Tissue [Tissue]
   827   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.6: Dev. 

Phrase: "Dev."
Processing 00000000.tx.7: Biol. 

Phrase: "Biol."
Processing 00000000.tx.8: 161, 522-529.[Medline]

Phrase: "161,"

Phrase: "522-529."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Maeno, M., Mead, P. 

Phrase: "Maeno,"

Phrase: "M."

Phrase: ","

Phrase: "Mead,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678406:mead [Food]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.2: E., Kelley, C., Xu, R. 

Phrase: "E.,"

Phrase: "Kelley,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Xu,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: H., Kung, H. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kung,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: F., Suzuki, A., Ueno, N. and Zon, L. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "A.,"

Phrase: "Ueno,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Zon,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.5: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.6: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.7: The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic mesoderm in Xenopus laevis. 

Phrase: "The role of BMP-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "GATA-2 in the induction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]
   760   C1427248:GatA [Gene or Genome]

Phrase: "and"

Phrase: "differentiation of hematopoietic mesoderm"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1708983:Mesodermal Differentiation [Finding]
   770   C0007589:Differentiation [Cell Function]
   770   C1511938:Differentiation [Clinical Attribute]
   770   C2945687:Differentiation [Functional Concept]

Phrase: "in Xenopus laevis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0043343:Xenopus laevis [Amphibian]
           Xenopus
   861   C0043342:Xenopus [Amphibian]
   861   C1504663:Xenopus [Amphibian]
Processing 00000000.tx.8: Blood 88, 1965-1972.[Abstract/Free Full&nbsp;Text]

Phrase: "Blood 88,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "1965-1972."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Mead, P. 

Phrase: "Mead,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678406:mead [Food]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.2: E., Kelley, C. 

Phrase: "E.,"

Phrase: "Kelley,"

Phrase: "C."
Processing 00000000.tx.3: M., Hahn, P. 

Phrase: "M."

Phrase: ","

Phrase: "Hahn,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.4: S., Piedad, O. and Zon, L. 

Phrase: "S."

Phrase: ","

Phrase: "Piedad,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "Zon,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.5: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.6: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.7: SCL specifies hematopoietic mesoderm in Xenopus embryos. 

Phrase: "SCL"

Phrase: "specifies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521902:Specify [Qualitative Concept]

Phrase: "hematopoietic mesoderm in Xenopus embryos."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0025485:Mesoderm [Embryonic Structure]
Processing 00000000.tx.8: Development 125, 2611-2620.[Abstract/Free Full&nbsp;Text]

Phrase: "Development 125,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "2611-2620."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Medvinsky, A. and Dzierzak, E. 

Phrase: "Medvinsky,"

Phrase: "A."

Phrase: "and"

Phrase: "Dzierzak,"

Phrase: "E."
Processing 00000000.tx.2: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.3: Definitive hematopoiesis is autonomously initiated by the AGM region. 

Phrase: "Definitive hematopoiesis"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C2262993:definitive haematopoiesis [Cell Function]
   861   C0018951:Haematopoiesis [Organ or Tissue Function]
   789 E C0018957:Haematopoietic [Body System]
   789 E C0229601:Hematopoietic [Functional Concept]

Phrase: "is"

Phrase: "autonomously"

Phrase: "initiated by the AGM region."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C1415932:AGM [Gene or Genome]
   726   C1548602:Initiate [Idea or Concept]
   726   C1704686:Initiate [Functional Concept]
Processing 00000000.tx.4: Cell 86, 897-906.[Medline]

Phrase: "Cell 86,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "897-906."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Metz, A., Knochel, S., Buchler, P., Koster, M. and Knochel, W. 

Phrase: "Metz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332083:Metz [Health Care Related Organization]

Phrase: "A.,"

Phrase: "Knochel,"

Phrase: "S."

Phrase: ","

Phrase: "Buchler,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Koster,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Knochel,"

Phrase: "W."
Processing 00000000.tx.2: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.3: Structural and functional analysis of the BMP-4 promoter in early embryos of Xenopus laevis. 

Phrase: "Structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "functional analysis of the BMP-4 promoter"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0558024:Functional analysis [Health Care Activity]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "in early embryos"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013935:Embryos [Embryonic Structure]
   827 E C1305370:Embryo [Embryonic Structure]

Phrase: "of Xenopus laevis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0043343:Xenopus laevis [Amphibian]
           Xenopus
   861   C0043342:Xenopus [Amphibian]
   861   C1504663:Xenopus [Amphibian]
Processing 00000000.tx.4: Mech. 

Phrase: "Mech."
Processing 00000000.tx.5: Dev. 

Phrase: "Dev."
Processing 00000000.tx.6: 74, 29-39.[Medline]

Phrase: "74,"

Phrase: "29-39."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Nieuwkoop, P. 

Phrase: "Nieuwkoop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.2: D. and Faber, J. 

Phrase: "D."

Phrase: "and"

Phrase: "Faber,"

Phrase: "J."
Processing 00000000.tx.3: (1967) Normal Table of Xenopus laevis (Daudin). 

Phrase: "(1967"

Phrase: ")"

Phrase: "Normal Table of Xenopus laevis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0039224:Table [Manufactured Object]
   760   C1706073:Table [Medical Device]
   760   C1706074:Table [Intellectual Product]

Phrase: "(Daudin"

Phrase: ")."
Processing 00000000.tx.4: Amsterdam: North Holland.

Phrase: "Amsterdam"

Phrase: ":"

Phrase: "North Holland."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027778:Holland [Geographic Area]
Processing 00000000.tx.1: Ono, Y., Fukuhara, N. and Yoshie, O. 

Phrase: "Ono,"

Phrase: "Y.,"

Phrase: "Fukuhara,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Yoshie,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.2: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.3: TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. 

Phrase: "TAL1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0378781:TAL1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796355:TAL1 [Gene or Genome]

Phrase: "and"

Phrase: "LIM-only proteins synergistically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by acting"

Phrase: "as"

Phrase: "cofactors for GATA3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0178555:cofactors [Biologically Active Substance]
Processing 00000000.tx.4: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.5: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.6: Biol. 

Phrase: "Biol."
Processing 00000000.tx.7: 18, 6939-6950.[Abstract/Free Full&nbsp;Text]

Phrase: "18,"

Phrase: "6939-6950."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Pevny, L., Simon, M. 

Phrase: "Pevny,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Simon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:Simon [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: C., Robertson, E., Klein, W. 

Phrase: "C., Robertson,"

Phrase: "E.,"

Phrase: "Klein,"

Phrase: "W."
Processing 00000000.tx.3: H., Tsai, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tsai,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: F., DAgati, V., Orkin, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "DAgati,"

Phrase: "V.,"

Phrase: "Orkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.5: H. and Costantini, F. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Costantini,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.6: (1991). 

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.7: Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. 

Phrase: "Erythroid differentiation in chimaeric mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]

Phrase: "blocked by a targeted mutation"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0079870:Targeted Mutation [Genetic Function]
   760   C0026882:Mutation [Genetic Function]
   760   C0028778:Blocked [Pathologic Function]
   760   C0332206:Blocked [Functional Concept]
   760   C1521840:Targeted [Functional Concept]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
   760   C2983591:BLOCKED [Research Activity]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
   726 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "in the gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "for transcription factor GATA-1."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0209278:Transcription Factor 1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1420631:TRANSCRIPTION FACTOR 1 [Gene or Genome]
   861   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1333663:GATA-1 [Gene or Genome]
   861   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   812   C1427248:GatA [Gene or Genome]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.8: Nature 349, 257-260.[Medline]

Phrase: "Nature 349,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "257-260."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Porcher, C., Swat, W., Rockwell, K., Fujiwara, Y., Alt, F. 

Phrase: "Porcher,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Swat,"

Phrase: "W.,"

Phrase: "Rockwell,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Fujiwara,"

Phrase: "Y.,"

Phrase: "Alt,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.2: W. and Orkin, S. 

Phrase: "W."

Phrase: "and"

Phrase: "Orkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.5: The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. 

Phrase: "The T cell leukemia oncoprotein SCL/tal-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   845   C0023492:Leukemia, T-Cell [Neoplastic Process]
   818   C0039194:T-cell [Cell]
   818   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0007634:Cell [Cell]
   795   C0023418:Leukaemia [Neoplastic Process]
   795   C0029005:Oncoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1269647:Cell [Cell]
   795   C1428449:TAL [Gene or Genome]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "essential for development of all hematopoietic lineages."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.6: Cell 86, 47-57.[Medline]

Phrase: "Cell 86,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "47-57."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Porcher, C., Liao, E. 

Phrase: "Porcher,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Liao,"

Phrase: "E."
Processing 00000000.tx.2: C., Fujiwara, Y., Zon, L. 

Phrase: "C., Fujiwara,"

Phrase: "Y.,"

Phrase: "Zon,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.3: I. and Orkin, S. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Orkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.5: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.6: Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. 

Phrase: "Specification of hematopoietic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348235:Specification [Conceptual Entity]

Phrase: "and"

Phrase: "vascular development by the bHLH transcription factor SCL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]
   743   C1160250:blood vessel development [Organ or Tissue Function]

Phrase: "without direct DNA binding."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1148673:DNA Binding [Genetic Function]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
Processing 00000000.tx.7: Development 126, 4603-4615.[Abstract/Free Full&nbsp;Text]

Phrase: "Development 126,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "4603-4615."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Robb, L., Lyons, I., Li, R., Hartley, L., Kontgen, F., Harvey, R. 

Phrase: "Robb,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Lyons,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hartley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324525:Hartley [Mammal]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kontgen,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Harvey,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: P., Metcalf, D. and Begley, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Metcalf,"

Phrase: "D."

Phrase: "and"

Phrase: "Begley,"

Phrase: "C."
Processing 00000000.tx.3: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.4: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.5: Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. 

Phrase: "Absence of yolk sac hematopoiesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "from mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "with a targeted disruption"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332453:Disruption [Functional Concept]

Phrase: "of the scl gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.6: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.7: Natl. 

Phrase: "Natl."
Processing 00000000.tx.8: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.9: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.10: USA 92, 7075-7709.[Abstract]

Phrase: "USA 92,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "7075-7709."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Royer-Pokora, B., Loos, U. and Ludwig, W. 

Phrase: "Royer-Pokora,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Loos,"

Phrase: "U."

Phrase: "and"

Phrase: "Ludwig,"

Phrase: "W."
Processing 00000000.tx.2: D. 

Phrase: "D."
Processing 00000000.tx.3: (1991). 

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.4: TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). 

Phrase: "TTG-2,"

Phrase: "a new gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "a cysteine-rich protein with the LIM motif,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0599731:cysteine rich protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1413766:CYSTEINE-RICH PROTEIN [Gene or Genome]
   800   C1420342:cysteine-rich protein [Gene or Genome]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C0752190:Protein Motif [Spatial Concept]
   767   C1514562:Protein Motif [Amino Acid Sequence]
   744   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0699759:Rich [Qualitative Concept]

Phrase: "is"

Phrase: "overexpressed in acute T-cell leukaemia"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   882   C1961099:T-Cell Leukemia, Acute [Neoplastic Process]
   851 E C0023493:t cell acute leukemia [Neoplastic Process]
   833   C0023492:Leukemia, T-Cell [Neoplastic Process]
   790   C0039194:T-cell [Cell]
   783   C0085669:Acute leukaemia [Neoplastic Process]
   783   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   753   C0007634:Cell [Cell]
   753   C0023418:Leukaemia [Neoplastic Process]
   753   C0205178:acute [Temporal Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   748   C1517806:Leukemic Cell [Cell]
   719   C1514559:overexpress [Genetic Function]

Phrase: "with the t(11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: ";14"

Phrase: ")"

Phrase: "(p13"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334535:p13 [Gene or Genome]
  1000   C1424876:p13 [Gene or Genome]
  1000   C3470427:p13 [Gene or Genome]

Phrase: ";q11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549863:Q11 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.5: Oncogene 6, 1887-1893.[Medline]

Phrase: "Oncogene 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "1887-1893."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Shivdasani, R. 

Phrase: "Shivdasani,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: A., Mayer, E. 

Phrase: "A.,"

Phrase: "Mayer,"

Phrase: "E."
Processing 00000000.tx.3: L. and Orkin, S. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Orkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.5: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.6: Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. 

Phrase: "Absence of blood formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the T-cell leukaemia oncoprotein tal-1/SCL."
Processing 00000000.tx.7: Nature 373, 432-434.[Medline]

Phrase: "Nature 373,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "432-434."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Smith, W. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "W."
Processing 00000000.tx.2: C. and Harland, R. 

Phrase: "C."

Phrase: "and"

Phrase: "Harland,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.3: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: (1992). 

Phrase: "(1992"

Phrase: ")."
Processing 00000000.tx.5: Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. 

Phrase: "Expression cloning of noggin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0599958:expression cloning [Molecular Biology Research Technique]
   770   C0009015:Cloning [Research Activity]

Phrase: "a new dorsalizing factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "localized to the Spemann organizer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0752269:Spemann Organizer [Embryonic Structure]
   760   C0392752:Localized [Spatial Concept]
   760   C2609570:ORGANIZER [Medical Device]

Phrase: "in Xenopus embryos."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013935:Embryos [Embryonic Structure]
   827 E C1305370:Embryo [Embryonic Structure]
Processing 00000000.tx.6: Cell 70, 829-840.[Medline]

Phrase: "Cell 70,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "829-840."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Suzuki, A., Thies, R. 

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "A.,"

Phrase: "Thies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1080058:thies [Eukaryote]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.2: S., Yamaji, N., Song, J. 

Phrase: "S."

Phrase: ","

Phrase: "Yamaji,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.3: J., Wozney, J. 

Phrase: "J.,"

Phrase: "Wozney,"

Phrase: "J."
Processing 00000000.tx.4: M., Murakami, K. and Ueno, N. 

Phrase: "M."

Phrase: ","

Phrase: "Murakami,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ueno,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.5: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.6: A truncated bone morphogenetic protein receptor affects dorsal-ventral patterning in the early Xenopus embryo. 

Phrase: "A truncated bone morphogenetic protein receptor"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   884   C0053932:Bone Morphogenetic Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   804   C0391978:Bone [Tissue]
   804   C1266908:Bone [Body Part, Organ, or Organ Component]
   804   C1266909:Bone [Body System]
   804   C2610491:bone morphogenesis [Organism Function]
   733   C0026559:Morphogenesis [Organism Function]
   733 E C0443157:Bony [Functional Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "dorsal-ventral patterning in the early Xenopus embryo."
Processing 00000000.tx.7: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.8: Natl. 

Phrase: "Natl."
Processing 00000000.tx.9: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.10: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.11: USA 91, 10255-10259.[Abstract/Free Full&nbsp;Text]

Phrase: "USA 91,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "10255-10259."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Thompson, M. 

Phrase: "Thompson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: A., Ransom, D. 

Phrase: "A.,"

Phrase: "Ransom,"

Phrase: "D."
Processing 00000000.tx.3: G., Pratt, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Pratt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: J., MacLennan, H., Kieran, M. 

Phrase: "J.,"

Phrase: "MacLennan,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kieran,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.5: W., Detrich, H. 

Phrase: "W., Detrich,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.6: W., 3rd, Vail, B., Huber, T. 

Phrase: "W., 3rd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205437:3rd [Quantitative Concept]

Phrase: "Vail,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Huber,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.7: L., Paw, B., Brownlie, A. 

Phrase: "L., Paw,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0687080:Paw [Body Part, Organ, or Organ Component]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Brownlie,"

Phrase: "A."
Processing 00000000.tx.8: J. et al. 

Phrase: "J. et al."
Processing 00000000.tx.9: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.10: The cloche and spadetail genes differentially affect hematopoiesis and vasculogenesis. 

Phrase: "The cloche"

Phrase: "and"

Phrase: "spadetail genes differentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Genes [Gene or Genome]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "hematopoiesis"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0018951:Haematopoiesis [Organ or Tissue Function]
   928 E C0018957:Haematopoietic [Body System]
   928 E C0229601:Hematopoietic [Functional Concept]

Phrase: "and"

Phrase: "vasculogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1123009:vasculogenesis [Organ or Tissue Function]
Processing 00000000.tx.11: Dev Biol 197, 248-69.[Medline]

Phrase: "Dev Biol 197,"

Phrase: "248-69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Tsai, F. 

Phrase: "Tsai,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.2: Y., Keller, G., Kuo, F. 

Phrase: "Y.,"

Phrase: "Keller,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kuo,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.3: C., Weiss, M., Chen, J., Rosenblatt, M., Alt, F. 

Phrase: "C., Weiss,"

Phrase: "M."

Phrase: ","

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "J.,"

Phrase: "Rosenblatt,"

Phrase: "M."

Phrase: ","

Phrase: "Alt,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.4: W. and Orkin, S. 

Phrase: "W."

Phrase: "and"

Phrase: "Orkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.5: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.6: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.7: An early haematopoietic defect in mice lacking the transcription factor GATA-2. 

Phrase: "An early haematopoietic defect in mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1457869:Defect [Functional Concept]
   753   C1861101:DEFECT [Disease or Syndrome]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "the transcription factor GATA-2."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0118890:Transcription Factor GATA-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0126037:Transcription Factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C1420636:TRANSCRIPTION FACTOR 2 [Gene or Genome]
   861   C0040648:TRANSCRIPTION FACTOR [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0040649:Transcription [Genetic Function]
   812   C1427248:GatA [Gene or Genome]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.8: Nature 371, 221-226.[Medline]

Phrase: "Nature 371,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "221-226."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Visvader, J., Begley, C. 

Phrase: "Visvader,"

Phrase: "J.,"

Phrase: "Begley,"

Phrase: "C."
Processing 00000000.tx.2: G. and Adams, J. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "J."
Processing 00000000.tx.3: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: (1991). 

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.5: Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. 

Phrase: "Differential expression of the LYL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "SCL"

Phrase: "and"

Phrase: "E2A helix-loop-helix genes within the hemopoietic system."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0017337:Genes [Gene or Genome]
Processing 00000000.tx.6: Oncogene 6, 187-194.[Medline]

Phrase: "Oncogene 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "187-194."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Visvader, J. 

Phrase: "Visvader,"

Phrase: "J."
Processing 00000000.tx.2: E., Mao, X., Fujiwara, Y., Hahm, K. and Orkin, S. 

Phrase: "E.,"

Phrase: "Mao,"

Phrase: "X.,"

Phrase: "Fujiwara,"

Phrase: "Y.,"

Phrase: "Hahm,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Orkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.5: The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. 

Phrase: "The LIM-domain binding protein Ldb1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1416809:LDB1 [Gene or Genome]
   804   C1416810:LDB1 [Gene or Genome]
   722   C1334343:LIM Domain Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C1149345:LIM domain binding [Molecular Function]

Phrase: "and"

Phrase: "its partner LMO2"

Phrase: "act as negative regulators of erythroid differentiation."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   748   C0007589:Differentiation [Cell Function]
   748   C0079613:ACT [Therapeutic or Preventive Procedure]
   748   C0182953:regulators [Medical Device]
   748   C0205160:Negative [Qualitative Concept]
   748   C1511938:Differentiation [Clinical Attribute]
   748   C1513916:Negative [Finding]
   748   C1516960:Erythroid [Qualitative Concept]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]
   748   C2945687:Differentiation [Functional Concept]
   714 E C1704734:Regulator [Medical Device]
   714 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.6: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.7: Natl. 

Phrase: "Natl."
Processing 00000000.tx.8: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.9: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.10: USA 94, 13707-13712.[Abstract/Free Full&nbsp;Text]

Phrase: "USA 94,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "13707-13712."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Visvader, J. 

Phrase: "Visvader,"

Phrase: "J."
Processing 00000000.tx.2: E., Fujiwara, Y. and Orkin, S. 

Phrase: "E.,"

Phrase: "Fujiwara,"

Phrase: "Y."

Phrase: "and"

Phrase: "Orkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.3: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.5: Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. 

Phrase: "Unsuspected role for the T-cell leukemia protein SCL/tal-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "in vascular development."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   972   C1160250:blood vessel development [Organ or Tissue Function]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]
Processing 00000000.tx.6: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.7: 12, 473-479.[Abstract/Free Full&nbsp;Text]

Phrase: "12,"

Phrase: "473-479."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Vitelli, L., Condorelli, G., Lulli, V., Hoang, T., Luchetti, L., Croce, C. 

Phrase: "Vitelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Condorelli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lulli,"

Phrase: "V.,"

Phrase: "Hoang,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Luchetti,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Croce,"

Phrase: "C."
Processing 00000000.tx.2: M. and Peschle, C. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Peschle,"

Phrase: "C."
Processing 00000000.tx.3: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.4: A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts. 

Phrase: "A pentamer transcriptional complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "tal-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0378781:TAL-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1428449:TAL [Gene or Genome]

Phrase: "and"

Phrase: "retinoblastoma protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0080113:Retinoblastoma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "downmodulates"

Phrase: "c-kit expression in normal erythroblasts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.5: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.6: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.7: Biol. 

Phrase: "Biol."
Processing 00000000.tx.8: 20, 5330-5342.[Abstract/Free Full&nbsp;Text]

Phrase: "20,"

Phrase: "5330-5342."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Vyas, P., McDevitt, M. 

Phrase: "Vyas,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "McDevitt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: A., Cantor, A. 

Phrase: "A.,"

Phrase: "Cantor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0108263:Cantor [Organic Chemical,Pharmacologic Substance]

Phrase: "A."
Processing 00000000.tx.3: B., Katz, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Katz,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.4: G., Fujiwara, Y. and Orkin, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Fujiwara,"

Phrase: "Y."

Phrase: "and"

Phrase: "Orkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.5: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.6: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.7: Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. 

Phrase: "Different sequence requirements for expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1514873:Requirement [Functional Concept]

Phrase: "in erythroid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516960:Erythroid [Qualitative Concept]

Phrase: "and"

Phrase: "megakaryocytic cells within a regulatory element"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C1268010:Megakaryocytic cell [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "upstream of the GATA-1 gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C1333663:GATA-1 [Gene or Genome]
   734   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.8: Development 126, 2799-2811.[Abstract/Free Full&nbsp;Text]

Phrase: "Development 126,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "2799-2811."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Wadman, I. 

Phrase: "Wadman,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.2: A., Osada, H., Grutz, G. 

Phrase: "A.,"

Phrase: "Osada,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Grutz,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.3: G., Agulnick, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Agulnick,"

Phrase: "A."
Processing 00000000.tx.4: D., Westphal, H., Forster, A. and Rabbitts, T. 

Phrase: "D."

Phrase: ","

Phrase: "Westphal,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Forster,"

Phrase: "A."

Phrase: "and"

Phrase: "Rabbitts,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.5: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.6: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.7: The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. 

Phrase: "The LIM-only protein Lmo2"

Phrase: "is"

Phrase: "a bridging molecule assembling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706853:Assemble [Activity]

Phrase: "an erythroid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516960:Erythroid [Qualitative Concept]

Phrase: "DNA-binding complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1148673:DNA Binding [Genetic Function]
   827   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0243122:binding [Functional Concept]
   827   C0439855:Complex [Qualitative Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the TAL1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0378781:TAL1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796355:TAL1 [Gene or Genome]

Phrase: "E47,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1336596:E47 [Gene or Genome]

Phrase: "GATA-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1333663:GATA-1 [Gene or Genome]
  1000   C1530719:GATA-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1427248:GatA [Gene or Genome]

Phrase: "and"

Phrase: "Ldb1/NLI proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.8: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.9: 16, 3145-3157.[Abstract/Free Full&nbsp;Text]

Phrase: "16,"

Phrase: "3145-3157."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Walmsley, M. 

Phrase: "Walmsley,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: E., Guille, M. 

Phrase: "E.,"

Phrase: "Guille,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: J., Bertwistle, D., Smith, J. 

Phrase: "J.,"

Phrase: "Bertwistle,"

Phrase: "D."

Phrase: ","

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.4: C., Pizzey, J. 

Phrase: "C., Pizzey,"

Phrase: "J."
Processing 00000000.tx.5: A. and Patient, R. 

Phrase: "A."

Phrase: "and"

Phrase: "Patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.6: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.7: (1994). 

Phrase: "(1994"

Phrase: ")."
Processing 00000000.tx.8: Negative control of Xenopus GATA-2 by activin and noggin with eventual expression in precursors of the ventral blood islands. 

Phrase: "Negative control of Xenopus GATA-2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1639518:% negative control [Quantitative Concept]
   790   C1947986:Negative Control [Conceptual Entity]
   753   C0205160:Negative [Qualitative Concept]
   753   C0243148:control [Qualitative Concept]
   753   C1513916:Negative [Finding]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "by activin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0050668:Activin [Amino Acid, Peptide, or Protein,Hormone]
  1000   C1135154:ActiVin [Organic Chemical,Pharmacologic Substance]
  1000   C1149454:activin [Molecular Function]
  1000   C1522182:Activin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "noggin with eventual expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1417753:noggin [Gene or Genome]

Phrase: "in precursors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1709634:Precursor [Idea or Concept]

Phrase: "of the ventral blood islands."
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   867   C1511224:Blood Island [Embryonic Structure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0022130:Islands [Geographic Area]
   827   C0229664:Blood [Body Substance]
   827   C1704448:Ventral [Spatial Concept]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.9: Development 120, 2519-2529.[Abstract/Free Full&nbsp;Text]

Phrase: "Development 120,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "2519-2529."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Yamada, Y., Warren, A. 

Phrase: "Yamada,"

Phrase: "Y.,"

Phrase: "Warren,"

Phrase: "A."
Processing 00000000.tx.2: J., Dobson, C., Forster, A., Pannell, R. and Rabbitts, T. 

Phrase: "J.,"

Phrase: "Dobson,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Forster,"

Phrase: "A.,"

Phrase: "Pannell,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Rabbitts,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.3: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.4: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.5: The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. 

Phrase: "The T cell leukemia LIM protein Lmo2"

Phrase: "is"

Phrase: "necessary for adult mouse hematopoiesis."
Processing 00000000.tx.6: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.7: Natl. 

Phrase: "Natl."
Processing 00000000.tx.8: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.9: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.10: USA 95, 3890-3895.[Abstract/Free Full&nbsp;Text]

Phrase: "USA 95,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "3890-3895."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Zhang, C. and Evans, T. 

Phrase: "Zhang,"

Phrase: "C."

Phrase: "and"

Phrase: "Evans,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.2: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.3: BMP-like signals are required after the midblastula transition for blood cell development. 

Phrase: "BMP-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0053932:BMP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0279266:BMP [Therapeutic or Preventive Procedure]

Phrase: "like signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "required after the midblastula transition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0599156:Transition [Cell or Molecular Dysfunction]
   760   C1514873:Required [Functional Concept]
   760   C2700061:Transition [Activity]

Phrase: "for blood cell development."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0815089:cell development [Cell Function]
   871   C1160250:blood vessel development [Organ or Tissue Function]
   827   C0243107:development [Physiologic Function]
   827   C0678723:Development [Organism Function]
   827   C1527148:Development [Functional Concept]
   755 E C0458003:Developmental [Qualitative Concept]
   734   C0005773:Blood cell [Cell]
   706 E C2328697:Hemal cell [Cell]
Processing 00000000.tx.4: Dev. 

Phrase: "Dev."
Processing 00000000.tx.5: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.6: 18, 267-278.[Medline]

Phrase: "18,"

Phrase: "267-278."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"
Processing 00000000.tx.1: Zon, L. 

Phrase: "Zon,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.2: I., Mather, C., Burgess, S., Bolce, M. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mather,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Burgess,"

Phrase: "S."

Phrase: ","

Phrase: "Bolce,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.3: E., Harland, R. 

Phrase: "E.,"

Phrase: "Harland,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.4: M. and Orkin, S. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Orkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.5: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.6: (1991). 

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.7: Expression of GATA-binding proteins during embryonic development in Xenopus laevis. 

Phrase: "Expression of GATA-binding proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "during embryonic development"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0013936:Embryonic Development [Organ or Tissue Function]
  1000   C0243100:embryonic development [Functional Concept]
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "in Xenopus laevis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0043343:Xenopus laevis [Amphibian]
           Xenopus
   861   C0043342:Xenopus [Amphibian]
   861   C1504663:Xenopus [Amphibian]
Processing 00000000.tx.8: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.9: Natl. 

Phrase: "Natl."
Processing 00000000.tx.10: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.11: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.12: USA 88, 10642-10646.[Abstract]

Phrase: "USA 88,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "10642-10646."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"
Processing 00000000.tx.1: Zon, L. 

Phrase: "Zon,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.2: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.3: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.4: Developmental biology of hematopoiesis. 

Phrase: "Developmental biology of hematopoiesis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0011756:Developmental Biology [Occupation or Discipline]
   770   C0005532:Biology [Biomedical Occupation or Discipline]
   748 E C0678723:Biologic Development [Organism Function]
Processing 00000000.tx.5: Blood 86, 2876-2891.[Abstract/Free Full&nbsp;Text]

Phrase: "Blood 86,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "2876-2891."

Phrase: "[Abstract/Free Full&nbsp"

Phrase: ";Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1527021:Text [Intellectual Product]
  1000   C1554111:Text [Idea or Concept]
  1000   C1705606:Text [Intellectual Product]
  1000   C3541382:Text [Intellectual Product]

Phrase: "]"

